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Research Summary 
 
This dissertation describes the characterization of photochromic ligands and 
photopharmacological approaches for vision restoration approaches.  
 
BACKGROUND 
Photochromic ligands (PCLs) are small, freely diffusible molecules, which contain a 
photoswitchable moiety (azobenzene) and a pharmacophore. The pharmacophore is a 
functional group, such as a potassium channel blocker (triethyl ammonium) or glutamate. 
The azobenzene can exist in two different states, the thermodynamically stable trans-
configuration or the less-stable cis-configuration. Illumination with specific wavelengths 
induces a change in the configuration of the PCL. Classic PCLs need shorter wavelengths 
for switching from trans- to cis- and longer wavelengths for switching from cis- to trans-
configuration. In addition, azobenzenes can also relax back to trans thermally within 
milliseconds or days, depending on the substituents. By changing the configuration with 
light, the affinity of the PCL towards its target receptor is changed. Thereby, neural activity 
can be controlled by toggling between the two states (Figure 1). A great advantage of PCLs 
is that they can be actively switched off using light in contrast to the diffusion -limited off-
kinetics of caged ligands. 
The photopharmacological approach has been widely used not only for light -control of 
voltage-dependent ion channels, ionotropic glutamate receptors and GPCRs, but also for 
TRP-channels and even enzymes (Fehrentz et al. 2011, Broichhagen et al. 2014b, 
Schonberger and Trauner 2014, Stawski et al. 2012, Broichhagen et al. 2014a) . 
 
TOPICS 
This work covers four main topics. Parts 1-3 describe the use of PCL for vision 
restoration approaches, whereas basic characteristics of PCLs are investigated in part 4.  
In the first part the photochromic potassium channel blocker diethylamine-
azobenzene-diethylamine (DAD) is described for the use in vision restoration approaches in 
blind mice. The second part covers the use of a photochromic AMPA receptor agonist, azo-
tetrazol-AMPA (ATA), and in the third part a combination of both, DAD and ATA, is shown to 
elicit light-responses in blind retinae similar to those in wild type retinae. In the last part of 
this thesis the characterization of photochromic ligands, in particular azobenzene -triazole-
glutamate (ATG) and its derivatives, are shown utilizing acute murine brain slices. All 
experiments and their outcome are summarized in tables at the end of this research 
summary.  
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RESULTS 
Part 1 
DAD: A photochromic potassium channel blocker for restoration of vision 
DAD is non-permanently charged photochromic ligand. In acute coronal brain slices 
DAD blocks potassium channels in its thermodynamically stable trans-configuration. 
Switching from trans- and cis-configuration is achieved using 440-480 nm light and DAD 
relaxes back thermally within milliseconds. 
When applied to blind retinae (TKO: cnga3
-/-
, rho
-/-
, opn4
-/-
) on a multielectrode 
array (MEA) setup, DAD induces an increase in retinal ganglion cell (RGC) spiking upon 
illumination with blue light, whereas it is inactive in the dark (Figure 1E). Furthermore, 
pharmacological experiments revealed that DAD specifically activates retinal bipolar cells 
and that the remaining retinal network is utilized in the same fashion as in wild type retinae. 
In addition, experiments with five different blind and partially blind mouse models 
demonstrated that DAD photosensitizes bipolar cells in degenerating retinae, not affecting 
healthy tissue.  
For application of DAD in vivo, concentrations between 5 mM and 7.5 mM DAD in 
PBS have been shown to reliably induce robust light responses after intravitreal injections. 
Between 2 and 6 hours post-injection the DAD-mediated light-responses were strongest. 
Based on these experiments, behavioral studies (light-dark box test) were performed in 
collaboration with Dr. Kuldeep Kaur (Prof. Russell Van Gelder, University of Washington, 
Seattle, USA). The experiments revealed that DAD is able to induce light -dependent 
behavior in blind mice. Further studies addressing learned-behavior could not be performed 
yet, because the persistence of DAD in the vitreal cavity is limited to approximately 12 
hours. However, we are currently working on small -particle release approaches to have a 
constant level of DAD released over a longer time period post injection.  
 
Part 2 
ATA: A photochromic AMPA receptor agonist for restoration of vision 
To date, only photochromic ion channel blockers have been used in vision 
restoration approaches (Tochitsky and Kramer 2015). In the present work the use of a 
freely diffusible photochromic receptor agonist for vision restoration is described for the 
first time. Here, ATA was used, which has been shown to be active in its dark -adapted 
trans-configuration and to selectively activate AMPA receptors in cortical neurons (Stawski 
et al. 2012). MEA experiments not only showed that ATA has the same selectivity for AMPA 
receptors in blind TKO retinae, but that it can be switched with both, blue and white light 
(Figure 1E). The light intensities required for switching from trans- to cis-configuration were 
in the same range as for activation of DAD. 
Furthermore, detailed pharmacological experiments were performed to isolate input 
from different cell types, which revealed that ATA primarily activates amacrine and RGCs.  
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Part 3 
Combination therapy: DAD and ATA induce wild type like responses when applied in 
combination 
In contrast to DAD, which increases spiking activity in RGCs during illumination, 
ATA is active in the dark. When switching light on and off, wild type retinae respond only to 
the change in the stimulus with transient increases in RGC firing rate, so-called light-on and 
light-off responses. It is therefore conceivable that the combination of DAD and ATA would 
induce similar responses compared to wild type. Indeed, it could be shown that the 
combinatorial approach led to transient on/off responses and furthermore that not all cells 
responded in the same manner. Similar to wild type retinae, populations of cells increased 
spiking rate to either light-on or light-off or both stimuli. 
 
CONCLUSION Parts 1-3 
The results from these studies demonstrate that PCLs are powerful tools for vision 
restoration strategies. Although this approach is relatively new, it has many advantages 
over other, currently more developed, therapies (e.g. viral gene transfer or implantation of 
electronic light-sensing devices). The photopharmacological approach is not only minimally 
invasive, more flexible in terms of application and cheaper, but also treatment could be 
terminated in case of undesirable side-effects or other PCLs can be applied. 
 
Part 4 
Characterization of photochromic ligands in acute murine brain slices 
The last part of this work mainly covers the characterization of the PCL 
azobenzene-triazole glutamate (ATG) in acute murine brain slices. ATG can be switched 
from trans to cis using near UV light (360-380 nm) and switching back to trans is maximally 
accelerated using blue light (420-440 nm) 
ATG is the first PCL based on glutamate that is inactive in the dark -adapted trans-
configuration and furthermore it is the first selective NMDA receptor PCL. This has been 
demonstrated in several experiments covering pharmacology, calcium imaging and 
coincidence detection. Due to an NMDA receptor specific magnesium block they are 
defined as coincidence detectors. Both, neurotransmitter binding and concomitant 
postsynaptic depolarization are required to activate the ion channel. Experiments with 
electrical stimulation and ATG-mediated light activation prior, during and after the electrical 
stimulation were able to demonstrate that ATG-activated NMDA receptors can also function 
as coincidence detectors. In collaboration with Dr. David DiGregorio (Institute Pasteur, 
Paris, Frankreich) we could further show that ATG can be switched to cis using two-photon 
activation (720 nm) and that it can be activated in very small areas, such as a single spine. 
Moreover, inactivation of ATG-activated NMDA receptors was achieved within milliseconds 
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using 420 nm light, which is significantly faster compared to caged agonists such as MNI 
glutamate. 
Further studies of this work cover the application of ATG in Purkinje cells of the 
cerebellum and the investigation of ATG derivatives. In addition, I analyzed the activity of a 
photoswitchable α7-nicotinic acetylcholine receptor agonist, AzoCholine, in acute 
hippocampal brain slices using the MEA. 
 
  
Figure 1 - Vision restoration approaches. (A) Schematic representation of the photoswitch mechanism. The 
azobenzene moiety (red) can be switched between trans- and cis-configuration using specific wavelengths. 
Depending on the ligand (orange ball) the photochromic ligand can either bind to a specific receptor or (B) 
function as a channel blocker. On the right: Molecular structures in trans- and cis-configuration of DAD (A) and 
ATA (B). (C) MEA recording of an untreated blind TKO retina. Raster plot is shown on the top, light stimulation 
protocol in the middle and histogram of all cells at the bottom. (D) MEA recording of an DAD-treated TKO 
retina. Same representation as in (C). (E) MEA recording of an ATA-treated TKO retina with the same 
representation as in (C) and (D).   
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1 Introduction 
1.1  The eye/retina 
Human eyes are remarkable organs making it possible to sense the world around us in 
great detail. Vision is probably the most fundamental sense in humans and its loss is 
devastating.  
In the late 19
th
 century Ramón y Cajal was the first person describing neural cell types in 
the retina in comprehensive detail, providing essential information about their structures 
and building the basis for the future understanding of the retina's function (Masland 2001, 
Cajal 1893). Now, more than 100 years later, the retina is probably the best understood 
neural network in sensory neuroscience, however, many mechanisms remain unclear.  
Visual perception underlies an astonishing system, which is capable of remarkable tasks, 
such as detecting single photons in the dark and, on the other hand, coping with more than 
10
16
 photons cm
-2
 s
-1
 in bright sunlight. 
1.1.1 Basic anatomy of the eye  
The functional properties of the eye for transferring the image onto photoreceptor cells are 
the iris, pupil size, cornea and lens. Using these four features an inverted image is 
projected onto the retina. 
The amount of light hitting the retina is controlled by the pupil size; the iris serves as an 
aperture, which is a contractile structure consisting mainly of smooth muscle. The iris is 
situated between the cornea and the lens in the anterior chamber of the eye. At bright light 
intensities the iris constricts, thereby decreasing the number of photons entering the eye 
and vice versa at low light intensities. 
The refractive properties of the eye are determined by the cornea and the lens. While the 
cornea's curvature is fixed, the lens can be adjusted by smooth muscles. In relaxed mode 
the lens is flattened thereby bringing objects in the distance into focus. Together, cornea 
and lens are producing a sharp image on the level of photoreceptor cells , which are the 
integral part of the retina (Figure 1.1 A) (Squire et al. 2008).  
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Figure 1.1 - Structure of the eye and the retina. (A) Schematic section of the human eye. Light enters 
the eye via the pupil, an aperture surrounded by the iris. The iris and pupil therefore control how 
much light enters the eye. The cornea and the lens focus the light onto the retina. The 
accommodation reflex controls the shape of the lens, thereby focusing on objects nearby or at 
greater distance. (B) Enlargement of the box in (A) with a schematic representation of the retina. 
Light is perceived by photoreceptor cells and transmitted to the bra in via bipolar cells and retinal 
ganglion cells. Horizontal and amacrine cells provide lateral inhibitory input in the outer plexiform and 
inner plexiform layer, respectively. 
 
1.1.2  Structure of the retina 
The retina is the fundamental element responsible for light perception and image 
processing. Essentially, the retina is a biological extension of the brain, receiving its 
information directly from the outside and transmitting it to the brain. The retina has evolved 
to already process much of the information, thereby providing a first phase of computation 
and relaying the rest to higher brain regions (Hoon et al. 2014). 
The retina is composed of five different cell types, divided in a vertical (photoreceptor, 
bipolar and retinal ganglion cells) and a lateral signaling pathway (horizontal and amacrine 
cells) (Figure 1.1 B). These cells are arranged in five distinguishable retinal layers: Three 
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layers of cell bodies (outer nuclear layer, ONL; inner nuclear layer, INL; ganglion cell layer, 
GCL) separated by two layers of neural processes, in which the cells interact via synap tic 
contacts (outer plexiform layer, OPL; inner plexiform layer, IPL). The only cell type bridging 
the two plexiform layers are bipolar cells by having processes in both, the IPL and OPL. 
Light hitting the retina needs to travel through all these layers until reaching the 
photoreceptor cells, which are in tight contact to the retinal pigment epithelium (RPE) 
(Figure 1.1 B). The ONL contains the cell bodies of rod and cone photoreceptor cells, while 
the INL contains cell bodies of interneurons, i.e. bipolar cells, horizontal cells and amacrine 
cells. Retinal ganglion cells (RGC) located in the innermost layer, the ganglion cell layer 
(GCL), provide the sole output of the retina. The axons of RGCs form the optic nerve, the 
pathway from the retina to the rest of the central nervous system (Figure 1.1 B). 
1.1.3 Pathways/cell types in the retina  
*Photoreceptor cells 
Photoreceptor cells are neurons that transform light, an electromagnetic signal, into a 
chemical signal. Two different classes of photoreceptor cells evolved, rods and cones. In 
humans, rods and cones exhibit a distinct distribution pattern in the retina. While cones are 
almost exclusively located in the foveal region (Figure 1.1 B), rods are evenly distributed 
over the peripheral parts of the retina. The functional relevance is reflected by the physical 
properties of the respective photoreceptors and the synaptic connectivity of the 
photoreceptor cells. Rods are optimized for scotopic vision, i.e. under low light conditions, 
primarily contributing to peripheral vision and the detection of movements. Whereas they 
are able to detect single photons, they are not able to discriminate between colors. In 
contrast, cones are optimized for photopic vision, i.e. under bright light conditions, allow 
color perception and exhibit high spatial resolution. In an adult human retina approximately 
only 5 % of photoreceptor cells are cones and the remainder are rods (Curcio et al. 1990). 
In humans only one type of rod photoreceptor and three different kinds of cone 
photoreceptors exist (trichromats). The absorption spectra of cones cover the 
electromagnetic spectrum from 380 nm (near UV light) to 760 nm (red light), i.e. the visible 
range: short wavelength cone (S-cone: absorption peaks at 420440 nm), green (M-cone: 
534545 nm) and red (L-cone: 564580 nm) cone photoreceptor. The spectral variation 
depends on the expression of different cone opsins (Nathans et al. 1986) (Figure 1.2). 
Usually less than 10 % to 15 % of all cones are S-cones and the remaining 80 % are M- and 
L-cones (Wikler and Rakic 1990, Wikler et al. 1990). For color perception at least two 
wavelengths need to be compared. Missing either the red or the green cone leads to the 
commonly known red-green blindness (dichromacy). This term, however, is misleading, 
since these people are not completely color-blind. They just cannot discriminate between 
red and green, but all other colors. With the exception of primates, all other mammals are 
Introduction Pathways/cell types in the retina 4   
in principle dichromats, possessing one type of rod and two types of cone photoreceptor 
cells, one for shorter and one for longer wavelengths (Bowmaker 1998). 
 
Figure 1.2 - Spectral sensitivity of rods and cones in primates. Blue: Short wavelength (S-) cones. 
Black: Rod photoreceptor. Green: M-cones. Red: L-cone. In yellow wavelength spectrum of daylight. 
 
In addition to the previously described rod and cone photoreceptor cells, melanopsin has 
been described as a third class of photoreceptor cell. Melanopsin is expressed in 
intrinsically photosensitive retinal ganglion cells (ipRGCs) , exhibits slow kinetics and do not 
contribute to normal visual perception, but are responsible to set the circadian rhythm 
(Foster et al. 1991).  
 
*Phototransduction cascade 
Photoreceptor cells in the outer retina consist of two major components, the inner 
segments and the outer segments. The inner segments comprise the nucleus, mitochondria 
and other important organelles and form the synaptic connections to bipolar and horizontal 
cells. In the outer segments of photoreceptor cells the molecular machinery for the 
phototransduction cascade is located (Figure 1.3) (Fu 2011, Pulagam and Palczewski 
2011).  
 
Figure 1.3 - Phototransduction cascade in rod photoreceptors. (1) Light activation of rhodopsin leads 
to the activation of the G-protein transducin. (2) The Gαo subunit of transducin activates the 
phosphodiesterase (PDE), resulting in a decreased level of cGMP. (3) Lower cGMP levels allow CNG-
channels to close, thereby stopping the influx of cations (red circles) and hyperpolarizing the cell in 
light. 
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The different cone opsins are the essential parts for light perception. The detected 
wavelength depends on the cone opsin expressed, whereas rod photoreceptors only 
express one type of opsin, rhodopsin. Rhodopsin and cone opsins are holoproteins 
consisting of the apoprotein and a covalently bound 11-cis retinal via a protonated Schiff 
base (Wald 1968, Palczewski 2006). Upon illumination 11-cis retinal isomerizes to all-trans 
retinal, thereby inducing molecular changes in the opsin, which lead to the activation of an 
intracellular G-protein signaling cascade (Figure 1.3 - 1). Exchange of a G-protein 
(Transducin)-bound GDP for GTP leads to the dissociation of Gα and Gβγ subunits. Gα(GTP) 
activates the phosphodiesterase (PDE), which in turn result in the hydrolyzation of cGMP to 
GMP (Figure 1.3 - 2). The reduction of intracellular cGMP levels leads to closure of cyclic 
nucleotide-gated cation channels (CNG-channels) in the outer segment membrane (see 
section 1.1.5 CNG-channels) (Figure 1.3 - 3). Thereby the photoreceptor cell hyperpolarizes 
and reduces the glutamate release; the neurotransmitter of photoreceptor cells. Taken 
together, incoming light leads to photoreceptor cell hyperpolarization and reduction in 
neurotransmitter release, while decrements of light lead to depolarization and increase 
neurotransmitter release (Squire et al. 2008).  
*Principles of cone vision  
The vertical pathway 
Color perception is mediated by different types of cone photoreceptors, which are sensitive 
to specific wavelengths (see section 1.1.3 Photoreceptor cells). These cone photoreceptors 
are associated with different types of cone-driven bipolar cells, each of them possessing a 
specific function in visual processing. Bipolar cells are divided into two main classes, on- 
and off-bipolar cells. On-bipolar cells respond to light increments, while off -bipolar cells are 
activated by light decrements. Importantly, photoreceptor cells as well as bipolar cells 
respond to light with graded potentials rather than action potentials , due to constant 
stimulation of either the on- or off-pathway.  
In darkness photoreceptor cells constantly release glutamate from their synapses to bipolar 
cells, the so-called 'dark current' (Trifonov 1968). Light stimulation, in contrast, leads to a 
hyperpolarization in photoreceptor cells and less glutamate release due to a decrease in 
cGMP levels. Depending on bipolar cell type the change in glutamate release is detected 
either as an on- or an off-response (Figure 1.4). The polarity of the light response is 
determined by the subtype of glutamate receptor expressed in the bipolar cell dendrites 
(Kolb et al. 2001). On-bipolar cells become depolarized upon less glutamate release from 
photoreceptor cells. This signal is processed via the metabotropic glutamate receptor 
mGluR6. In darkness, mGluR6 is activated in on-bipolar cells leading to the closure of 
TRPM1 channels via Gαo and therefore to hyperpolarization (Figure 1.4 A). Therefore less 
glutamate release from photoreceptor cells during light stimulation reduces the stimulation 
of mGluR6, thereby activating TRPM1 channels, which depolarizes the on-bipolar cell. In 
Introduction Pathways/cell types in the retina 6   
contrast, glutamate release from photoreceptor cells onto off -bipolar cells leads to the 
activation of non-NMDA receptors (AMPA and kainate receptors). This leads to a 
depolarization of off-bipolar cells in darkness and no stimulation during light (Figure 1.4 B).  
 
 
Figure 1.4 - Bipolar cell light responses. (A) On- and off-bipolar cell responses during a light flash. 
Left: Schematic drawing of the retina. Right: Enlargement of photoreceptor to bipolar cell synapse. In 
on-bipolar cells expression of mGluR6 leads to an inversion of the photoreceptor cell stimulus. 
Hyperpolarization of photoreceptor cells during light prevents the activation of mGluR6, thereby 
allowing TRPM1 to open and to depolarize the on-bipolar cell (i.e. influx of cations). The off-pathway 
is determined by the expression of non-NMDA receptors, thereby less glutamate during light 
stimulation induces less activation of the off-bipolar cell (i.e. no current through non-NMDA 
receptors). (B) Same structure as in (A). In darkness, glutamate is released from photoreceptor cells, 
thereby activating mGluR6 (on-bipolar cell) and non-NMDA receptors (off-bipolar cells).  
 
 
 Cone bipolar to RGCs signal transmission is directly mediated via ionotropic 
glutamate receptors (iGluRs). RGCs can be divided into three different classes: On, off and 
on/off RGCs depending on the bipolar cells they are connected with. On -RGCs receive 
glutamatergic input during illumination of their receptive fields and therefore depolarize, 
while off-RGCs are depolarized in darkness (Figure 1.5 top). When light is applied 
surrounding the receptive fields, on-RGCs are inactivated during the stimulation and 
depolarize after switching light off. Off-RGCs, however, become depolarized with peripheral 
applied light stimulation (Figure 1.5 bottom). RGCs responding to light on as well as light 
off within their receptive fields are connected to both types of bipolar cells, therefore 
receive both stimuli. Importantly, RGCs are not only the sole output of the retina, but are 
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also the only cell type of the vertical pathway, which transmits its signals with action 
potential firing (Chaudhuri 2011). 
 
 
Figure 1.5 - Receptive field properties of RGCs. Left: Schematic representation of light stimulation 
shape. (A) On-center/off-surround RGC response. When flashing a spot of light in the receptive field, 
the spontaneous firing rate increases. A light flash to the surrounding area of the receptive field does 
not change spontaneous firing rate of the RGC, however, when light is switched off, the spiking 
frequency transiently increases. (B) Off-center/on-surround RGC response. The RGC responds to the 
same stimulation as in (A) with the exact opposite in firing pattern. Bars indicate light protocol and 
raster plots show the spiking activity of the RGCs. 
 
In the human fovea the retinal cells underwent an additional specialization. The fovea is  
located in the macula lutea of the retina (Figure 1.1), and is composed of cone 
photoreceptor cells only, which are densely packed. Each cone photoreceptor in the fovea 
is in general connected to a single bipolar cell (midget bipolar cell), which are again 
connected almost solely to a single midget RGCs (Kolb and Dekorver 1991, Kolb and 
Marshak 2003, Adams et al. 2013). Midget RGCs represent around 70% of all RGCs and 
are therefore the most numerous of all RGCs. This specialized structure in the focal point of 
the retina allows a point-to-point resolution of the image only limited by the packing density 
of the cone photoreceptor cells . 
 
The lateral pathway: Horizontal and amacrine cells 
Horizontal cells are the interneurons of the outer retina, which modulate the synaptic activity 
between photoreceptor and bipolar cells (Figure 1.1 B). As their name already indicates, 
horizontal cells span laterally over a large area. They provide diverse feedback signals, 
such as gain adjustment of photoreceptor synaptic output or lateral surround inhibition to 
improve spatial resolution (Thoreson and Mangel 2012, Baylor et al. 1971). In most 
mammals, horizontal cells are divided into two morphologically distinct cell types, which are 
both GABAergic and feed back onto cone axon terminals in the center of the bipolar cell's 
receptive field.  
In addition to center-surround modulation between cone photoreceptor and bipolar cells, it 
has also been demonstrated, that receptive field surround responses are dramatically 
shaped by amacrine cell inputs in the inner retinal circuits (Lukasiewicz 2005, Zhang and 
Wu 2009) (Figure 1.1 B). To date, more than 30 different morphological subtypes of 
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amacrine cells have been classified (Cherry et al. 2009). These can be structurally divided 
into four distinct groups by both, their dendritic field diameter (narrow-field, small-field, 
medium-field and wide-field) and by their stratification (Kolb et al. 1981, Masland 2001). 
Most amacrine cells use either GABA or glycine as their neurotransmitter . However, it has 
been shown, that some amacrine cell types co-release, acetylcholine and GABA, and are 
therefore not exclusively inhibitory interneurons (O'Malley et al. 1992). Besides the major 
amacrine cell neurotransmitters GABA, glycine and acetylcholine, eight other 
neurotransmitters are released, including several neuropeptides (see section 1.1.4 
Neuropeptides) (Squire et al. 2008). In contrast to horizontal cells, amacrine cells exhibit 
much more specialized functions, with each amacrine cell type connecting to a particular 
type of bipolar cell. Although great progress has been made in the understanding of 
amacrine cell function, most of the amacrine cell mediated interactions are still poorly 
understood (Chaudhuri 2011).  
Taken together, horizontal and amacrine cells mediate lateral inhibition in the OPL between 
photoreceptor and bipolar cells, and in the IPL between bipolar and retinal ganglion cells, 
respectively. 
*Principles of rod vision 
The retina is able to cover changes in light level by a factor of 100,000,000, from starlight 
(10
-3
 cd/m
2
) to bright sunlight 10
5
 cd/m
2
 (Heeger 2015). Whereas cone photoreceptors are 
responsible for vision under bright daylight conditions (>3 cd/m
2
), rod photoreceptors are 
able to detect single photons and transmit light below approximately 0.01 cd/m
2
. In most 
mammalian retina, rod photoreceptor cells outnumber cone photoreceptor  cells by 
approximately 20-fold, but cone bipolar cells outnumber rod bipolar cells (Martin and 
Grunert 1992, Strettoi and Masland 1995, Curcio et al. 1990). The reason for this 
phenomenon is, that many rod photoreceptor cells converge onto a single rod bipolar cell. 
Therefore, the rod system trades acuity for sensitivity. In addition, rods evolved after cones 
and piggyback on the cone visual system. Rod photoreceptor cells do not directly transmit 
their signal via rod bipolar cells to RGCs, but instead use an indirect route via AII amacrine 
cells to the axon terminals of cone bipolar cells (Figure 1.1 B) (Famiglietti and Kolb 1975). 
Therefore, a single set of RGCs can be used under daylight and starlight conditions and the 
network did not have to be reinvented for the additional rod pathway. Furthermore, the rod 
system is much simpler compared to the cone pathways. Only one type of rod 
photoreceptor cell exists, which exclusively synapse onto a single type of rod bipolar cell  
(Cajal 1893, Bloomfield and Dacheux 2001).  
Interestingly, not only the vertical rod pathway is build on the preexisting cone pathway, but 
also rod photoreceptors take advantage of preexisting horizontal cells. In the OPL, rod 
photoreceptors have contact to a specialized horizontal cell (b/H2 type), which synapse to 
both, cone and rod photoreceptors. Synaptic connections between cone photoreceptors 
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and horizontal cells are made over large dendritic areas and induce lateral inhibition over a 
wide range of neighboring cones. Rod photoreceptors, on the other hand, make synaptic 
connection far away from the horizontal cell's soma and are isolated within the dendritic 
tree. Therefore, lateral inhibition between rod photoreceptors is not influencing the lateral 
inhibition between cones, although both use the same horizontal cell (Nelson et al. 1975). 
1.1.4 Neurotransmitter receptors in the retina 
This section covers some of the important neurotransmitter receptors in the retina and is 
not meant to be a comprehensive review of all neurotransmitter receptors in the retina. 
 
 *Glutamate receptors 
      Glutamate   NMDA        AMPA         Kainate  
 
The synaptic connections in the retina, which shape the vertical pathway from 
photoreceptors via bipolar cells to RGCs are entirely mediated by glutamate (Thoreson and 
Witkovsky 1999). Two distinct classes of glutamate receptors contribute to this pathway, (i) 
ionotropic and (ii) metabotropic glutamate receptors. 
 
Ionotropic glutamate receptors (iGluRs) 
Ionotropic glutamate receptors (iGluRs) are classified according to their specific agonists 
into NMDA, AMPA and kainate receptors. They are composed of an extracellular amino-
terminal domain (ATD), a transmembrane domain (TMD) and a ligand binding domain 
(LBD). The ATD is responsible for receptor assembly, trafficking and localization, whereas 
the TMD builds a four-fold symmetrical pore structure of 16 helices. The LBD has a two-fold 
symmetry, the so-called clamshell domain. Binding of glutamate leads to a conformational 
change that closes the clamshell, resulting in a tightly bound glutamate and opening of the 
non-selective cation channel.  
Non-NMDA (AMPA and kainate) receptors act as non-selective cation channels upon 
activation and are more permeable to sodium (Na
+
) and potassium ions (K
+
) compared to 
calcium ions (Ca
2+
). Competitive antagonists are CNQX (6-cyano-7-nitroquinoxaline-2,3-
dione), NBQX (1,2,3,4-tetrahydro-6-nitro-2,3-dione-benzoquino-xaline-7-sulfonamide), and 
DNQX (6,7-dinitroquinoxaline-2,3-dione) (Alford and Grillner 1990, Goldstein and Litwin 
1993). GYKI52466 has been shown to be a potent non-competitive antagonist for non-
Introduction Neurotransmitter receptors in the retina 10   
NMDA receptors (Donevan and Rogawski 1993, Solyom and Tarnawa 2002).  
NMDA receptors, like non-NMDA receptors, form non-selective cation channels. However, 
they comprise three special features compared to non-NMDA receptors: (i) they have a 
higher permeability to Ca
2+
, (ii) for full activation they require in addition to glutamate 
binding to GluN2 subunits, a co-agonist (either glycine or D-serine) binding to the GluN1 
subunits of the heterotetramer (Stevens et al. 2003, Johnson and Ascher 1987); (iii) they 
exhibit a voltage-dependent block by magnesium ions (Mg
2+
) at membrane resting 
potential. Therefore these channels can act as a coincidence detector of presynaptic 
glutamate release  and postsynaptic depolarization (Nowak et al. 1984, Mayer et al. 1984). 
In addition, this mechanism is thought to prevent NMDA receptor-mediated excitotoxicity 
(Nowak et al. 1984). Several antagonists are available, which act on different sites of the 
receptor: (i) D-AP5 (competitive glutamate site antagonist) , (ii) 7-Cl-kynurenate (competitive 
glycine site antagonist), (iii) MK-801 (channel blocker). 
In the retina non-NMDA receptors play a significant role not only for signaling between 
photoreceptor cells and off-bipolar cells (Figure 4B), but have also been identified in 
horizontal, amacrine and RGCs (Gilbertson et al. 1991, Zhou et al. 1993, Boos et al. 1993, 
Cohen and Miller 1994, Yu and Miller 1995). NMDA receptors are expressed to a lesser 
extend compared to non-NMDA receptors and were primarily detected in RGCs as well as 
subsets of amacrine cells. In very few species, NMDA receptors were also found in 
horizontal and bipolar cell subtypes, but their specific functions in these cell types remain 
to be elucidated (Shen et al. 2006).  
The distribution of NMDA and non-NMDA receptors in the retina is thought to strongly 
influence signal transmission. NMDA receptors mediate rather slow sustained light -
responses, while non-NMDA receptors are in principle responsible for a more transient 
light-response transmission (Shen et al. 2006, Ozawa et al. 1998).  
 
Metabotropic glutamate receptors 
Metabotropic glutamate receptors (mGluRs) belong to the group C family of G-protein 
coupled receptors (GPCRs) and are structurally and physiologically very different from 
iGluRs. Each mGluR consists of a single protein chain and does not form an integral ion 
channel pore, but activates second messenger cascades. These cascades mediate various 
intracellular responses, such as release of Ca
2+
 from intracellular stores or inhibition of 
adenylyl cyclase (AC) (Squire et al. 2008). Overall eight mGluRs have been cloned so far, 
which can be divided into three distinct groups, depending on their agonist or activated 
second messenger system: Group I (mGluR1 and mGluR5), group II (mGluR2 and mGluR3) 
and group III (mGluR4, mGluR6, mGluR7 and mGluR8) (Conn and Pin 1997, Niswender 
and Conn 2010). Receptors of group I respond most strongly to L-quisqualate, those of 
group II react to DCG-IV (dicarboxycyclopropyl), while L-SOP and L-AP4 selectively 
activates receptors of group III.  
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In the retina all mGluR subtypes have been detected, except for mGluR3 (Koulen et al. 
1996, Koulen et al. 1997). Most mGluRs are expressed in the IPL or in both the IPL and 
OPL. The only exception is the mGluR6 receptor, which has been shown to be exclusively 
expressed in the OPL or more precisely, in on-bipolar cell dendrites. This specific 
expression pattern was further explored in studies of mGluR6 knock-out mice, which 
revealed that this receptor is mandatory for synaptic transmission from photoreceptors to 
on-bipolar cells (Masu et al. 1995, Nomura et al. 1994). More recent studies on the sign-
inverting intracellular pathway of on-bipolar cells discovered, that mGluR6 activation leads 
to the inhibition of the transient receptor potential cation channel TRPM1 (Figure 1.4 A) (Xu 
et al. 2012, Shen et al. 2012). The majority of mGluRs, however, are less specific than 
mGluR6 and are mostly found postsynaptically to off- and on-cone bipolar cells 
(Brandstatter et al. 1996, Koulen et al. 1996, Koulen et al. 1997) . 
 
*Neurotransmitters of inhibitory pathways 
 
GABA receptors 
 
    
         GABA 
 
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the vertebrate 
retina. Most lateral interactions by amacrine cells and horizontal cells are mediated by 
GABA in the inner and outer retina, respectively. GABA receptors are divided into three 
functional families, the ionotropic GABAA  and GABAC receptors and the metabotropic 
GABAB receptors (Chebib and Johnston 1999).  
GABAA receptors are ligand-gated chloride (Cl
-
) channels mediating fast inhibition in a wide 
distribution of neurons throughout the central nervous system (CNS). In the retina GABAA 
receptors have been found to be ubiquitously expressed throughout all retinal cell types 
(Wassle et al. 1998, Feigenspan and Weiler 2004, Yang 2004). Specific GABAA activation 
is achieved using either muscimol or THIP (4,5,6,7-Tetrahydroisoxazolo5,4-cpyridin-3-ol) 
and can be blocked by bicuculline or the unselective chloride channel blocker picrotoxin. In 
addition, modulation of GABAA activation is possible by benzodiazepines, barbiturates, 
ethanol or steroids (Johnston 1996, Moehler et al. 2010).  
Like GABAA receptors ionotropic GABAC receptors are permeable for chloride (Cl
-
) ions, 
but mediate rather slow and sustained responses compared to GABAA receptors 
(Lukasiewicz et al. 2004). Until today no selective agonist have been identified for GABAC 
receptors. Effective antagonists of GABAC activation are 1,2,5,6-Tetrahydropyridin-4-
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yl)methyl-phosphinic acid (TPMPA), THIP and picrotoxin, with only one exception: In the 
mammalian retina GABAC receptors are only slightly blocked by picrotoxine (Ragozzino et 
al. 1996, Zhang et al. 1995, Johnston et al. 2003, Feigenspan et al. 1993) . In addition, 
GABAC receptor mediated currents can be modulated by divalent cations, in particular by 
low concentrations of zinc ions (Wang et al. 1995). 
Metabotropic GABAB receptors, in contrast to ionotropic GABA receptors, mediate 
responses indirectly via G-proteins, which activate potassium or calcium channels. G-
protein mediated signaling not only provides the possibility of signal amplification, but can 
also induce intracellular changes, such as the reduction of AC activity. To date, the only 
specific agonist and antagonist for GABAB receptors identified, are baclofen and phaclofen, 
respectively (Bettler et al. 2004).  
In contrast to GABAA receptors, GABAB and GABAC receptors are found only in subsets of 
retinal neurons and are not ubiquitously distributed. In addition, GABAC receptors have also 
predominantly been found in the vertebrate retina compared to the remaining CNS, 
reinforcing a more important role of GABAC receptors for signal processing in the visual 
system (Lukasiewicz 1996, Lukasiewicz et al. 2004). 
 
Glycine receptors 
 
     
      Glycine 
 
Glycine is the second most important inhibitory neurotransmitter in the mammalian retina. 
Glycine receptors are ligand-gated chloride channels, hyperpolarizing the postsynaptic 
membrane in mature neurons upon ligand binding. Complete block of the glycine receptor 
ion channel can be achieved with the competitive antagonist strychnine, while no agonist or 
potentiating compounds are known to be selective for glycine receptors (Betz and Laube 
2006, Webb and Lynch 2007). About half of the amacrine cells in the mammalian retina, 
which synapse onto bipolar cells, other amacrine cells and RGCs, are glycinergic. The most 
prominent glycinergic amacrine cells are small-field amacrine cells, which network within 
the different sublayers of the IPL, as well as AII amacrine cells, which transmit the signal 
from rod bipolar cells to RGCs via cone bipolar cell axon terminals (Menger et al. 1998). 
Overall glycine receptors are widespread throughout the retina and have been identified in 
all retinal cell types (Lam 1997, Balse et al. 2006).  
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Dopamine receptors 
 
 
       Dopamine 
 
Dopamine is a slow modulator of the fast neurotransmission mediated by glutamate and 
GABA. Five different dopamine receptors have been identified (D1-D5), which all belong to 
the group of GPCRs (Beaulieu and Gainetdinov 2011). They can be further divided into two 
major groups, namely D1 and D2 (Andersen et al. 1990). D1 receptor subtypes (D1 and 
D5) generally stimulate the AC via Gαs or Gαo proteins, thereby indirectly activating cAMP-
dependent kinases (Spano et al. 1978, Tiberi et al. 1991). D2 dopamine receptor subtypes 
(D2, D3, D4) on the other hand inhibit the AC generally via Gαi proteins (Kebabian and 
Calne 1979, Niznik and Van Tol 1992). In addition to G-protein mediated signaling, it has 
been shown that dopamine receptors also connect to a G-protein independent signaling 
pathway, namely the late D2-arrestin mediated signaling. This pathway is involved in 
important cellular functions such as actin cytoskeletal rearrangement and cell migration 
(Luttrell et al. 1999, Luttrell and Lefkowitz 2002, Luttrell and Gesty -Palmer 2010).  
In the mammalian retina the presence of dopamine has been identified by Tyrosine 
hydroxylase (TH) immunostaining in a specific set of amacrine cells, with the most 
prominent staining in A18 amacrine cells (Kolb et al. 1991, Witkovsky 2004, Kolb et al. 
1981, Tauchi et al. 1990). Dopamine receptors of the D1- and D2-families are expressed 
widely throughout the retina and have been recognized in rod and cone photoreceptor cells 
(D2 family), as well as in bipolar, horizontal, amacrine and RGCs (D1 family) using 
autoradiography and immunocytochemistry (Muresan and Besharse 1993, Veruki and 
Wassle 1996, Nguyen-Legros et al. 1997, Witkovsky and Schutte 1991). In amacrine cells, 
which release dopamine, only D1 dopamine receptors are expressed. Their function is auto-
inhibitory (autoreceptors), i.e. dopamine bound to the receptor leads to less dopamine 
release (Dubocovich and Weiner 1985). In the rod pathway dopaminergic neurons synapse 
onto AII and A17 amacrine cells, but also bipolar cells have been shown to be negatively 
affected by dopamine (Hampson et al. 1992).  
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Acetylcholine receptors (AChRs) 
 
 
      Acetylcholine 
 
Acetylcholine (ACh) is a classic neurotransmitter for fast excitatory neurotransmission in the 
nervous system, where it can bind to two very different types of receptors, muscarinic and 
nicotinic AChRs (mAChR and nAChR, respectively). Muscarinic AChR are named as such, 
because they are more sensitive towards muscarine than nicotine and all mAChRs belong 
to the class of GPCRs. They are not only expressed in various types of neurons, but also in 
other cells, such as smooth muscle cells. Nicotinic AChRs (nAChRs), on the other hand, 
are more sensitive to nicotine and form non-selective cation channels. Although nAChRs 
are permeable to most cations, such as Na
+
, K
+
 and Ca
2+
, monovalent cations are preferred 
(Squire et al. 2008). To date, 12 different genes have been cloned forming a 
heterogeneous family of pentameric receptors (Le Novere et al. 2002). In general, two main 
classes of nAChR subunits are distinguished: (i) α-subunits, which are responsible for ACh-
binding, and (ii) other subunits (β,γ,δ) which are not able to bind the agonist, but contribute 
to the binding affinity (Lindstrom et al. 1996, Corringer et al. 2000).  
In the vertebrate retina two types of ACh-releasing amacrine cells ("starburst") have been 
described, of which one has its cell body in the amacrine cell layer (ACh-b type), and the 
other is located more in the RGC layer (ACh-b type) (Masland and Tauchi, 1986). Both 
ACh-type amacrine cells exhibit a two mirror symmetry and importantly, co-release GABA, 
implying two different functionalities (Vaney and Young 1988, Brecha et al. 1988). ACh-type 
amacrine cells receive input from various sites, including cone bipolar cells and other 
amacrine cells. The only site of synaptic output, however, is through distal dendrites onto 
RGCs. Both, ACh-a and ACh-b type amacrine cells connect to ON-OFF directional selective 
RGCs, while ACh-b type amacrine cells additionally synapse to ON-directionally selective 
RGCs (Amthor et al. 1984, Amthor et al. 1989, Famiglietti 1987, Tauchi and Masland 1984, 
Vaney 1994, Famiglietti 1991, Briggman et al. 2011) . 
In addition, it has been demonstrated that the earliest stages of development, before 
phototransduction and during neural outgrowth and synaptogenesis, critically rely on 
spontaneous bursting activity (retinal waves) induced by ACh-neurotransmission (Bansal et 
al. 2000). These retinal waves have been shown to be necessary for correct size and 
complexity of RGC dendrites as well as for the refinement of connections between retinal 
axons and higher brain regions (Wong 1999, Feller 2002, Moretti et al. 2004).  
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*P2X receptors 
 
       Adenosine-5'-triphosphate 
 
Purinergic P2X receptors are ligand-gated ion channels, which are activated by extracellular 
adenosine-5'-triphosphate (ATP). Although it was believed for a long time that P2X 
receptors play only a minor role in direct signal transmission, their indispensability for 
neural activity becomes more and more evident. In the CNS P2X receptors were shown to 
mediate fast synaptic transmission in addition to their several regulatory functions (Buell et 
al. 1996, Brake and Julius 1996). Therefore, ATP is now a well established extracellular 
neurotransmitter for fast synaptic transmission (Evans et al. 1992). 
To date, eight P2X receptor subunits have been cloned, P2X1-7,P2XM, of which four are 
expressed in retinal neurons (P2X2-5) (Brandle et al. 1998). P2X mRNA was detected in 
various cell types of the retina, including photoreceptors, neurons of the outer nuclear layer 
and RGCs (Greenwood et al. 1997). ATP as well as adenosine were reported to not only 
influence ACh-release from amacrine cells, but P2X receptor activation is also correlated 
with GABAergic, glutamatergic, glycinergic, dopaminergic and serotonergic 
neurotransmission (Blazynski and Perez 1991, Feigenspan and Bormann 1994, Brandle et 
al. 1998). Although substantial progress has been made in the past decade, many effects 
of extracellular ATP on visual processing still remain unclear. 
 
 *Neuropeptides 
 
     Neuropeptide Y 
 
Neuropeptides are small polypeptides, varying in length between 3 and 36 amino acids. 
They can act either endocrine as neurosecretory peptide hormons or paracrine as co -
transmitters, which are almost always co-released with classical neurotransmitters 
(Lundberg 1996). In the mammalian brain about 100 different neuropeptides have been 
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characterized influencing all sets of different brain functions including metabolism, reward 
and learning and memory (neuropeptides). In addition, neuropeptides and their receptors 
have been shown to play an important role during the maturation of the nervous system 
(Hoyer and Bartfai 2012).  
In the retina most neuropeptides appear early in development, when synaptic connections 
are still immature; and exhibit transient features, which mature with eye opening (Bagnoli et 
al. 2003). During this period neuropeptides are believed to induce several direct and 
indirect effects, including cell division, neuronal survival and neurite sprouting (Emerit et al. 
1992, Muller et al. 1995, Bagnoli et al. 2003, Akiyama et al. 2008) . In the mature retina, 
neuropeptides have been shown to be expressed in amacrine cells and RGCs in the inner 
retina. Neuropeptide receptors, however, have been found in a wide distribution among 
several retinal cell populations. This finding suggests, that neuropeptides act in a more 
paracrine manner, thereby influencing retinal circuits in a more general mode. In this 
context, recent studies demonstrated that neuropeptides in the retina not only influence 
neurotransmitter release directly, but also have an impact on cellular activity of bipolar, 
amacrine and RGCs (Bruun and Ehinger 1993, Zalutsky and Miller 1990b, Zalutsky and 
Miller 1990a). In the mammalian retina several peptidergic systems have been identified, 
including tachykinin peptides, vasoactive intestinal peptide (VIP), PACA, somatostatin 
(SRIF), neuropeptide Y (NPY), opioid peptides and others, all of which are summarized in 
great detail elsewhere (Bagnoli et al. 2003, Akiyama et al. 2008, Casini 2005) . 
1.1.5 Ion channels in the retina 
This section, as the one before, is only a short summary of some important ion channels in 
the retina and is not meant to be a comprehensive review. 
*Voltage-gated sodium (Nav) channels 
Voltage-gated sodium (Nav) channels are integral membrane proteins essential for action 
potential initiation and propagation in excitable cells. They are composed of a large pore -
forming α-domain and smaller auxiliary β-subunits. Overall nine sodium channel α-isoforms 
have been identified in mammals (Nav1.1-1.9), with each consisting of a long polypeptide 
chain organized into four domains. Each of the four domains has six transmembrane 
helices (TMH) and are connected via intra- and extracellular loops (Figure 1.6) (Dib-Hajj 
and Priestley 2010). The voltage sensor is located in TMH S4, which contains a positively 
charged amino acid in every third position.  
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Figure 1.6 - Schematic representation of the sodium-channel subunits. Roman numerals indicate the 
domains of the α subunit (I-IV); segments 5 and 6 (shown in green) are the pore-lining segments and 
the S4 helices (yellow) make up the voltage sensors. The blue circles in the intracellular loops of 
domains III and IV indicate the inactivation gate motif h, its inactivation gate; P, phosphorylation sites 
for either PKA (red circles) or PKC (red diamonds); The circles in the re -entrant loops in each domain 
represent the amino acids that form the ion selectivity filter (the outer rings have the sequence EEDD 
and inner rings DEKA). (Adapted from(Yu and Catterall 2003)) 
 
The central pore is generally opened by an increase in membrane potential up to 30 mV 
to 20 mV and pore block can be achieved by various types of neurotoxins. All together six 
different neurotoxin receptor sites have been identified and the most prominen t Nav 
blockers are tetrodotoxin (TTX) and saxitoxin (STX), which both block via neurotoxin 
receptor site 1 (Catterall et al. 2005). Nav-channels can exist in three different states, (i) 
closed, (ii) open and (iii) inactivated. The open state of the channel usually lasts less than 
1 ms after which the channel becomes quickly inactivated. This inactivation is due to the 
movement of a globular portion containing the hydrophobic cluster of amino acids in the III -
IV linker region, the IFMT motif ('ball -and-chain' mechanism), which occludes the channel 
pore. Only when the membrane potential repolarizes, the block is relieved and the channel 
is back in its closed-state, ready for a new activation (Goldin 2003). In addition, the 
intracellular C-terminal domain has been shown to play a role in fast -inactivation as well as 
modulation by accessory β subunits was reported (Zimmer and Benndorf 2002, Chen and 
Cannon 1995, McCormick et al. 1998, McCormick et al. 1999).  
In the retina Nav channels are primarily expressed in RGCs, the sole output of the retina, 
and are responsible for inducing and propagating action potentials. However, some 
amacrine cell types, such as AII and dopaminergic A18 amacrine cells, are able to induce 
TTX-sensitive spike-like potentials as well (Miller et al. 2002, Boos et al. 1993, Feigenspan 
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et al. 1998). Interestingly, Nav channels have also been found in retinal cells, which are not 
able to fire action potentials, such as A17, starburst amacrine cells (Hartveit 1999, Cohen 
2001), cone bipolar cells (Pan and Hu 2000, Zenisek et al. 2001, Ichinose et al. 2005) and 
cone photoreceptor cells (Ohkuma et al. 2007). The specific role of Nav currents in these 
cell types remain to be elucidated. Recent work, however, could demonstrate that Nav 
channels in these cell types are important for adjusting the sensitivity over a wide range of  
illuminations and that they are directly involved in amplifying the light response of cone 
bipolar cells (Smith et al. 2013). 
*Voltage-gated potassium channels 
Voltage-gated potassium channels belong to a large family of potassium channels 
comprising the classic voltage-gated (Kv), Ca
2+
-activated (KCa), inward-rectifier (Kir), 
tandem-pore domain (K2P) and ATP-sensitive (KATP) channels (Coetzee et al. 1999, Szabo 
et al. 2010).  
Based on their membrane topology with two, four and six membrane spanning domains , 
potassium-channels can be subdivided into three groups,. wherein Kv-channels belong to 
the last group with six transmembrane domains (S1-S6). A single Kv-channel is formed by 
four of these subunits. Transmembrane segments S5 and S6 of each subunit are 
connected to the pore loop, being responsible for ion selectivity and gating, while S4 
confers membrane voltage sensitivity (Figure 1.7 A) (MacKinnon and Yellen 1990, Yool and 
Schwarz 1991). In vertebrates at least 8 different subfamilies have been described, which 
show this typical structure, containing the voltage sensor domain (S4), toxin binding sites 
and a single ion-conducting pore (Lehmann-Horn and Jurkat-Rott 1999). Interestingly, Kv-
channels are found in both excitable and non-excitable cells and are responsible for a 
variety of different functions. Not only do they control membrane resting potential and 
influence the frequency of action potential firing, but they are also important for neural 
development and have shown to be regulators of programmed cell death (Jan and Jan 
1997, Augustine 1990, McFarlane and Pollock 2000, Szabo et al. 2010, Pollock et al. 
2002, Zhong et al. 2013). 
Under normal conditions Kv-channels open upon depolarization and inactivate relatively fast 
even with prolonged stimulation. To date, two inactivation mechanism have been 
characterized: (i) N-type inactivation and (ii) P/C-type inactivation. The N-type inactivation is 
achieved through the cytoplasmic N-terminal domain that acts as a blocking peptide 
entering the channel pore. This model is also called 'ball-and-chain' mechanism and is 
relatively fast (Aldrich 2001, Hoshi et al. 1990). The P/C-type mechanism has not been fully 
understood, but the basic principle of this deactivation is a time-dependent conformational 
change that reduces the pore opening (Hoshi et al. 1991).   
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Figure 1.7 - Voltage-gated potassium channels. (A) Model of the structure of Shaker: A single Shaker 
subunit consists of six transmembrane alpha helices. The positive charges on the fourth 
transmembrane helix represent basic amino acids which function as the voltage sensor. The segment 
between the fifth and sixth helices is the pore region (P). In a tetramer of Shaker subunits four P 
regions form the channel pore.  (B) Summary of KV channel expression patterns in the retina. The 
summary is based upon immunohistochemical localization,  in situ hybridization and RT-PCR results 
from identified neurons Stippled regions indicate known sub-cellular location; striped regions 
indicated presence of mRNA in that cell type with unknown protein subcellular distribution. RPE: 
Retinal pigment epithelium; ROS: Rod outer segments; RIS: Rod inner segements; ONL: Outer 
nuclear layer; OPL: Outer plexiform layer; INL: Inner nuclear layer; IPL: Inner plexiform layer; GCL: 
Ganglion cell layer. Adapted from (Pinto and Klumpp 1998). 
 
In the mouse retina at least six different Kv-channels have been identified, each expressed 
in specific cell types (Figure 1.7 B). In RGCs Kv-channels exhibit a specific expression 
pattern in the axon, thereby controlling action potential shape. In photoreceptor cells K v-
channels are important for the neuronal excitabil ity and are thought to shape postsynaptic 
responsiveness, signal integration and neurotransmitter release (Misonou et al. 2005, 
Klumpp et al. 1995, Beech and Barnes 1989). In addition, Kv-channels have been identified 
in cholinergic and dopaminergic amacrine cells (Tian et al. 2003). For instance, studies 
demonstrated that Kv3-channels play an important role in electrical isolation of starburst 
amacrine cells, which is thought to be essential for the specific input on direction -selective 
RGCs (Ozaita et al. 2004). In the mouse rod bipolar cell different Kv-channels (Kv1.1.-
Kv1.3.) with very specific subcellular distribution have been identified by 
immunohistochemistry and RT-PCR. Kv1.1. immunoreactivity was primarily detected in the 
dendrites and axon terminals, whereas Kv1.2. subunits were localized to the axon and 
Kv1.3. to the postsynaptic membrane of the rod ribbon synapse. Their delayed outward 
rectifying currents are thought to allow complex modulation of retinal synaptic signals and 
therefore play a role in modulation of physiologic responses (Klumpp et al. 1995).  
 
Hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels are widely 
distributed throughout the CNS. The family of HCN-channels comprises four members 
(HCN1-4), with each possessing different gating properties and expression levels. As their 
name indicates HCN-channels belong to the super family of voltage-gated ion channels, 
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being activated by hyperpolarizing membrane potentials and display a reversal potential 
between 20 mV and 30 mV under physiological conditions (Seifert et al. 1999, Gauss et 
al. 1998, Ludwig et al. 1998, Kuisle and Luethi 2010). The channel pore is selective for 
both, K
+
 and Na
+
, and can be fully blocked by extracellular cesium (Cs
+
), depending on 
membrane potential (Pape 1996). In addition, HCN-channels can also be effectively 
modulated by cAMP and cGMP from the intracellular site (Ludwig et al. 1998) 
In the retina, HCN-currents were first characterized in rod photoreceptor cells in 1978, in 
which they counteract the strong hyperpolarization at high light intensities and shape the 
light response (Fain et al. 1978). In depolarizing cells, such as on-bipolar cells, it is 
hypothesized that HCN-channels set a suitable membrane potential under constant 
darkness for a fast light-response onset. Throughout the retina HCN-channels have been 
identified in various cell types, including rod and cone photoreceptor cells, bipolar cells 
and RGCs (Fyk-Kolodziej and Pourcho 2007, Muller et al. 2003, Stradleigh et al. 2011) .  
Studies in isolated rod bipolar cells from rats revealed slow inward-rectifying currents 
during hyperpolarizing steps, which are similar to H-type rectifier Ih currents, first described 
in cardiac cells and rod inner segments in salamander (Karschin and Wassle 1990).  
 
Kir channels induce a different potassium current in retinal bipolar cells besides K v- and 
hyperpolarization-activated channels. These time-independent Kir currents are primarily 
present in a subset of cone bipolar cells and show typical biophysical and pharmacological 
properties, i.e. inward-rectification, sensitivity towards Barium (Ba
2+
) and a reversal potential 
of around 87 mV (Ma et al. 2003). However, Kir channels are also highly expressed in 
retinal glial cells, thereby controlling extracellular K
+
 concentration by K
+
buffering currents, 
due to their high open-probability around resting potential (Ishii et al. 1997). 
 
 It is supposed, that the combination of outward- and inward-rectifying potassium 
channels may be responsible for setting the membrane resting potentials in bipolar cells. 
However, the differential expression of Kv, Ih and Kir currents in specific subsets of retinal 
bipolar cells suggest a more complex role in respect of physiological relevance.  
 
*Voltage-dependent calcium channels 
In contrast to sodium and potassium ions, calcium not only play an electrogenic role for 
altering the membrane potential, but it is also a major intracellular signal controlling 
numerous cellular events (Berridge et al. 2000). Opening of voltage-dependent calcium 
channels (Cavs) lead to the influx of calcium into the cytosol. Under normal resting potential 
the intracellular calcium concentration only reaches about 100 nM due to calcium buffering 
molecules and intracellular stores (Clapham 2007). Upon activation of Cavs, the 
intracellular concentration can rise into the high micromolar range (Wadel et al. 2007), 
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ultimately leading to diverse processes, such as neurotransmitter release, activation of 
calcium-dependent enzymes or gene transcription. Therefore Cavs are transmitting 
information between electrical, i.e. depolarization of the cell membrane, and chemical 
signals, i.e. activation of a signaling cascade.  
Cavs are large, multi-subunit transmembrane proteins and are divided into two major 
groups, low voltage-activated (LVA) and high voltage-activated (HVA) channels(Armstrong 
and Matteson 1985, Bean 1985). LVA calcium channels require only modest depolarization 
to activate, around the resting membrane potential of 70 mV, and show rapid inactivation, 
whereas HVA channels require larger depolarization. The threshold for HVA Cav-activation 
usually lie between 40 mV and 20 mV (Baumgart and Perez-Reyes 2010). HVA Cavs are 
heteromultimeric receptors comprising the channel domain Ca vα1 and two ancillary 
proteins Cavβ- and Cavα2δ, whereas LVA Cavs do not require additional subunits (Catterall 
et al. 2005). 
All α1-subunits are composed of four domains (I-IV) and each domain consist of six 
transmembrane helices (S1-6). The voltage-sensor (S1-4) and the pore-forming amino acid 
residues (S5-6) both belong to domain I (Catterall 2000, Arikkath and Campbell 2003). The 
sides for intracellular communication reside at the cytoplasmic N- and C-termini, as well as 
in three inter-domain loops (I-II, II-III and III-IV) (Van Petegem and Minor 2006) (Figure 1.8). 
 
 
Figure 1.8 - Subunit structure of CaV1 channels. The subunit composition and structure of calcium 
channels purified from skeletal muscle are illustrated. The model is updated from the original 
description of the subunit structure of skeletal muscle calcium channels. This model fits available 
biochemical and molecular biological results for other CaV1 channels and for CaV2 channels. 
Predicted α-helices are depicted as cylinders. The lengths of lines correspond approximately to the 
lengths of the polypeptide segments represented. Click image for full size. Figure adapted from 
(Catterall et al. 2005). 
 
The Cavα1-subunits are divided into three major groups, Cav1, Cav2 and Cav3 (Figure 1.9). 
The Cav1-family encodes four different channels (Cav1.1-Cav1.4), which are sensitive to 
various dihydropyridines (DHP) agonists and antagonists (Randall and Tsien 1995). Except 
for Cav1.1, which is a skeletal muscle L-type calcium channel, the remaining three Cav1 are 
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all neuronal L-type calcium channels. These channels exhibit a long-lasting activation with 
slow deactivation kinetics and play a major role in heart tissue, neuroendocrine cells and in 
the retina. Cav1.2 channels interact with Calmodulin (CaM) and have been linked to play an 
essential role in CREB signaling in the hippocampus during LTP and spatial learning, as 
well as cardiac contraction. Cav1.3 channels have been identified in the dendritic arbors of 
postsynaptic cells regulating its excitability, whereas Cav1.4 channels are mainly expressed 
in the retina. Dysfunction of Cav1.4 channels has been linked to myopia and night 
blindness (Morgans et al. 2005), as it is mainly localized at the ribbon synapse of rod 
photoreceptor cells. Here, they regulate sustained neurotransmitter release by tonic calcium 
influx at low depolarization. 
The Cav2-family is divided into three subtypes (Cav2.1, Cav2.2, Cav2.3), of which the Cav2.1 
subtype give rise to P- and Q-type channels, Cav2.2 to N-type channels and Cav2.3 to R-
type channels (Figure 1.9). P-/Q-type, and N-type calcium channels have been linked to 
neurotransmitter release at the presynaptic terminal and exhibit fast activation kinetics 
(<3 ms). R-type channels are mainly expressed in the brain, but have been also found in 
the pancreas, kidney and the heart (Grabsch et al. 1999, Vajna et al. 1998). They exhibit 
fast activation and inactivation kinetics (1 ms and >100 ms, respectively) providing a 
transient surge of calcium influx.   
For the family of Cav3-channels three members have been identified (Cav3.1, Cav3.2 and 
Cav3.3), which all belong to the group of T-type calcium channels. T-type calcium channels 
are activated in the same range as voltage-dependent sodium channels near resting 
potential (55 mV) and are important for repetitive firing of action potentials (i.e. burst 
firing) for instance in cardiac myocytes.  
 
 
Figure 1.9 - Graphical overview of voltage-gated calcium channel α1-subunits. Cav-subunits are 
structurally divided into three main groups 1-3, comprising three to four subtypes. Blue: High-voltage 
activated (HVA), green: Intermediate-voltage activated (IVA) and purple: Low-voltage activated (LVA) 
calcium channels. At the bottom of the diagram the specific blockers for the channel families are 
shown. 
 
Due to the importance of calcium as a cellular signal and the fact that prolonged calcium 
entry is associated with cell death, calcium-influx is tightly regulated.  
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All Cavs are regulated by voltage- and/or calcium-dependent inactivation (VDI and CDI, 
respectively). In HVA calcium channels the VDI is partially modulated by the ancillary Ca vβ-
subunit and amino acid residues in the I-II linker region or in S6 of the major 
transmembrane domains. The Cavβ-subunits are cytoplasmic proteins which are furthermore 
important for the trafficking of the Cavα1-subunit, as they prevent ubiquitination and mask 
intrinsic ER-retention signals leading to higher cell surface expression levels. For LVA 
calcium channels, on the other hand, VDI has been proposed to be mediated by an 
inactivation particle in the linker III-IV domain similar to sodium channel inactivation (Simms 
and Zamponi 2014). Yet, exact mechanism is still unclear and need further investigation. 
CDI has been described in greater detail and has been shown to be highly dependent on 
CaM, which is anchored to the C-terminus of the Cavα1-subunit. Upon binding of Ca
2+
, CaM 
undergoes conformational changes inducing CDI. For Cav1.2 and Cav1.3 only local Ca
2+
 
rises are required, whereas global Ca
2+
 increase is necessary for CDI in Cav2 channels. 
Cav2.1 channels exhibit an additional Ca
2+
-dependent regulation, calcium-dependent 
facilitation (CDF), which is also mediated through CaM-binding and requires only local 
calcium concentration increase, in contrast to CDI (Chaudhuri et al. 2007). 
Current density is furthermore affected by Cav-expression, which is highly influenced by 
expression of Cavα2δ subunits. Cavα2δ subunits are only associated with HVA channels and 
are mainly responsible for channel trafficking to the plasma membrane. They are composed 
of two peptides (Cavα2 and Cavδ) that are linked through disulfide bonds. The Cavδ subunit 
contains a transmembrane helix anchoring the Cavα2-subunit which extends to the 
extracellular space (Wolf et al. 2003).  
An additional ancillary protein, Cavγ, has been identified for skeletal muscle Cav1.1 
channels. Cavγ subunits are not only responsible for regulating channel functions of Cav1.1, 
but have also been shown to influence AMPA receptor trafficking ('stargazin') . Therefore, 
their function may be more general and it is a matter of debate whether they are true Cav 
subunits (Simms and Zamponi 2014).  
*Transient receptor potential (TRP) channels 
Transient receptor potential (TRP) channels, are non-selective cation channels (Owsianik et 
al. 2006). Altogether 28 TRP channels have been identified in mammals, divided into six 
subfamilies, TRPA, TRPC, TRPM, TRPML, TRPP and TRPV channels, which are combined to 
either homo- or heterotetramers (Gilliam and Wensel 2011). 
TRP channels are expressed in neural as well as non-neural tissue and their physiological 
roles are diversified. Activation and modulation of TRP channels can be achieved by many 
different stimuli, inter alia: ligand binding, membrane stretch, temperature change, 
endocannabinoids or phospholipids (Song and Yuan 2010, Damann et al. 2008).  
Although most TRP channels have not been characterized in detail in the retina, diseases 
affecting TRP channels provide deep insight into their physiological roles. For instance, TRP 
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channels have been reported to contribute to pressure-induced apoptosis in RGCs in 
glaucoma (TRPV1 and TRPV4) (Sappington et al. 2009, Ryskamp et al. 2011). Due to the 
essential role of TRPM1 and TRPML1 in the excitability of on-bipolar cells (see section 
1.1.3), mutations in these genes are a major cause for night blindness and retinal 
degeneration (Audo et al. 2009, Sun et al. 2000). A more comprehensive overview of TRP 
channel expression and function in the mammalian retina has been provided by Gilliam and 
Wensel, 2011. 
*Cyclic nucleotide-gated (CNG) channels 
Cyclic-nucleotide gated (CNG) channels are opened by intracellular binding of cGMP and 
cAMP, and are only weakly voltage-dependent; nonetheless, the CNG-channels belong to 
the class of voltage-gated ion channels. Six different subtypes divided into two groups (A1-
A4 and B1-B2) combine to three distinct heterotetrameric channels with either two or three 
different subunits (Kaupp and Seifert 2002). Each subunit possesses six transmembrane 
segments and the pore loop between S5 and S6 is the best conserved region among 
channel subtypes.   
CNG-channels are non-selective cation channels and are therefore permeable to Na
+
, K
+
, 
as well as divalent cations, in particular Ca
2+
. Interestingly, for Ca
2+
 permeation the divalent 
cation needs to bind to a specific site inside the pore, thereby prohibiting the permeating of 
monovalent cations, allowing only Ca
2+
 to pass through the pore. This Ca
2+
 block is 
strongly voltage-dependent with inward currents being much more effected than outward 
currents (Colamartino et al. 1991, Frings et al. 1995). 
CNG channels have first been described in by Fesenko et al. in 1985. They revealed that 
cGMP can directly open light-dependent channels in rod photoreceptor cells. Shortly 
thereafter, CNG channels have also been identified in cone photoreceptors and in cilia of 
olfactory sensory neurons (Fesenko et al. 1985, Haynes and Yau 1985, Nakamura and 
Gold 1987). In the retina CNG-channels are strongly discriminating between cGMP and 
cAMP, while in chemosensitive cilia of the olfactory system most receptors respond to both 
cyclic nucleotides equivalently (Tanaka et al. 1989, Frings et al. 1992). Besides the retina 
and the olfactory system, CNG-channels have also been found in several other types of 
neurons and even in non-excitable cells, such as human aveolar cells or endothelial cells of 
pulmonary artery (Xu et al. 1999, Wu et al. 2000). Their specific role in non-excitable cells, 
however, is rarely understood and requires further investigation (Biel and Michalakis 2007). 
1.2 Retinal diseases/Retinal degeneration 
Degenerative diseases that affect the retina, such as retinitis pigmentosa (RP) or age -
related macular degeneration (AMD), result in visual impairment and blindness, with no 
cure currently available. To date, it is estimated that more than 270 million people are 
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suffering from blindness or impaired vision worldwide (WHO 2014). In the progression of 
most retinal degeneration diseases at first rod and secondly cone photoreceptor cells 
slowly degenerate, which eventually is followed by a remodeling of the remaining retinal 
circuitry (Marc et al. 2014, Marc et al. 2008).  
1.2.1 Inherited retinal diseases (RP and AMD) 
In industrialized countries, retinitis pigmentosa (RP) and age-related macular degeneration 
(AMD) are the two most occurring inherited retinal diseases causing blindness  by 
photoreceptor cell degeneration. RP has a prevalence of about 1:4,000, thus affecting 
more than 1 million people worldwide (Hartong et al. 2006). The age of disease onset 
strongly depends on the type of RP and varies from early childhood to late adulthood. 
Generally three types of RP are distinguished based on their mode of inheritance: (i) 
autosomal recessive, (ii) autosomal dominant, or (iii) X-linked recessive mode. However, 
some cases have also been linked to other systemic diseases, such as Usher syndrome 
and Bardet-Biedl syndrome (Samardzija et al. 2010). Often the onset of RP is accompanied 
with some degree of night blindness, caused by rod photoreceptor cell death  in the 
periphery. In many cases also the cone-mediated peripheral vision is lost in early stages of 
the disease, leading to an effect called tunnel vision (Figure 1.10 B). 
 
Figure 1.10 - Examples for visual experiences of RP and AMD patients. (A) Example of a normal visual 
perception. (B) Visual perception in RP patients. Peripheral vision is lost first due to death of rod 
photoreceptor cells eventually leading to complete blindness. (C) Visual perception in AMD patients. 
Due to drusen accumulation and neovascularisation central vision in the macula lutea is lost first 
followed by death of photoreceptor cells in the periphery of the retina . 
 
In the final stage of the disease, people eventually undergo complete photoreceptor 
degeneration, although in most types of RP only rod photoreceptor genes are affected. This 
effect is also described as rod-cone dystrophy (FoundationFightingBlindness 2015).  
AMD is a very heterogeneous disease affecting mainly adults older than 65 years (Klein et 
al. 2002). The disease is not only caused by genetic factors, but also environmental 
aspects play a role in its emergence. As the name indicates, the disease first manifests in 
the macula lutea (Figure 1.1 A), therefore central vision is lost first (Figure 1.10 C and 
Figure 1.11). AMD can occur in two different forms, "dry" and "wet" AMD. "Dry" AMD is a 
non-neovascular form and is the most common type of macular degeneration. It is 
characterized by the presence of yellow deposits (drusen), accumulation of extracellular 
material between the RPE and Bruch's membrane (Figure 1.11 A). Small and rigid deposits 
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appear normally during the aging process, while in AMD patients an increased number and 
much softer drusen appear (Figure 1.11 C and D). This different appearance of drusen is 
leading to an atrophy in the RPE. With the RPE being the main source of nutrients of the 
photoreceptor cells, drusen eventually cause photoreceptor cell death.   
 
 
Figure 1.11 - Age-related macular degeneration. (A) Schematic drawing of a healthy retina.  (B) 
Normal macula of an elderly patient. The asterisk represents the location of the fovea, which lies 
directly in the visual axis. The macula (boxed area), which is adapted for high acuity v ision, is located 
temporal to the optic nerve (arrow). It is approximately 6 mm in diameter and centered on the fovea. 
The vascular arcades are indicated by arrowheads.  (C) Schematic drawing of a retina with "dry" 
AMD. (D) Color fundus photograph from an individual with dry AMD. Numerous small and 
intermediate-sized drusen are visible in the macular region (oval) . (E) Schematic drawing of a retina 
with "wet" AMD. (F) Color fundus photograph from an individual with end stage "wet" AMD. A large 
disciform scar (arrowhead) covering the macular region is distinctly visible . Figure B, D and F 
adapted from (Hagemann). 
 
While this degenerative process is rather slow, in "wet" AMD retinal degeneration 
progresses more rapidly. Deposits and other factors, such as genetic predisposition, eye 
color or sex are associated with "wet" AMD and may induce inflammatory processes and 
oxygen deficiency in the eye (Green 1999, Zarbin et al. 2014, Age-Related Eye Disease 
Study Research 2000, Klaver et al. 1998). This in turn leads to increased release of the 
growth factor VGEF-A (vascular endothelial growth factor A), which induces the outgrowth 
of new blood vessels (neovascularization) (Kvanta et al. 1996, Lopez et al. 1996). These 
blood vessels even break through Bruch's membrane, invading the retina, thereby causing 
even stronger inflammation (Figure 1.11 E and F). This turns into a vicious cycle, since 
stronger inflammatory processes cause stronger neovascularization, which leads to fast 
degeneration of the photoreceptor cells, not only effecting central vision, but eventually 
leading to complete blindness (Zarbin 2004, Zarbin et al. 2014). 
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1.3 Mouse models of ret inal  degenerat ion 
Animal models of retinal degeneration are indispensible for understanding the underlying 
mechanisms of retinal diseases and testing possible treatments. Numerous mouse lines 
exist, which exhibit specific mutations linked to retinal diseases. The most prominent RP 
model is the naturally occurring rd1 mouse model. In this mouse line rod 
phosphodiesterase 6B (PDE6B) is affected, inducing an early onset and very aggressive 
form of RP, similar to the progression in PDE6B-associated autosomal recessive RP in 
human patients (Bowes et al. 1990, Chang et al. 2002, Danciger et al. 1995, McLaughlin et 
al. 1995). Like rd1 other naturally occurring mouse lines have been identified for retinal 
degeneration, such as the rd10 mouse model. In this mouse line, PDE6B is also affected, 
however the mutation has less impact on protein function, thereby leading to a much later 
onset and slower progression of disease. In contrast to early onset of retinal degeneration 
in rd1 mice, in rd10 mice the retina is terminally matured before signs of disease occur 
(Chang et al. 2007, Gargini et al. 2007, Han et al. 2013). In addition to naturally occurring 
mouse lines with retinal degeneration, also transgenic animals have been developed. By 
mutating specific proteins important for vision, progression and impact on diseases can be 
closely monitored.  
 In addition to the specific retinal degeneration models mimicking human diseases, 
mouse models have been developed that have no light perception from birth. These mouse 
lines lack all essential proteins for light perception in rod and cone photoreceptor cells as 
well as melanopsin (opn4), the light perceiving protein in ipRGCs. Two of these mouse 
lines are the opn4
-/-
,rd1/rd1 mice (Polosukhina et al. 2012) and a not yet published mouse 
line cnga3
-/-
,rho
-/-
,opn4
-/-
, which is based on the double knock-out mouse line cnga3
-/-
,rho
-/-
 
by Claes et al. 2004.(Claes et al. 2004) 
Many diseases, such as AMD, RP, diabetic retinopathy, however, have multiple origins, inter 
alia mutations in different gene loci, and may also be influenced by environmental factors 
(Fletcher et al. 2011). Therefore, mouse models of retinal degeneration can provide only 
limited information about the causes of disease and progression in human patients. For 
instance several mouse models for AMD have been established, but none of the lines are 
able to mimic both, early and late features of the disease (Zeiss 2010). Furthermore, the 
major drawback of using mouse models is the lack of an anatomical macula, the area of 
AMD onset and the area for central high-acuity vision in humans (Pennesi et al. 2012). 
Therefore, mouse models can only provide first insights into possible treatments and 
experiments must be followed up in higher animals.  
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1.4 Current approaches for restoration of vision 
Restoration of vision is a complex challenge and several research approaches are currently 
under investigation. The furthest in terms of clinical application is retinal  prosthesis 
implantation. However, other approaches including gene therapy and photopharmacology 
have made substantial progress within the past decade, representing promising alternative 
approaches. 
1.4.1 Retinal prostheses 
Prostheses are divided into extraocular prostheses, i.e. cortical and optic nerve prostheses. 
and intraocular, i.e. epi- and subretinal implants (Figure 1.12 A, red and blue, respectively). 
Epiretinal prostheses are sitting closely on top of the RGC layer stimulating the remaining 
RGCs with an image captured and transformed by a digital camera (Kien et al. 2012, 
Chuang et al. 2014). The most prominent epiretinal prostheses is the Intraocular Retinal 
Prosthesis by Mark Humanyun (Second Sight Medical products, Inc.)  (Javaheri et al. 2006). 
This device was the basis for further development resulting in Argus I, which has firstly 
been used in humans, and the second version currently available, Argus II (Stronks and 
Dagnelie 2014, da Cruz et al. 2013).  
Subretinal prostheses are micro-photodiode arrays based on a semiconductor chip 
technology. In this approach the electric current is generated within the device by 
transforming light into electric current. This current is transmitted directly from micro-
photodiodes to the output of the device, the micro-electrodes (Zrenner et al. 1997, Zrenner 
et al. 1999). The principle has first been designed by Chow et al. (Chow 1993) and to date 
different approaches that utilize this technology, such as alpha-IMS, are under investigation 
in animal studies (Chow and Chow 1997, Colthurst et al. 2000, Chow et al. 2002, Gekeler 
and Zrenner 2005, Stingl et al. 2013). 
Prosthetic approaches are promising for restoration of low resolution images, nevertheless, 
they entail certain drawbacks. Not only is implantation of a retinal device highly invasive  
and expensive, but also the durability of the materials is limited and further research for 
better components needs to be done (Colthurst et al. 2000, Chow et al. 2002, Weiland et 
al. 2011, Chuang et al. 2014). 
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Figure 1.12 - Vision restoration approaches. (A) Retinal implants, such as Argus II (red) or the alpha-
IMS subretinal microchip (blue) are the most advanced approach for vision restoration in terms of 
clinical application. (B) Stem cell transplantation is used in the context of replacing the RPE for 
diseases such as LCA and recessive dystrophies. (C) Channelrhodopsin-2 and other light-sensitive 
proteins can be virally delivered to retinal cells, thereby rendering them sensitive to light.  (D)  
Enlargement of boxes in figure (C). D1: In this approach, ChR-2 is expressed in on-bipolar cells. D2: 
The light-sensitive kainate receptor LiGluR is specifically expressed in on-bipolar cells. The 
photoswitch needs to be injected into the intravitreal cavity to bind to the genetically engineered 
receptors. 
 
1.4.2 Gene therapy 
*Stem cell therapy  
Stem cell therapy approaches for retinal diseases are currently in phase I clinical. Many 
different cell types are under investigation, such as human embryonic, fetal or umbilical 
cord-tissue derived stem cells as well as bone-marrow derived stem cells (Ramsden et al. 
2013). To date, stem cell transplantation is primarily used in the context of replacing the 
RPE (Figure 1.12 B). Not only in diseases like Leber's Congenital Amaurosis (LCA) and 
recessive retinal dystrophies, but also in AMD the RPE is a major component involved in 
retinal degeneration (Jazwa et al. 2013, den Hollander et al. 2010, Schwartz et al. 2012) .  
Many clinical trials are currently recruiting patients, nevertheless, this approach still has 
challenges to overcome. Firstly, this approach is only limited to early onset of disease, 
when the retina is still intact. Secondly, the surgical approach is highly invasive and 
surgeons need to be trained accordingly, which is associated with high costs, as it is the 
case for retinal prosthetics. Thirdly, the approach is irreversible, which will be problematic 
for future innovation and improvement of the therapy in single patients. And finally,  possible 
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immune responses (immunogenicity) cannot be eliminated, neither short term nor long 
term. 
*Channelrhodopsin et al. 
A different genetic approach is based on the introduction of optogenetic tools (Figure 1.12 
C and D). Microbial opsins, such as Channelrhodopsin (ChR) and Halorhodopsin (NpHR) 
(Figure 1.12 D1) have been demonstrated to successfully restore visual responses in 
animal models of RP (Lagali et al. 2008, Busskamp et al. 2010, Doroudchi et al. 2011, Bi 
et al. 2006, Thyagarajan et al. 2010). A more recent approach has shown that a chimera of 
mGluR6 and melanopsin, the intrinsic photoreceptor of ipRGCs, (opto-mGluR6) is able to 
elicit light responses in rd1/rd1 mice, activating the native signaling pathway at ambient 
light intensities (van Wyk et al. 2015). In a similar approach, an intrinsic receptor iGluR is 
modified in such a way that an introduced artificial azobenzene-based photochromic ligand 
can light-activate the receptor (photochromic tethered ligand (PTL) approach) (Figure 1.12 
D2) (Caporale et al. 2011, Gaub et al. 2014). The receptors can be expressed in retinal 
cells using either viral or non-viral gene transfer, and have successfully been implemented 
in remaining cone photoreceptors, on-bipolar cells and RGCs (Busskamp et al. 2010, 
Lagali et al. 2008, Doroudchi et al. 2011, Thyagarajan et al. 2010, Bi et al. 2006).  
Both approaches, however, have their caveats and tradeoffs. Gene transfer, and especially 
xenotransplantation, can be critical for immune responses and furthermore, the 
implementation is irreversible. Although the introduction of the gene is irreversible, the PTL 
approach has the advantage of an interchangeable photoswitch ligand. This not only rises 
the opportunity for further optimization by developing novel molecules, but also leaves the 
possibility of silencing the system, if required. Yet, once expressed, the target receptor 
cannot be optimized any further. 
1.4.3 Photopharmacology 
*Principles of photopharmacology 
The photopharmacological approach is a simple, yet effective way using a photochromic 
ligand (PCL) for the activation of a native channel with light. PCLs are small molecules that 
combine a pharmacophore with a photoswitchable moiety, such as an azobenzene 
(Fehrentz et al. 2011, Fortin et al. 2008). These PCLs can exist in two different 
configurations, i.e. (i) in their dark-adapted, thermodynamically stable trans-configuration, 
and (ii) in their less stable cis-configuration when illuminated with certain wavelengths 
(Figure 1.13 A). By changing the configuration of the PCL with light, its efficacy is changed, 
thereby controlling the open probability or activity of a channel or receptor, respectively. 
This approach has been used successfully to photosensitize various membrane proteins, 
such as voltage-gated potassium channels, KATP channels, GPCRs and AMPA receptors 
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(Fehrentz et al. 2011, Broichhagen et al. 2014b, Schonberger and Trauner 2014, Stawski 
et al. 2012). Furthermore, it has been demonstrated that also enzymes like the 
acetylcholine esterase can be activated and inactivated by light using photochromic ligands 
(Broichhagen et al. 2014a). 
 
 
Figure 1.13 - Principle of Photopharmacology. (A) Schematic representation of the photoswitch 
mechanism. The azobenzene moiety (red) can be switched between trans- and cis-configuration 
using specific wavelengths. Depending on the ligand (orange ball) the photochromic ligand can 
either bind to a specific receptor or function as a channel blocker.  (B) Molecular structure of AAQ, a 
first generation photoswitchable potassium channel blocker sensitive to UV light. (C) DENAQ, a 
second generation photoswitchable potassium channel blocker sensitive to blue and white light.  
 
This approach has great advantages by being a mere pharmacological treatment. Most 
importantly no genetic manipulation is required, and therefore the approach is less invasive 
and comparatively cheap. In addition, the photochromic ligand can be added or removed 
from the system as needed. This allows for further development and application of new 
photochromic ligands and in case of undesirable side effects treatment can be stopped at 
any time. 
 
*Photopharmacology for restoration of vision 
The application of photochromic open-channel blockers to blind retinae has been shown to 
be a promising approach towards restoration of vision. For sake of simplicity the blockers 
will divided into generations based on their basic properties. The first PCL applied to blind 
retina was AAQ (Figure 1.13 B), which has the basic characteristics of an azobenzene-
based photochromic ligand, i.e. the switching wavelengths are near UV light (360380 nm) 
for trans- to cis-isomerization and blue light (440480 nm) for reverting the molecule back 
to its thermodynamically more stable trans-configuration. Thermodynamic relaxation back to 
trans-configuration is too slow, therefore AAQ needs to be switched back actively for 
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application in fast biological systems (Polosukhina et al. 2012). In the retina, AAQ activates 
multiple retinal cell types, but primarily inhibitory neurons. With intravitreal injections of high 
AAQ concentration (80 mM AAQ containing 40 % DMSO) light-dependent behavior could 
be restored in rd1/rd1 mice, however, UV light and the very low solubility are two severe 
limitations for possible applications in human patients. 
The second generation PCL, DENAQ, was already superior to the first generation, by being  
switched to its active cis-configuration with blue light (440480 nm). Furthermore the 
thermodynamic relaxation back to trans-configuration is fast enough with no need for 
switching it back actively (Figure 1.13 C). In the retina, DENAQ primarily targets RGCs and 
interestingly, it does only photosensitize retina undergoing degeneration. This effect is 
caused by an up-regulation of HCN-channel expression, the target channel of DENAQ, in 
RGCs during retinal degeneration (Tochitsky et al. 2014, Tochitsky and Kramer 2015). In 
addition, DENAQ was able to restore light-dependent behavior after intravitreal injections 
with lower concentrations compared to AAQ. Nevertheless, the solubility of DENAQ is too 
low to apply the molecule without the need of additional solvents, such as DMSO (Tochitsky 
et al. 2014). 
Both, first and second generation photochromic blockers, have made great progress in the 
field of vision restoration using PCLs. However, PCLs with different selectivity and mode of 
action, as well as with higher solubility need to be developed to further improve the 
treatment of vision loss using this approach.  
1.5 Objectives 
1.5.1 Restoration of light sensitivity in blind retina 
The overall goal of this work is the restoration of light -sensitivity in blind retinae ex-vivo 
using novel (next-generation) PCLs. Ex-vivo studies represent the very first step towards 
vision restoration in human patients. To achieve this goal, different PCLs need to be 
analyzed for their mode of action and efficacy in explanted blind murine retinae. 
Investigation of possible candidates can be done by a combinatorial approach using multi -
electrode arrays (MEAs) and the whole-cell patch clamp technique.  
In this work I will not only provide information about a new, third generation photochromic 
open-channel blocker with a different mode of action than to AAQ and DENAQ. I will also 
demonstrate that a freely diffusible photochromic agonist for LGICs is able to induce light-
dependent spiking patterns in blind retinae, which has not been investigated before. 
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1.5.2 Basic characterization of PCLs in murine brain slices 
In the second part of my thesis I will investigate the specificity and properties of PCLs in 
murine brain slices. PCLs can be widely used in neuroscience to indentify underlying 
mechanisms of receptor activation. However, novel PCLs first need to be thoroughly tested 
to ensure high specificity for certain receptors. This can be done by heterologously 
expressing target receptors in HEK cells and performing patch clamp experiments.  To gain 
even deeper insight into the working mode of newly-synthesized PCLs, investigation of their 
actions in intact neural tissue, such as hippocampal brain slice from mice, is very useful. 
Using the patch-clamp technique and MEA recordings with different pharmacological 
profiles, one can thus identify target receptors in their native environment . 
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2  Materials and Methods 
2.1 Materials 
2.1.1 List of compounds 
 
Table 1 - List of compounds investigated in this work 
 
ATG Dr. Vilius Franckevicius 
rsATG Dr. Vilius Franckevicius 
cis-Stilbene Felix Hartrampf 
ATA Dr. Philipp Stawski 
ATA-Na
+
 Katharina Hüll 
DAD Dr. Marco Stein 
DAD-HCl Dr. David Barber 
GluAzo 
Dr. Matthew Volgraf,  
Dr. Alwin Reiter 
rsGluAzo Dr. Alwin Reiter 
AzoCholine Dr. Tatsuya Urushima 
BisQ 
Dr. Tatsuya Urushima,            
Dr. Johannes Broichhagen 
 
2.1.2 Solutions for patch-clamp and MEA recordings. 
Extracellular solutions 
Solutions were freshly prepared on the day of experiment to prevent bacterial outgrowth. 
For brain slice preparation a cutting solution was used for maximal integrity of neurons 
(Bischofberger et al. 2006). This solution was sucrose based and contained high Mg
2+
 
concentrations (table 2). Patch-clamp as well as MEA experiments were performed in ACSF 
(table 2). Both cutting solution and ACSF were oxygenated with carbogen 
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(5 % CO2/95 % O2) to set pH at 7.2. In 0MgCl2-ACSF Mg
2+
 was not replaced by a different 
ion.  
For retinal slice preparation the pH needed to be set at 7.2-7.4 without oxygenation, 
therefore NaHCO3 was replaced by HEPES and the pH was set to 7.4 using 1M NaOH or 1M 
HCl (HEPES ringer) (table 2). Slices were prepared in a 3 % low-melting agarose block in HEPES 
ringer (see section 2.2.3).  
 
 
Table 2 - Buffers and extracellular solutions 
 
ACSF [mM] 
125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, 
1 MgCl2, 20 glucose saturated with carbogen (95% O2 and 5% 
CO2) 
Cutting Solution [mM]  
87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 0.5 CaCl2, 
7 MgCl2, 25 glucose, 75 sucrose saturated with carbogen 
(95 % O2/5% CO2)  
HEPES Ringer (HR) [mM] 
125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 20 HEPES, 2 CaCl2, 
1 MgCl2, 20 glucose (pH 7.4) 
PBS [mM]:  137 NaCl, 2.7 KCl, 10 Na2HPO4, 1.8 KH2PO4  
low-melting agarose (3%) 25 mL HEPES Ringer w/ 0.75 g low melting agarose  
Eylea 
40 mg/ml Eylea in 10 mM sodium phosphate, 40 mM 
sodium chloride, 0.03% polysorbate 20, and 5% sucrose, 
pH 6.2 
 
Intracellular solutions 
Intracellular solutions for patch-clamp recordings are listed in table 3. All components 
except for ATG and GTP were added to 8 ml water. The solution was stirred for 30 min at 
room temperature and ATP and GTP were added. The pH was adjusted to 7.3 using KOH 
and the volume was filled to reach 10 ml. Finally the osmolarity was checked to be 
approximately 300 mOsm (table 3). For storage aliquants of approximately 200 µL were 
prepared and stored at 20 °C until further use. For patch-clamp recordings using LL2 the 
intracellular solution needed to be diluted with ddH2O (80:20 LL2'/ddH2O). For Ca
2+
 
imaging experiments Fura-2 was added to the intracellular solution to a final concentration 
of 50 µM. For immunohistological analysis a final concentration of 0.1 % neurobiotin (v/v) 
and for intracellular block of NMDA receptors a final concentration of 1 mM MK-801 was 
added to the LL2 solution. Before use the LL2 solution was filtered through a 0.2 µM filter 
device. 
All other intracellular solutions were filtered prior preparation of aliquants and stored at 
20 °C until further use. 
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Table 3 - Intracellular solutions 
 
LL1 [mM] 
110 Cs-gluconate, 15 NaCl, 10 HEPES, 5 TEA, 0.16 EGTA, 
4 Mg-ATP, 0.4 Na-GTP pH 7.3 with CsOH (300 mOsm) 
LL2' [mM] 
140 K-gluconate, 10 HEPES, 12 KCl, 4 NaCl, 4 Mg-ATP, 
0.4 Na-GTP, pH 7.3 with KOH (360 mOsm) 
LL3 [mM] 
120 Cs-methansulfonate, 5 TEA-Cl, 10 HEPES, 3 NaCl, 
10 EGTA, 2 QX-314ˑCl, 2 ATG-Mg, 0.3 GTP-Na, pH 7.3 with 
CsOH, 0.1 % Neurobiotin (300 mOsm) 
 
 
 
Antagonists and Blockers 
Antagonists and blockers were all added to the extracellular solution except for TEA, QX-
314 and MK-801, which were added to the intracellular solution, if required (table 3).  
 
Table 4 - List of antagonists and blockers  
 
NBQX 25 E Abcam 
D-AP5 50 E Abcam 
TTX 1 E Abcam 
Felodipine 40 E BioTrend 
MK-801 1000 I Abcam 
TEA 5000 I Sigma Aldrich 
QX-314 2000 I Tocris 
CdCl2 500 E Roth 
Strychnine 1 E Sigma Aldrich 
Picrotoxin 5 E Sigma Aldrich 
TPMPA 10 E Sigma Aldrich 
L-AP4 10 E Tocris 
Ivabradine 50 E Sigma Aldrich 
Cilobradine 50 E Sigma Aldrich 
2.1.3 Solutions for immunofluorescence staining 
Paraformaldehyde (PFA) solution was prepared under the hood to avoid inhalation of 
evaporating gases during the preparation process. 200 ml ddH2O with 10 g PFA and two 
drops 1 M NaOH were stirred at 60 °C for at least 30 minutes. Then 25 ml of 10x 
phosphate buffered saline (PBS) was added to the cleared solution and ddH2O was added 
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to a total volume of 250 ml (Table 5). The solution was filtered and aliquants of 
approximately 2 ml were stored at 20 °C. 
For immunohistological stainings wash and blocking solutions were prepared according to 
table 5. The blocking solution was also used for antibody incubation (see section 2.2.8).  
 
 
Table 5 - Solutions for immunofluorscence stainings 
 
PFA (4 %) 
200 ml of 1 X PBS with 10 g of paraformaldehyde powder, 
adjust volume to 250 l 
wash solution PBS + 0.3 % Triton X-100  
blocking solution PBS + 5 % normal goat serum (NGS) + 0.3 % Triton X-100 
 
2.2 Methods 
2.2.1 Acute brain slice preparation 
Brain slices were prepared from wild-type (wt) mice (P10-P15) if not stated otherwise. Mice 
were decapitated at the level of the cervical medulla using curved scissors. Skin and skull 
were cut sagitally from the caudal to the frontal until reaching the olfactory bulb. The left 
and right parts of the skull were carefully removed using curved forceps. The brain was cut 
caudal of the olfactory bulb and in rostral of the cerebellum. The brain was quickly removed 
using a spatula and transferred to ice-cold cutting solution. For coronal slices the brain was 
glued to the specimen disc with the rostral side downwards (UHU Sekundenkleber, Buehl, 
Germany). Slices (250 µm) were cut from the caudal side using a Campden vibratome 
7000 smz-2 (NPI Electronic). The hemispheres were divided and transferred to an 
incubation chamber (Figure 2.1 A). The slices were incubated at 34°C for at least 30 min 
and no longer than 1 hour in ACSF (O2/CO2). After incubation, slices were stored at room 
temperature for no longer than 5 hours prior recording and experiments were performed at 
room temperature unless stated otherwise.   
For preparation of horizontal slices the brain was placed rostral side down on a filter paper.  
Approximately 1  3 mm of the dorsal part of the brain was removed using a razor blade. 
The brain was then glued to the specimen disc with the dorsal side downwards.  And the 
chamber was filled with ice-cold cutting solution. Slices were cut starting from the rostral 
side (Figure 2.1 B). 
For preparations of cerebellar slices the skull was opened and the brain was vertically cut 
in the center using a razor blade. The brain was carefully removed with the cerebellum still 
attached to the cortex. The sides were sagitally cut by 0.5  1 mm and the brain was glued 
to the specimen disc sagitally (Figure 2.1 C). 
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Figure 2.1 - Graphical representation of the three planes of section in the mouse brain.  (A) The coronal 
plane cuts the brain into anterior and posterior parts. (B) The horizontal plane cuts the brain into 
dorsal and ventral parts. (C) The mid-sagittal plane would cut the left and right sides of  the brain into 
two equal parts.   
   
2.2.2 Whole-mount retina preparation 
Retinae were dissected from wt mice (3  6 months) or from cnga3
-/-
, rho
-/-
, opn4
-/-
 (TKO) 
mice (3  6 months) if not stated otherwise.  
After cervical dislocation eyes were rapidly removed using curved scissors and transferred 
to a petri dish containing ACSF (room temperature, aerated with 95%O2/5%CO2). Eyes were 
punctured using a cannula (25G) behind the conjunctiva (between the cornea and the 
choroid) to allow diffusion of buffer solution into the intravitreal cavity. The eye which was 
not readily dissected was moved to a falcon filled with ACSF and aerated.  
Dissection: Spring scissors were used to remove the cornea (Figure 2.2 A-B). The lens and 
remaining vitreous were gently removed using forceps and discarded (Figure 2.2 C). The 
eyecup was inverted and retina was detached (Figure 2.2 D and E). The connection to the 
optic nerve was cut using forceps. Retinae were immediately used for the experiments after 
dissection. For MEA experiments retinae were cut in two halves (Figure 2.2 F). For use in 
patch-clamp experiments retinae were incised at four to six sides to allow flattening and 
used as whole mount.  
 
 
Figure 2.2- Pictures of a retina preparation. (A) Removed eyes after cervical dislocation in ACSF. (B) 
Cornea was removed by cutting behind the conjunctiva. (C) After removing the lens with forceps. 
Remaining vitreous is carefully removed. (D) Retina is detached from the eye cup. (E) Dissected 
retina. (F) Retina was cut in two halves for MEA experiments.  
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2.2.3 Retinal slice preparation 
Retinae were dissected as described in section 2.2.2. A small Pasteur pipette was used to 
fill a 35 mm Petri dish with low melting-agarose (3 % in HEPES Ringer (HR), pH=7.4). 
Forceps were used to test consistency and after begin of solidification the flattened retina 
was transferred to the top of the agar. Excess solution was removed with a filter paper and 
a few drops of melted agar were placed directly on top of the retina. A circular plastic 
cylinder was placed over the retina to form a wall around it. Then the cylinder was filled 
with melted agar and the petri dish was placed on an ice water bath to cool. After complete 
solidification of the agar (approximately 1 min) the cylinder was removed and the agar 
containing the retina was extruded. A razor blade was used to cut out a small block of agar 
containing the retina. The agar block was glued to the specimen disc and filled with ice -
cold HR (Figure 2.3). Slices with a thickness of 250  350 µm were cut using a Campden 
vibratome 7000 smz-2 (NPI Electronic) and directly transferred to the recording chamber. 
The slice anchor was mounted to hold down the surrounding agar, while the retina is 
unobstructed for recordings. 
 
 
Figure 2.3 - Retinal slice preparation. Photos of a whole retina in a low-melting agarose block glued 
to the specimen disc of the vibratome. 
2.2.4 Multielectrode Array (MEA) recordings 
For extracellular spike recordings, one half of a flat-mounted retina was placed RGC layer 
down onto an MEA (200/30 ITO, Multichannel Systems, Reutlingen). The electrodes were 
30 µm in diameter, spaced 200 µm apart, and arranged in an 8 × 8 rectangular grid. The 
MEA with the mounted retina was placed in an MEA 1060-inv-BC system (Multi-Channel 
Systems) for read out (Figure 2.4 A). Prior each experiment it was checked whether the 
electrodes were clean. If many channels show a noise larger than 20 µV, the MEA was 
cleaned using 100 % Ethanol, as were the readout electrodes of the 1060-inv-BC. 
Retinae were pretreated with 200 µM DAD for 3 min or 25 µM ATA (or both simultaneously 
for combination approach), followed by a brief wash in ACSF. During the incubation as well 
as the wash period light stimulation of alternating 10 s with 460 nm light (High Power LED, 
Prizmatix) and darkness were applied. Afterwards the retinae were mounted on the MEA 
and constantly perfused with ACSF (at 34 °C with a flow rate of approximately 2-3 ml/min) 
for at least 15-30 min prior recording, while illuminating with the previously described 
protocol (Figure 2.4 B). Light stimulation was achieved through the EPC 10 USB amplifier, 
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controlled through the Patchmaster software (HEKA), externally triggered by the MCS 
system. Control experiments were performed with untreated retinae under the same 
conditions. In addition, wash-in experiments have been performed under illumination to 
demonstrate that baseline firing rate is not altered by photoswitch application.  
 
Figure 2.4 - Multielectrode array setup. (A) Graphical overview of the MEA setup. The computer 
controls the light stimulation protocol while recording via the MC_Rack software (Multichannel 
Systems). (B) Photo of a flat mounted retina on the 1060-inv-BC system MEA system. Illumination 
from the top with 460 nm light. 
 
For MEA experiments of acute hippocampal brain slices the slices were placed with the 
hippocampus centered onto the electrodes. Perfusion of ACSF (34 °C, flow rate 2-
3 ml/min) was performed for at least 15 min prior each recording. After reaching baseline 
firing, 7.5 mM K
+
-ACSF was perfused until reaching constant bursting activity. AzoCholine 
was prepared in 7.5 mM K
+
-ACSF and perfused while constantly switching between 370 nm 
and 440 nm using the Polychrome V monochromator (FEI systems). Control experiments 
were performed, (i) without increased K
+
 concentration to demonstrate that AzoCholine has 
no effect on baseline activity and (ii) with 7.5 mM K
+
-ACSF alone under illumination and (iii) 
with AzoCholine in 7.5 mM K
+
-ACSF without illumination.  
For all MEA experiments extracellular spikes were high-pass filtered at 300 Hz and digitized 
at 20 kHz. Generally a spike threshold of 4 SD (standard deviation) was set for each 
channel. Since each electrode recorded spikes from one to three cells a waveform analysis 
was performed with the MC_Rack software (Multi-Channel Systems). Spike times as well as 
light stimulation protocols were saved as .dat-files and further analysis was done using 
routines written in Matlab (Matlab R2013a) (see appendix 7.1).  
2.2.5 Light application 
High power LEDs (365 nm and 460 nm, Prizmatix) or a Polychrome-V monochromator (FEI 
systems) were used to switch between wavelengths. The light stimulation was controlled by 
the Patchmaster software (HEKA) and was brought to the slice/retina either coupled to 
microscope for patch-clamp recordings or directly via a glass fiber for MEA recordings. 
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2.2.6 Patch-clamp recordings in acute murine brain slices 
Hippocampal, coronal and cerebellar brain slice preparations 
Hippocampal and layer 2/3 coronal cells were patched using fire -polished glass electrodes 
with a resistance between 6-9 M and for Purkinje cells between 2-6 M.  
Current-clamp recordings with ATG and voltage-clamp recordings with DAD in acute brain 
slice preparations were performed using the LL2 intracellular solution (table 3), whereas the 
LL1 intracellular solution was prepared for voltage-clamp recordings with ATG. The 
photoswitches were prepared as stock solutions in DMSO and diluted in ACSF 1:1000. To 
improve solubility the ACSF was heated to 40 °C. Due to the hydrophobicity of the 
azobenzene moiety, the solution was not filtered. Photoswitches were constantly perfused 
during the experiments, if not stated otherwise. 
Antagonist and blocker application 
Antagonists and channel blockers were bath applied, except for MK-801, TEA and QX-314, 
which was loaded into the patch pipette (table 4). For voltage-clamp recordings in brain 
slices and RGCs 1 µM TTX was generally added to the ACSF.  
Hardware and software for patch clamp recordings 
Recordings were made using an EPC 10 USB amplifier controlled by the patchmaster 
software (HEKA) to record and to control light stimulation. Data was filtered at 2.9 - 10 kHz 
and digitized at 50 kHz.  
Puff application 
Puff application of NMDA (Sigma-Aldrich) was performed through a glass pipette and a 
pressure ejection system (PDES, NPI Electronic). The pipette was placed close to the 
dendritic field of the patched cell and the pressure was adjusted, so that no pressure-
induced artifacts were seen. Control experiments were performed with ACSF in the puff 
pipette. The temporal pattern of the puff application was controlled and recorded by the 
Patchmaster software (HEKA). 
Data analysis 
For analysis cells were rejected if leak currents were larger than 200 pA in cortical and 
hippocampal neurons, and if larger than 700 pA in RGCs or Purkinje cells. In addition, 
cells with a series resistance larger than 25 M were also rejected. The Igor Pro 
(Wavematrics) liquid-junction potential (LJP) calculator was used to calculate  the correction 
of the holding potential for the LJP. Data analysis was done using the Patcher's Power 
Tools (MPI Goettingen) and by routines written in IgorPro (Wavemetrics) and Matlab.  
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Calcium imaging experiments 
For calcium imaging experiments the photoswitch, azobenzene-triazole-glutamate (ATG), 
was switched between trans- and cis-configuration using the Polychrome V monochromator 
controlled by the Live Analysis software (FEI). Slices were incubated with the calcium 
indicator Quest-Fluo-8-AM (50 µM, MobiTec) added to ACSF for at least 20 minutes at 
37 °C inside a cell culture incubator. ATG activation was achieved using 380 nm and 
calcium transients were recorded at 480 nm. The images were digitized at 10 Hz and 
background was corrected. Further analysis was performed using IgorPro (Wavematrics) 
routines and ImageJ (NIH) to calculate ΔF/F0. 
Coincidence detection 
Coincidence detection experiments were performed in presence of 200 µM ATG. Glass 
electrodes with resistances between 4-6 M were filled with ACSF and placed in close 
proximity of the axon hillock (20 µm). The electrical antidromic stimulation was controlled 
by an isolated stimulation unit (A-M Systems) and intensity was set subthreshold, i.e. no 
action potential firing was induced. The stimulus pulse duration was 100 ms and the inter-
pulse interval of the paired-pulse stimulation was set 20 ms with an output range of 70 V. 
The temporal patterns of the antidromic stimulation and the ATG-mediated light-stimulation 
were controlled through the Patchmaster software (HEKA). 
2.2.7 Patch-clamp recordings in retinal whole mount preparations 
For patch-clamp recordings in RGCs pipettes with resistances between 3-5 M were pulled 
and the intracellular solution LL3 (table 3) was used. This intracellular solution was 
specifically chosen to prevent any internal activity thereby isolating the excitatory and 
inhibitory inputs from bipolar and amacrine cells, respectively. Retinae were incubated for 3 
minutes at 200 µM diethyl-azobenzene-diethyl (DAD) in ACSF prior the experiments. During 
recording the retinae were constantly perfused with ACSF at 34 °C.  
2.2.8 Immunohistology 
Immunohistological stainings were performed immediately after patch-clamp experiments. 
The retinae were incubated in 4 % PFA for 30 minutes and then washed 3x10 min with 
wash solution (table 5). Afterwards the retinae were incubated in 30 % sucrose solution in 
PBS overnight (o/n) at 4 °C and three freeze-and-thaw cycles at 80 °C and room 
temperature were performed the next day. Afterwards the retinae were incubated in 
blocking solution (table 5) and incubated for at least 1 hour at room temperature or o/n at 
4 °C. Antibody solution containing streptavidine antibodies was prepared in blocking 
solution (table 6). A petri-dish was covered with parafilm and approximately 200 µl were 
drops were made for each retina. To transfer the retinae from the blocking solution into the 
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drop of antibody solution a brush was used. During incubation time evaporation was 
prevented using a water-soaked tissue paper, which was placed along the edge of the petri-
dish. The dish was closed using parafilm and the slices were incubated at room 
temperature for 1 hour.  
 
Table 6 - Antibody preparations 
 
MFP 485 nm Streptavidine 1:1000 mobitec 
 
 
After incubation with the antibody the retinae were washed 3x10 min with  PBS and 
embedded in Vectashield Mounting Medium for confocal imaging. 
2.2.9 Confocal imaging 
Confocal analysis was performed on a Leica TCS SPE confocal System. Scanning was 
performed using a 20x objective or a 40x oil immersion objective. The fluorescent label 
was excited using 485 nm and readout was performed at 560 nm (table 7). 
 
Table 7 - Excitation and emission of secondary antibodies 
 
MFP485 485 560 
 
Laser intensity, photomultiplier voltage, detector gain, offset and pinhole size were adjusted 
for each scan and both channels were scanned separately . To reduce background noise 2 
to 4 images of the same stack were acquired and averaged. 
2.2.10 Intravitreal injections 
Before injection, animals were anesthetized with isofluorane (2 %) and their pupils were 
dilated with tropicamide (1 %). Mice were mounted in a stereotactic frame and eyes were 
covered with GenTeal Severe Dry Eye Gel Drops (Novartis Pharmaceuticals). A Hamilton 
syringe (Hamilton Neuros #7002, 30G) was filled with 2 µL of 5 mM DAD-HCl (in PBS) and 
fixed on the stereotactic frame to reduce movement during injection. An incision was made 
using a 30G needle through the sclera below the ora serrate. The Hamilton syringe was 
lowered and 1 µL DAD solution or vehicle only (sham) was injected. The mouse was 
removed from stereotax and put in a separate cage for wake-up. The experiments were all 
performed according to the ARVO Statement for Use of Animals in Ophthalmic and Vision 
Research.  
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2.2.11 UV/vis measurements and extinction coefficients 
50 µM of compound were dissolved in either DMSO or ACSF. UV/vis spectra were taken in 
a quartz cuvette (1 cm diameter) with the switching light (either monochromator or LED 
light sources (Prizmatix)) introduced through a glass fiber from the top of the cuvette 
perpendicular to the light path of the spectrometer (Varian, Cary 50).  The kinetics of the 
trans- to cis-conversion were recorded at the maximal absorption wavelength of  analyzed 
compound in trans-configuration.  
For determination of the extinction coefficient of DAD, the molecule was dissolved in DMSO 
as well as ACSF in concentrations ranging from 1.25 µM  25 µM. Pre-illumination for at 
least 5 minutes with 460 nm was performed to achieve maximal cis-DAD. Absorption was 
measured for each concentration at maximal absorption of the cis-compound (i.e. 
450 nm  460 nm) (Figure 2.5 A). Line fitting shows the acuity of the measurements 
(Figure 2.5 B). Extinction coefficient is determined by the Lambert-Beer equation (#1) for 
each concentration and the average taken from all.  
 
 
 
Figure 2.5 - Determining the extinction coefficient of DAD. (A) UV/vis spectra of different 
DAD concentrations in DMSO during illumination with 460 nm light. (B) Linear fit of maximal 
absorption at 460 nm light to determine the acuity of UV/vis measurements. 
 
(#1)   E = ε · c · d        
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3 Results: Vision restoration 
Most PCLs are designed after common receptor agonists, antagonists or pore blockers and 
their structural design already suggests their mode of action. However, subtle changes in 
molecular structure have been shown to induce dramatic changes in biological function  
(e.g. Picenadol (Zimmerman et al. 1985)). Therefore, the exact functional and biological 
properties of newly synthesized PCLs need to be investigated in several experimental steps. 
The basic characterization comprises properties such as solubility and switching behavior 
analyzed by UV/Vis spectroscopy. In the next step biological activity of the molecules need 
to be investigated in physiological experiments, e.g. with electrophysiology or Ca
2+
 imaging 
experiments.  
3.1 DAD: A red-shifted photoswitchable open channel blocker for 
vision restoration 
3.1.1 DAD characterization in acute murine hippocampal brain slices 
DAD is a non-permanently charged PCL for blocking and unblocking potassium channels 
(Figure 3.1 A and B). Its basic properties and biological activity have been investigated in 
acute murine hippocampal brain slices. For this, slices were incubated with 200 µM DAD in 
ACSF (0.1% DMSO) for 3 minutes and then transferred to the patch-clamp chamber. During 
the experiments ACSF without DAD was constantly perfused. In whole -cell patch-clamp 
experiments wavelength screenings revealed that optimal switching occurs with visible light 
between 400 nm and 480 nm, which is in accordance with previously measured UV/Vis 
spectra of DAD in physiological buffer (Stein 2014). In the dark-adapted thermodynamically 
more stable trans-configuration, DAD has been shown to block the channel pore, while 
illumination with blue light, i.e. the cis-configuration (480 nm) leads to unblocking of the 
channel pore (Figure 3.1 C-E) with a τ-value of approximately 25 ms 
(τunblock = 26.5±0.001 ms) (Figure 3.1 F). Thermal relaxation from cis- to trans-configuration 
occurred within 200 ms in the dark (τoff  = 201±0.01ms), however, τoff could be significantly 
decreased using green light (520 nm) (τoff = 72.1±0.01ms, p < 0.001) (Figure 3.1 G). On 
the other hand, switching from darkness to 520 nm also led to DAD-mediated currents 
(Figure 3.1 C, D), demonstrating that after switching off using 520 nm a small amount of 
cis-DAD remains.  
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Figure 3.1 - DAD, a red-shifted potassium channel blocker.  (A) Schematic drawing of DAD-mediated 
actions on K+-channels. (B) Molecular structure of DAD. The molecule is non-permanently charged. It 
can exist either deprotonated (top) or protonated (+2H
+
) (bottom) form. Irradiation with blue or white 
light converts DAD to its less stable cis-form, which converts back to its trans-form quickly in 
darkness. (C) Whole-cell voltage-clamp recording of a layer 2 neuron in an acute murine brain slice 
preparation after incubation with 200 µM red-DAD and 1 µM TTX. Voltage jump from 70 mV to 
+50 mV induce large potassium outward currents. Currents in darkness are compared to currents in 
presence of light (380 nm  520 nm). (D) Quantification of experiments as performed in (C). Currents 
induced by voltage jump to +50 mV in darkness were normalized to 1. All wavelengths without 
exception induce larger currents compared to darkness. (E) Current-voltage relationships compared 
in darkness (black) and under 480 nm light (blue). (F) Kinetic of unblocking the pore of potassium 
channels. Recording were performed at +50 mV holding potential. τunblock = 27±0.86 ms (n = 11 
cells). (G) Quantification of off-kinetics in respect to wavelength. Fastest off-kinetics were achieved at 
520 nm light (τoff = 72±8.7ms, n = 9 cells). DAD thermodynamically switches off within 201±12.1 ms 
(n = 8 cells). Figure adapted from (Laprell et al. 2015c). 
3.1.2 DAD restores light responses in blind degenerating retinae 
Photoswitchable potassium channel blockers have been shown to be a promising 
pharmacological approach for restoration of vision (Polosukhina et al. 2012, Tochitsky et al. 
2014, Tochitsky and Kramer 2015). In addition to previously published first and second 
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generation photochromic blockers, DAD exhibits different chemical properties. Not only is 
the molecule not permanently charged (Figure 3.1 B) and thereby crosses biological 
barriers more easily, but also the molecule has enhanced solubility in physiological buffers 
and more importantly in vitreous fluid (Figure 3.2).  
 
 
Figure 3.2 - Comparison of solubility of the second generation photochromic blocker PhENAQ with 
DAD in macaque vitreous. (A) Injection of 5 mM PhENAQ (a second generation VGIC blocker, 2.5% 
DMSO, left) and 5mM DAD-HCl in PBS (right) in macaque vitreous. DAD instantly dissolves well in 
vitreous whereas PhENAQ does not.  (B) Vitreous with PhENAQ and DAD-HCl after 24 hours 
incubation, DAD-HCl diffused through the whole vitreous solution ,while PhENAQ agglutinated. Figure 
has been adapted from (Laprell et al. 2015c). 
 
 
To test the ability of DAD to restore light sensitivity in blind, degenerating retinae, 3 - to 6-
month old blind triple knock-out (TKO) mice (cnga3
-/-
,rho
-/-
,opn4
-/-
) were utilized. These 
mice natively lack all light-responses and undergo complete photoreceptor degeneration 
within the first few months after birth (Claes et al. 2004). Retinae were dissected and 
placed RGC-layer down on a multi-electrode array (MEA) to record the spiking activity of 
RGCs. Before application of DAD, the retinae did not exhibit any changes in spiking 
frequency when switching between blue light and darkness (Figure 3.3 A). A short 3-minute 
incubation of the retina with 100200 µM DAD, however, was sufficient to endow the retina 
with light sensitivity. Illumination with 460 nm light results in a short transient light-
dependent increase in spiking frequency followed by a smaller plateau phase (Figure 3.3 
B). 
The difference in spiking frequency from dark to light is quantified in the photoswitch index 
(PI), which has been previously described by Polosukhina et al. (2012). The PI is the 
normalized change in spiking frequency and consequently, a PI  around zero indicates no 
light-dependent changes in spiking frequency (equation #2). A positive or negative PI, on 
the other hand, represents an increase or decrease upon illumination, respectively.  
 
 
(#2)   
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Figure 3.3 - DAD restores light-sensitivity in blind retinae. (A) Raster plot and histogram of a MEA 
recording in TKO retinae and (B) after treatment with 200 µM DAD. The bar underneath the raster 
plot indicates light/dark stimulation (blue: 460 nm, black: dark). (C) Statistics of light responses in 
untreated TKO retinae and (D) DAD treated TKO retinae. (Left) Distribution of PI for RGC populations 
(before n = 300 cells and after n = 1024 cells). The red arrow indicates the mean PI of all 
experiments. (Right) Average spiking rate in darkness and with 460 nm light (before and after DAD 
application: n = 6 retinae and n = 13 retinae, respectively). Statistical significance was calculated 
using the Wilcoxon rank sum test, * p<0.05, ** p<0.01, *** p<0.001. Figure adapted from (Laprell et 
al. 2015c). 
In untreated TKO retinae no correlation between the light stimulus and the spiking 
frequency (13.9 and 13.4 spikes/s, respectively, p = 0.43) could be determined, which 
resulted in an average PI of around zero (0.016±0.025, n = 6 retinae) (Figure 3.3 C). In 
contrast, after DAD-treatment a light-dependent 2.6-fold increase in RGC spiking frequency 
could be detected (p<0.001, n = 13 retinae) (Figure 3.3 D). This spiking increase resulted 
in a positive PI of 0.42±0.05 (n = 13 retinae). Interestingly, in some retinae a small transient 
light-off response was present (Figure 3.4 A). 
 
 
Figure 3.4 - DAD induces both, on and off responses in blind retinae.  (A) Raster plot and histogram of 
DAD-treated retina with strong transient on- and off-light responses. The bar underneath the raster 
plot indicates light/dark stimulation (blue: 460 nm, black: dark). (B) Quantification of light responses 
from MEA recordings in DAD-treated TKO retinae. In 66 % of all recorded RGCs spiking rates 
increased only with onset of light stimulation, whereas 22 % of all RGCs responded with an increase 
in firing rate upon onset, but also offset of light. 12 % off the recorded cells solely responded to 
switching off light (n = 687 RGCs in 11 retinae). Figure modified from (Laprell et al. 2015c). 
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Quantification of all experiments on single cell level revealed that 66 % of all RGCs 
(n = 687) responded to the onset of light with a transient increase of spiking frequency. 
However, in 12 % of RGCs an increase in spiking frequency could only be detected shortly 
after switching off light and 22 % of all RGCs respond to both, light onset and offset (Figure 
3.4 B). The correlated firing of RGCs in response to a light stimulus is depicted in figure 
3.5, before, during and after illumination of DAD-treated TKO retina. Before illumination no 
correlation between the single RGCs could be detected (blue-green) (Figure 3.5 A), 
whereas upon illumination almost all RGCs correlated positively with each other, i.e. they 
increased in spiking rate at the same time (yellow-red) (Figure 3.5 B). Furthermore, as 
indicated by the analysis of single cell responses (Figure 3.4 B), some RGCs exhibit a 
positive correlation within the first second after switching off the light (yellow -red) (Figure 
3.5 C). 
These complex and distinct RGC responses can only be explained with DAD acting 
upstream of RGCs, utilizing the remaining retinal circuitry to induce on- and partially off-
responses in RGCs. 
 
 
Figure 3.5 - Correlation plots for DAD-mediated light response reveals positive correlation for light -on 
and light-off RGC responses. Example of correlation of light responses in DAD-treated retina. (A) 
Correlation of RGC responses before light stimulation. (B) Correlation during light stimulation and (C) 
after switching off light. One second binning was applied. Red indicates high corre lation while green 
indicates no correlation. During light stimulation most cells and after switching off light a fraction of 
cells show a positive correlation in RGC firing. Binning for correlation was set to 1 second.  Figure 
adapted from (Laprell et al. 2015c). 
3.1.3 DAD specifically activates bipolar cells upon illumination 
In the next set of experiments the target cell type of DAD in the retina was determined. 
RGCs were synaptically isolated from the remaining retinal circuitry by blocking synaptic 
transmission with CdCl2. Under these conditions DAD-mediated light-responses were 
completely abolished (PI = 0.015±0.094, n = 8 retinae, p<0.05, Wilcoxon rank sum test, 
compared to PI without blockers) (Figure 3.6 A). A similar effect was observed after the 
application of antagonists for NMDA and non-NMDA receptors (D-AP5 and NBQX, 
respectively), which block excitatory synaptic input from bipolar cells  onto RGCs 
(0.00213±0.012, n = 6 retinae) (Figure 3.6 B). These two experiments clearly indicate 
that, first, DAD is not directly activating RGCs and second, identify bipolar cells as the main 
target of DAD. However, to exclude major inputs from amacrine cells, a cocktail of GABAA, 
GABAC and glycine receptors was applied (picrotoxin, TPMPA and strychnine, respectively). 
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After application of this cocktail, light-responses were still detectable and in contrast to 
AAQ, did not invert (PI = 0.32±0.03, n = 6 retinae, spikesdark/s = 10.9±2.15, 
spikes480/s = 19.9±4.16) (Figure 3.6 C). An inversion of the light response would have 
indicated a major input from inhibitory neurons rather than from bipolar cells (Polosukhina 
et al. 2012).  
  
Figure 3.6 - Pharmacology in TKO retinae revealed bipolar cells as the cellular target of DAD.  (A) 
Statistics of light responses in TKO retinae after wash in of CdCl2. (Left) Distribution of PI for RGC 
populations (n = 688 cells). The red arrow indicates the average PI = 0.015±0.094 (n = 8 retinae. 
(Right) Average spiking rate in darkness and with 460 nm light (n = 8 retinae). (B) Statistics of light 
responses in TKO retinae after wash in of NBQX and D-AP5. (Left) Distribution of PI for RGC 
populations (n = 477 cells). The red arrow indicates the average PI = 0.00123±0.012 (n = 6 
retinae). (Right) Average spiking rate in darkness and with 460 nm light. (Right). (C) Statistics of light 
responses in TKO retinae after wash in of strychnine, picrotoxine and TPMPA. (Left) Distribution of PI 
for RGC populations (n = 882 cells). The red arrow indicates the average PI = 0.32 ±0.030 (n = 6 
retinae). Figure adapted from (Laprell et al. 2015c). 
 
In addition to the pharmacological experiments on MEA, we performed patch -clamp 
experiments in retina whole mount preparations to confirm bipolar cells as the main cell 
type targeted by DAD. Isolation of the synaptic inputs onto RGCs was achieved by using an 
intracellular solution that blocked all intrinsic activity of the recorded RGC (see section 
2.1.2). Application of 1 µM TTX in the extracellular solution blocked spontaneous activity  of 
the retinal circuitry. Using this approach only excitatory and inhibitory postsynaptic 
potentials (EPSPs and IPSPs, respectively) mediated by DAD-activity onto bipolar and 
amacrine cells were recorded.  
Before treatment with DAD the average EPSPs and IPSPs were negligible (average 
EPSP = 2.97±0.77 pA, n = 9 cells, average IPSP = 3.51±0.52 pA, n = 9 cells) (Figure 3.7 
B and C). In contrast, after treatment in 94.1 % of all recorded RGCs light-dependent 
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EPSPs were recorded, and IPSPs in 82.4 % (EPSP = 76.97±8.65 pA, n = 17 cells, average 
IPSP = 135.24±41.73 pA, n = 16 cells) (Figure 3.7 D and E). Importantly, both EPSPs and 
IPSPs were significantly reduced by blocking excitatory input to RGCs by NBQX and D-AP5 
(average EPSP = 10.87±5.47 pA, n = 11 cells, p < 0.001, average IPSP = 7.03±3.79 pA, 
n = 13 cells, p = 0.01, Wilcoxon rank sum test) (Figure 3.7 D and E, red traces. 
Quantification in figure 3.7 F). This indicates an indirect signal transduction from bipolar to 
amacrine onto RGCs. A simplified overview of the pathway for DAD activity in the retina is 
depicted in figure 3.7 G. 
 
Figure 3.7 - DAD specifically photosensitizes bipolar cells in TKO retinae.  (A) Immunofluorescence 
stainings of two example RGCs patched and filled with neurobiotin. Bar indicates 40 µm.  (B) EPSP 
recording in whole-cell RGC patch clamp configuration at holding potential of 60 mV in TKO retinae 
before treatment with DAD. A blue line above the recorded trace indicates the light pulse with 460 
nm. (C) IPSP recording in the same cell as in (B) at 0 mV holding potential. An error in holding 
potential was corrected (Manookin et al. 2010). A blue line above the recorded trace indicates the 
light pulse with 460 nm. (D) and (E) RGC patch-clamp recordings in DAD-treated TKO retina with the 
same light stimulation and holding potentials as in (A) and (B), respectively (black traces). After 
application of NBQX and D-AP5 both, excitatory and inhibitory postsynaptic potentials are inhib ited 
(red traces). (F) Quantification of EPSPs and IPSPs in DAD-treated TKO RGCs, before and after 
inhibition of AMPA and NMDA receptors with NBQX and D-AP5, respectively (average EPSP =  
10.87±5.47 pA, n = 11 cells, p<0.001, average IPSP = 7.03±3.79 pA, n = 13 cells, p = 0.01). (G) 
Graphical overview for three possible scenarios of DAD-mediated light-response pathways. Either 
cone bipolar cells (CBP) transmitting the signal onto RGCs directly (1), or rod bipolar cells (RBP) are 
activated signaling to AII amacrine cells, which synapse onto CBP (2). Off-light responses are most 
likely transmitted via the rod bipolar, AII amacrine pathway which synapse on off -RGCs (3). Figure 
modified from Figure modified from (Laprell et al. 2015c). 
 
 
Taken together, the findings of MEA and patch-clamp experiments demonstrate that DAD 
does primarily activate bipolar cells rather than acting on amacrine or RGCs, thus utilizing 
the intrinsic retinal signaling pathways. 
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3.1.4 Visual acuity of DAD photoswitching in the retina 
Visual acuity strongly relies on the precision of the stimulated retinal area. The smaller the 
illuminated area can be, the more precise the image can get. Also the duration of the pulse 
needed for significant increase of RGC spiking is critical for image formation. Therefore , 
different light pulse durations, light intensity threshold and also spatial acuity of DAD 
activity was tested. 
Under bright light conditions (12.5 x 10
15
 photons cm
-2
 s
-1
) pulses between 25 ms and 
1000 ms have been applied to DAD-treated retinae. A short light pulse of 50 ms was able 
to trigger a significant increase in spiking frequency (p<0.05, n = 8 retinae) and the 
maximal spiking frequency was achieved with 500 ms to 1000 ms light stimulation 
(average PI = 0.49±0.03, n = 8 retinae) (Figure 3.8 A and B). After switching off light, the 
spiking frequency returns to baseline with τoff = 621.4±51.3 ms (n = 8 retinae) (Data not 
shown). Thus, the off-response in retina is much slower compared to the recorded cortical 
slice data (τdarkness = 0.201±0.012 s, Fig. 3.1 G). Yet, one has to keep in mind that the off-
signal is a combination of cells responding with an increase in spiking frequency to light off 
and those, which go back to baseline firing immediately. Furthermore, the cells recorded 
(RGCs) are not the cells, which are stimulated by DAD (i.e. bipolar cells). This is in contrast 
to cortical slice preparations, in which the cell recorded is also the cell targeted by DAD. To 
accelerate the relaxation process and thereby achieve faster changes in spiking 
frequencies for on/off stimulation, green light could be used instead of darkness, as has 
been demonstrated in brain slice experiments (τgreen = 0.072±0.01 s) (Figure 3.1. G).  
Next, DAD-mediated light-responses were compared with other PCLs in terms of the 
minimum light-intensity needed for activation. Together with Ivan Tochitsky (UC Berkeley, 
Prof. Richard Kramer's lab) the minimum light intensity for RGC responses was determined 
(3 x 10
13
 photons cm
-2
 s
-1
) (Figure 3.8 C, indicated with *), and is therefore slightly lower 
compared to the threshold for DENAQ-treated rd1/rd1 retinae (Tochitsky et al. 2014), and 
similar to ChR2 and NpHR applications in vision restoration approaches (Pan et al. 2014, 
Busskamp et al. 2010). Furthermore, we determined the dynamic range of DAD-activity in 
the retina by increasing the light intensity over three orders of magnitude, from 10
13 
 10
16
 
photons cm
-2
 s
-1
. The half-maximal response was achieved at a light intensity of 1 x 10
14
 
photons cm
-2
 s
-1
 (Figure 3.8 C dashed line).  
Spatial acuity and precisely patterned DAD-light stimulation is critical in order to restore 
shape recognition and natural scene perception (Reutsky-Gefen et al. 2013). We therefore 
determined the response properties of small spot stimulation (Figure 3.8 D). Small 90 µm 
spots were able to spatially increase spiking frequency in RGCs (PI  = 0.41±0.15, n = 22 
cells) with none of the surrounding, not illuminated RGCs, affected (PI  = 0.00±0.11, 
n = 1206 cells, p < 0.001, Wilcoxon rank sum test) (Figure 3.8 E). Even a precise 30 µm 
spot stimulation led to an increase in almost all RGCs recorded. With increasing the 
diameter of the spot the RGC-light response saturated at a spot size of 240 µm, which is 
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close to the average dendritic field diameter of mouse RGCs (Figure 3.8 F) (Ren et al. 
2010).  
 
Figure 3.8 - Light sensitivity of DAD and small spot stimulation in TKO retinae. (A) Examples for short 
light-pulse stimulation (intensity = 12.5 x 10
15
 photons cm
-2
 s
-1
) in DAD TKO treated retinae. (B) 
Quantification of light-pulse stimulation in DAD treated TKO retinae. 50 ms light pulses significantly 
increase spiking rate above background spiking (p<0.05, n = 8 retinae). Maximum stimulation is 
reached within 200-500 ms. (C) Light-intensity versus PI response curve for DAD treated TKO retinae 
(n = 5 retinae). Significant increase in spiking activity was achieved with 3x10
13
 photons cm
-2
 s
-1
 
(marked with *) and reached maximum at 1 x 10
16
 photons cm
-2
 s
-1
 covering 4 log units of light 
intensity. (D) Small spot stimulation of an rd1/rd1 retina treated with 200 µM DAD. Illumination was 
centered on a single electrode (D4) with a diameter of 90 µm. A PI index was only detected from 
RGCs in the targeted area. (E) Quantification of experiment depicted in (A). RGCs in targeted area 
showed an increase, whereas surrounding RGCs were unaffected (PI= 0.41±0.15, n = 22 cells and 
PI = 0.00±0.11, n = 1206 cells, respectively). Single photoswitch indices are depicted as black 
circles as a function of distance from the targeted electrode. Binning of distance 200 µm. Mean±95% 
confidence intervals are shown in red. (F) Receptive field mapping experiment. Light responses of 
DAD-treated TKO retinae in respect to increasing diameter of light stimulation spots. Saturation of 
light response is achieved with 240 µm spot size. Data are mean±SEM, n = 16 cells). Figure modified 
from (Laprell et al. 2015c). Figures (C)-(F) by Ivan Tochitsky, University of California, Berkeley 
 
Altogether, DAD light-sensitivity is comparable to other approaches in vision restoration and 
in principle, all RGCs can be independently controlled from one another in temporal and 
spatial precision, thus allowing the possibility of restoring high acuity vision.  
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3.1.5 DAD frequency stimulation 
Vision relies on both, spatial and temporal precision. High spatial precision of DAD 
activation has been demonstrated in the previous section (3.1.4). In this section the 
temporal precision of DAD is elucidated. For slow stimulation patterns such as 0.2 or 0.5 
Hz the RGC responses matches the light stimulation almost perfectly (Figure 3.9 A and B, 
respectively). However, when faster light stimulation protocols are applied, the retina is not 
able to match each light flash with an increase in RGC firing rate. For a 1 Hz stimulation 
12±5 % of all light flashes is mismatched (Figure 3.9 C). This effect is dramatically 
increased for the application of 2 Hz light flashes (Figure 3.9 D). Here, 39±8 % are 
mismatched and the maximum spiking frequency is significantly reduced compared to 0.2 
Hz (19.4±2.3 spikes/s and 35.3±5.9 spikes/s, respectively) (Figure 3.9 E and F).  
Thus, a reliable light stimulation of DAD lies between 0.5 Hz and 1 Hz flashes in blind 
retinae. However, as for the τoff (see section 3.1.1), high frequency pattern might be 
achieved better, when monochromatic green light would be used to actively switch DAD 
back to its trans-state. 
 
Figure 3.9 - DAD can follow light stimulation frequencies up to 1 Hz. (A)-(D) Histograms of a MEA 
recordings in TKO retinae after treatment with 200 µM DAD with different light stimulation 
frequencies. Threshold for spike detection indicated by the red line. (A) 0.2 Hz light stimulation. (B) 
0.5 Hz light stimulation. (C) 1 Hz light stimulation and (D) with a 2 Hz light stimulation. The bar above 
the  histogram indicates light/dark stimulation (blue: 460 nm, black: dark). (E) Quantification missed 
spikes depending on the light stimulation frequency. Results quantified from 6 independent 
experiments. (F) Analysis of maximal spiking frequency depending on the light stimulation protocol  
from the same experiments as in (E).  
3.1.6 DAD only photosensitizes retinae undergoing degeneration 
Retinal degeneration is a complex process involving inter alia synaptic remodeling and 
neural reprogramming (Marc et al. 2008, Jones et al. 2012). Dramatic changes, such as an 
increase in specific membrane-receptors, may lead to different accessibility or changed 
functionality of applied photoswitches. For instance, it has been previously demonstrated 
that expression levels of HCN-channels are strongly increased in RGCs of degenerating 
retina, but not in wt retinae or blind non-degenerating retinae. HCN-channels are the 
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primary target cell type of DENAQ, thereby only retinae undergoing degeneration are 
photosensitized (Tochitsky et al. 2014). 
Preference analysis of DAD-mediated activation in degenerating versus non-degenerating 
retinae was performed in retinae from five different mouse lines: Two blind mouse lines 
undergoing retinal degeneration (cnga3
-/-
, rho
-/-
, opn4
-/-
 and rd1/rd1; opn4
-/-
), two mouse 
models for stationary night blindness, which do not undergo retinal degeneration (gnat1
-/-
, 
gnat2
-/-
, opn4
-/-
 and tra
-/-
, cnga3
-/-
, opn4
-/-
) (Chang et al. 2006) (Lyubarsky et al. 2002) 
(Panda et al. 2002), and in wt retinae under two different conditions (wt in ACSF  and wt in 
presence of NBQX and L-AP4 to block synaptic transmission between photoreceptor cells 
and bipolar cells). A schematic overview of the experiments is depicted in figure 3.10 A.  
 
In wt retinae DAD application had no significant effect. The overall light response was not 
changed (Fig. 3.10 B and C) and the strength of on- and off-light responses remained 
similar (difference in PI(Δ)wt = 0.081±0.032, n = 5) (Fig. 3.10 D and E), as was the 
distribution of on- to off- light responses  (Figure 3.11). However, the naturally occurring 
light responses in wt retinae may overlay the DAD-mediated light responses, therefore the 
experiments were performed again, but in the presence of the mGluR6 agonist L-AP4 and 
the AMPA/kainate antagonist NBQX. Using this cocktail, light-on and light-off responses in 
the wt retina are completely abolished (PIon = 0.046±0.060, n = 5 retinae) (Slaughter and 
Miller 1981, DeVries and Schwartz 1999, DeVries 2000). The retinae were then treated with 
DAD, which was not able to recover light responses (PIon = 0.052±0.067, n = 4 retinae, 
Δwt+block = 0.0043±0.059) (Figure 3.10. D and E). To demonstrate that NMDA receptor 
signaling is in principle sufficient to transmit DAD-induced light responses via the bipolar-
RGC synapse, the same pharmacological approach was performed in TKO retinae resulting 
in large light-depending spiking patterns (PI = 0.505±0.108, n = 5 retinae, p  = 0.05, 
Wilcoxon rank sum test) (Figure 3.12). 
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Figure 3.10 - DAD only photosensitizes retinae undergoing degeneration. (A) Overview of retinae 
tested for their ability to induce DAD-dependent changes in spiking frequency upon illumination. (B) 
Raster plot and histogram of a MEA recording in wt retinae before and (C) after treatment with 
200µM DAD. The bar underneath the raster plot indicates light/dark stimulation (white: white light, 
black: darkness). (C) Difference in light responses before and after treatment with DAD of wt 
(Δspikes = 0.081±0.032, n = 5 retinae, p<0.5), wt in presence of NBQX and L-AP4 (wt+block, 
Δspikes = 0.004±0.059, n = 5 retinae, p<0.01), gnat1
-/-
gnat2
-/-
mel
-/-
 (gnat mel, 
Δspikes= 0.039±0.017, n = 6, p<0.001), cnga3
-/-
gnat1
-/-
mel
-/-
 (A3 gnat mel, 
Δspikes = 0.0087±0.022, n = 5, p<0.01), opn4
-/-
-rd/rd mice (mel rd, Δspikes = 0.38±0.075, n = 5 
retinae, p>0.05) and TKO mice (Δspikes=0.44±0.095, n=13). Statistical tests were performed in 
respect to change in TKO mice (Wilcoxon rank sum test). (D) Maximum peak spiking frequencies of 
wt (85.6 spikes/s, n = 5, p>0.05), wildtype in presence of NBQX and L-AP4 (wt+block, 4.32 spikes/s, 
n=4, p<0.01), gnat1
-/-
gnat2
-/-
opn4
-/-
 (gnat mel, 18.7 spikes/s, n = 6, p<0.01), cnga3
-/-
gnat1
-/-
opn4
-/-
 
(A3 gnat mel, 1.81 spikes/s, n = 5, p<0.001), opn4
-/-
rd/rd mice (mel rd, 71.1 spikes/s, n=5, p>0.5) 
compared to TKO mice (52.6 spikes/s, n=13). Statistical tests were performed in respect to change 
in TKO mice (Wilcoxon ranks sum test). (E) PIs for DAD-treated TKO retinae from young (< 3 weeks, 
average PI = 0.29±0.01, n = 7 retinae) versus old mice (> 6 months) (average PI = 0.48±0.03, n = 6 
retinae, p<0.01). Figure modified from (Laprell et al. 2015c). 
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Figure 3.11 - DAD application to wild type retina does not influence single cell responses. 
Distribution of PI for wild type RGC populations before (black) and after treatment (red) with 200 µM 
DAD (p = 0.46, Wilcoxon rank sum test). Figure adapted from (Laprell et al. 2015c). 
 
In a next set of experiments DAD was tested on blind, but non-degenerating retinae, to 
investigate, whether loss of light-driven activity from photoreceptor cells alone is sufficient 
for DAD activity. In both blind, but structurally intact retinae, the gnat1
-/-
,gnat2
-/-
,opn4
-/-
 
(gnat-mel) and the tra
-/-
,cnga3
-/-
,opn4
-/-
 (A3-gnat-mel), DAD was not able to photosensitize 
the retinae. The only responses detected were small remaining light -responses in gnat1
-/-
,gnat2
-/-
,opn4
-/-
 mice, most likely due to alternative G-protein pathways (max firing rategnat1-/-
,gnat2-/-,opn4-/- = 18.7 spikes/s, TKO = 52.6 spikes/s, p <0.001, Wilcoxon rank sum test) 
(Figure 3.10 E) (Allen et al. 2010). However, this response was 2.5-fold smaller compared 
to DAD-induced light responses in TKO and could not be increased by application of DAD. 
Therefore, the difference of maximum spiking frequencies before and after appl ication of 
DAD was negligible (Δspikesgnat-mel= 0.039±0.018, n = 6 retinae). In the second blind, but 
non-degenerating mouse line (tra
-/-
,cnga3
-/-
,opn4
-/-
) no light responses were detected, 
neither before nor after treatment with DAD (max firing ratetra-/-,cnga3-/-,opn4-/-  =1.8 spikes/s, 
ΔA3-gnat-mel= 0.0087±0.022, n = 5 retinae) (Figure 3.10. D and E).  
In addition, DAD was tested in retinae from a different mouse model also undergoing retinal 
degeneration (rd1/rd1; opn4
-/-
) (Panda et al. 2003), to exclude the possibility that DAD 
specifically photosensitizes TKO retinae due to a mutation specific mechanism. The rd/rd, 
opn4
-/-
 mouse line suffers from a null mutation in phosphodiesterase-6 (PDE-6) and lack 
melanopsin the ipRGCs (Bowes et al. 1990). The loss of PDE-6 result in elevated cGMP- 
and calcium levels leading to the apoptosis of rod photoreceptor cells and subsequent 
retinal degeneration starting within 2-3 weeks after birth (see section 1.3). These mice have 
lost all intrinsic light responses not only from rod photoreceptor cells, but also from cones 
within the first three months due to the effect called rod-cone dystrophy. After treatment 
with DAD, however, robust light-responses comparable to those in TKO mice were detected 
(PI = 0.39±0.067, Δmel-rd = 0.38±0.075, n = 5 retinae, p<0.001, Wilcoxon rank sum test, and 
ΔTKO = 0.43±0.095, n = 6) (Figure 3.10. D and E). 
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Figure 3.12 - Block of mGluR and AMPA signal transmission in TKO mice incubated with DAD. (A) 
Raster plot and histogram of DAD-treated TKO retina in presence of L-AP4 and NBQX. The bar 
underneath the raster plot indicates light/dark stimulation (blue: 460 nm, black: dark). (B) Statistics 
of light responses. Average spiking rate in darkness and with 460 nm light (n = 5 retinae). (C) 
Distribution of photoswitch index for RGC populations (n = 439 RGCs). The red arrow indicates the 
average PI = 0.51±0.11 (n = 5 retinae). 
 
These six experiments demonstrate that in degenerating retinae, such as the TKO and 
rd1/rd1; opn4
-/-
 mouse models, the death of rods and cones and the following changes in 
neurotransmitter release and increase in the activity of downstream retinal neurons , e.g. AII 
amacrine cells (Borowska et al. 2011) and RGCs (Margolis et al. 2014, Stasheff 2008) is 
necessary for DAD-induced light responses.  
The importance of retinal degeneration for the action of DAD is further substantiated by 
comparison of DAD-mediated effects in young versus old TKO retinae. In three week-old 
mice the retinae are structurally mostly intact, whereas in TKO mice older than 6 months 
the photoreceptor cells already did undergo severe degeneration and associated 
physiological changes (Claes et al. 2004). Maximum light-dependent spiking frequency 
after DAD application in retinae from young TKO mice were overall 62 % smaller compared 
to light responses in retinae from old TKO mice (3-week old and >6-month old) 
(PIold = 0.48±0.03, nold = 6 retinae, PIyoung = 0.29±0.01, nyoung = 7 retinae, p = 0.007, 
Wilcoxon rank sum test) (Figure 3.10.F). This result further highlights the importance of 
retinal degeneration for the effectiveness of DAD. 
3.1.7 Towards the identification of the molecular target channel of DAD 
DENAQ primarily acts on RGCs and more specifically on HCN channels, which are up -
regulated in degenerated retinae (Tochitsky et al. 2014). Although DAD targets bipolar 
cells, the finding that DAD only photosensitizes retinae undergoing degeneration, hints 
towards a similar mode of action (Tochitsky et al. 2014). Therefore, additional experiments 
were performed to determine whether DAD acts on HCN-channels. Here, DAD was directly 
compared to the second generation compound PhENAQ (not published), which is very 
similar to DENAQ, in respect to the effect of the HCN-channel blockers on their light-
induced spiking patterns. Two HCN-channel blockers were tested individually, ivabradine 
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and cilobradine (n = 1 retinae and n = 2 retinae, respectively). Both abolished light induced 
spiking patterns of PhENAQ (Example given for RGC light response with PhENAQ and 
PhENAQ+ivabradine in figure 3.13. A and B, respectively). 
 
 
Figure 3.13 - HCN-channel blocker Ivabradine strongly affect PhENAQ induced light responses.  (A) 
Raster plot and histogram of rd1/rd1;opn4
-/-
 retina after incubation with PhENAQ. (B) Raster plot and 
histogram of the same retina as in (A), but after application of the specific HCN-channel blocker 
ivabradine (50 µM). The bar underneath the raster plot indicates light/dark stimulation (white: Xenon, 
black: dark). 
 
In the case of DAD, the spiking pattern was altered, but not abolished by application of 
ivabradine or cilobradine (with experiment numbers n = 2 and n = 4, respectively). 
Examples for ivabradine and cilobradine application are given in figures 3.14 A,B and 3.14 
C,D, respectively). The effect seen in DAD-treated retinae was probably induced by 
changed spontaneous spiking activity after application of HCN-channel blockers rather than 
by directly effecting DAD activation.  
Taken together, the activation of bipolar rather than RGCs and the findings that HCN-
channel blockers have no significant effect on DAD-activity suggest a very different mode of 
action for DAD compared to previous generation blockers, DENAQ and PhENAQ.  
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Figure 3.14 - HCN-channel blockers ivabradine and cilobradine only effect the spontaneous spiking 
activity, but not the DAD light response in rd1/rd1;opn4
-/-
 retina. (A) Raster plot and histogram of 
rd1/rd1;opn4
-/-
 retina after incubation with DAD and the same retina after wash-in of ivabradine (50 
µM) (B). (C) Raster plot and histogram of rd1/rd1;opn4
-/-
 retina after incubation with DAD and after 
wash-in of cilobradine (50 µM) (D). The bar underneath the raster plot indicates light/dark stimulation 
(white: Xenon, black: dark). 
 
3.1.8 Intravitreal injections of DAD and DAD-HCl 
Ex-vivo MEA and patch-clamp experiments have demonstrated that DAD is able to light -
activate the neural network of a blind degenerating retina. However, the experiments can 
only give little information about the accessibility of retinal tissue in-vivo. To determine 
whether DAD is able to penetrate the retina in-vivo and which concentrations are needed 
for behavioral experiments, 1 µL DAD at different concentrations were injected into the 
vitreal cavity of rd1/rd1; opn4-/- mice. After 4-24 hours mice were sacrificed, retinae 
dissected and retinal spiking was investigated on MEA. Dissected retinae after 4 -6 hours 
showed the typical yellowish coloring by DAD, which was uniformly distributed over the 
whole tissue. Furthermore, analysis on MEA revealed that almost all RGCs showed light -
dependent spiking activity after 4 and after 6 hours post injections (Figure 3.15 A and B, 
respectively). Retinae dissected 24 hours post injection did show no significant spiking 
differences between darkness and 460 nm light (data not shown). These results 
demonstrate that DAD is highly soluble in vitreous fluid (see also figure 2.2.) and that it is 
able to activate retinal neurons in-vivo.  
For future in-vivo studies additional solvents (e.g. DMSO) need to be avoided. Therefore, 
DAD was also formulated as DAD-HCl salt, which was readily soluble in water or buffer 
(200 mM). The HCl formulation of DAD was at least as effective as DAD in DMSO (data not 
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shown) and was therefore used for all in-vivo experiments and also for ex-vivo experiments 
after it was confirmed that there was no difference in activity.  
 
Figure 3.15 - MEA recordings after intravitreal injections of 5-7.5 mM DAD-HCl in rd1/rd1; opn4-/- mice.  
(A) Retina was dissected 4 hours post intravitreal injection of 7.5 mM DAD-HCl. Stimulation protocol 
was 10 s 460 nm light and 10 s darkness alternating. (B) Retina was dissected 6 hours post 
intravitreal injection of 5 mM DAD-HCl. Stimulation protocol was 5 s 460 nm light and 5 s darkness 
alternating. 
 
3.1.9 Discussion DAD 
DAD has been demonstrated to be a promising photochromic ligand approach for vision 
restoration in blind retinae. DAD can be activated using light in the visible range and 
thermodynamically relaxes back to its trans-configuration in the dark (see section 3.1). DAD 
can be dissolved in DMSO up to 200 mM or it can be formulated as an HCl-salt, to 
increase solubility in water and buffer (DAD-HCl); thereby possible DMSO effects can be 
circumvented. This may especially be important for in-vivo studies, in which higher 
concentrations need to be injected into the vitreous cavity due to possible wash -out effects 
and accessibility issues (see section 3.1.8). DAD and DAD-HCl have been shown to induce 
light-dependent spiking activity in RGCs after intravitreal injection of 5.0  7.5 mM and 
behavioral studies in rd1/rd1; opn4
-/-
 mice are currently under investigation in the lab of 
Prof. Van Gelder (UW Washington, Seattle, USA). Intravitreal injections, however, have not 
only demonstrated that DAD and DAD-HCl are able to penetrate the retina and activate 
retinal bipolar cells (pharmacology data not shown), but also that it completely diffuses 
throughout the eye cup within 3  4 hours. The high diffusion rate and good penetration 
properties have good and bad aspects. On the negative side are possible absorption 
problems: DAD not only penetrates the retina, but also the lens when applied in very high 
concentrations, which will lead to loss of light intensity entering the eye (Figure 3.16 A 
inset). Calculations for the loss in light intensity are given in figure 3.16 B. At a final 
concentration of 0.4 mM DAD in the lens almost all light with an initial intensity of 300 
W/m
2
 will be absorbed by DAD (Figure 3.16 C). This effect, however, will be less dramatic 
in human applications due to a smaller lens relative to the eye size compared to mice 
(Figure 1.1 A and Figure 3.16 A, respectively). Furthermore, the lens can be easily removed 
during eye surgery and artificial lenses can be implanted instead. Depending on the 
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material these lenses may not be stained by DAD. Also, the working concentration of DAD 
lies between 100 and 200 µM and for human applications slow particle release approaches 
will be undertaken. Therefore high concentrations, such as 1  10 mM, will not occur in the 
vitreous. 
 
 
 
Figure 3.16 - Calculation for absorption of DAD after intravitreal injections in mice. (A) Schematic 
representation of a mouse eye. Figure modified from (Remtulla and Hallett 1985) and 
http://prometheus.med.utah.edu/~marclab/eyes.pdf (last accessed on 17 March 2015). Inset: 
Example of two lenses after intravitreal injection of vehicle only (white) and 15 mM DAD-HCl (yellow). 
Dissections were performed 4 hours post injection. (B) Calculation for DAD absorption in the mouse 
eye based on sizes of a mouse eye. Extinction coefficient ε was determined by UV/Vis spectroscopy 
at 460 nm light. Lengths of the lens was estimated with 0.25 cm and initiative light intensity was set 
to 300 W/m
2
.  (C) Graphical representation of calculations from figure B. Inset shows extinction 
coefficients determined in DMSO and ACSF in darkness and at 460 nm light. Calculations have been 
performed with the extinction coefficient at 460 nm in ACSF.  
 
The high solubility of DAD has been shown by the good penetration into the retina and the 
lens, the latter one only at high concentrations. Furthermore, injections into macaque 
vitreous revealed good solubility properties, as has the short persistence after intravitrea l 
injections. The solubility as well as the fast clearance is in stark contrast to previously 
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published less soluble photochromic blockers (e.g. DENAQ) and is advantageous for first 
clinical applications. In case of side effects treatment can be readily te rminated. 
Furthermore, DAD penetrates the whole retina and not only a small portion due to diffusion 
limits and with this a more complex visual image might be achieved. And finally, the high 
solubility of DAD in water or buffer and the possibility of diffe rent formulations without 
changing the molecule's properties make it a perfect candidate for micro -particle release 
approaches. Small particle release approaches would also dramatically lower the 
concentration of DAD in the vitreous, because the working concentration lies between 
100 µM and 200 µM. Therefore, the absorption problem will be limited in human patients.  
Besides these pharmacokinetic properties, DAD has been shown to activate primarily 
bipolar cells in degenerating retinae. It is therefore the f irst diffusible photochromic ligand 
that selectively activates a specific cell type upstream from RGCs. Previous approaches 
with ChR2- and LiGluR-expression in on-bipolar cells revealed that utilizing the remaining 
neural network of the retina result in more complex output signals compared to the direct 
activation of RGCs (Mace et al. 2015, Gaub et al. 2014). The same effect holds true for 
DAD-induced light responses. Not only does DAD induce strong transient light -on 
responses, but it also leads to small transient light-off responses (see section 3.1.2). The 
same effect has been observed after ChR2-expression in on-bipolar cells of blind mice and 
has been attributed to lateral interactions between different bipolar cell types and amacrine 
cells (Mace et al. 2015). Although LiGluR-expression in on-bipolar cells should in principle 
induce the same light response, this effect has not been observed with this approach 
(Gaub et al. 2014). One explanation might be that ChR2 is localized throughout the whole 
plasma membrane of bipolar cells, whereas LiGluR expression is more localized to 
dendrites. Therefore, activation of ChR2 may lead to a much stronger depolarization 
compared to LiGluR activation. The same would hold true for DAD-induced activation, since 
potassium channels are not specifically localized to dendrites, but are rather distributed 
over the whole cell membrane. This stronger depolarization may contribute to the additional 
transient off-response in ChR2-expressing and DAD-treated retinae.  
Genetic approaches have the advantage of being highly specific due to AAV-mediated 
delivery of the gene and promotor choice (i.e. mGluR6 promotor). This means that the 
genes can be targeted to only on-bipolar cells with no additional expression in off -bipolar 
cells or other retinal cell types. The PCL approach, on the other hand, is a simple 
pharmacological approach. Therefore, selectivity for on- versus off-bipolar cells cannot be 
guaranteed. It remains to be determined, whether DAD is more selective for one of the 
bipolar cell types. This, however, is a complicated task due to experimental limitations. 
First, DAD only acts on bipolar cells in degenerating retinae (see section 3.1.6). For clinical 
use this would be a great advantage, but for cell type identification DAD-activated cells 
cannot be compared to natural light responses. Second, DAD is a potassium channel 
blocker and therefore activation may depend on membrane potential. Studies in retinal 
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bipolar cells have demonstrated that retinal degeneration leads to changes in membrane 
potential in bipolar cells (Borowska et al. 2011). This might also explain why DAD only 
activates bipolar cells in degenerating retina. However, whole cell patch -clamp recordings 
and subsequent identification with immunohistochemistry of bipolar cells will not reveal the 
exact cell type activated by DAD, due to artificial changes in membrane potential. Two 
approaches that might reveal the exact bipolar cell type are currently under investigation. 
First, DAD-induced light responses in degenerating retinae are compared with CPPG 
application on MEA. CPPG is a selective antagonist for mGluR6, therefore RGCs activated 
by CPPG-stimulated on-bipolar cells can be identified. If DAD-mediated light responses 
would only be observed in the same RGCs as CPPG-induced responses, DAD would 
specifically activate on-bipolar cells. In a second approach, RGCs from DAD-treated retinae 
are patched with an intracellular solution containing neurobiotin (Neurobiotin tracer, vector 
laboratories, SP-1120). After detection of the light responses, the retinae are fixed with PFA 
and immunostained for neurobiotin and cholin acetyltransferase (ChAT). The ON and OFF 
ChAT bands in the IPL can then be used as landmarks for identifying stratification of bipolar 
cells and RGCs, which synapse in different layers depending on their type (Figure 3.17). 
 
 
Figure 3.17 - Schematic representation of bipolar cell identification via ChAT bands.  Starburst 
amacrine cells express high levels of cholin acetyltransferase (ChAT). Furthermore, they are divided 
into on- and off-starburst amacrine cells with distinct dendritic fields and are therefore useful  as 
landmarks for bipolar cell stratification in the IPL. 
 
This approach, however, may be limited due to retinal remodeling during the degeneration 
process (Marc et al. 2007, Marc et al. 2008). Recent studies further revealed that 
remodeling of the retina involves massive changes in glutamate receptor expression levels, 
i.e. on-bipolar cells exhibit high AMPA receptor expression levels (Chua et al. 2009, Dunn 
2015, Jones et al. 2011, Marc et al. 2007). Furthermore, Lin et al. showed that not only the 
expression pattern, but also the AMPA receptor composition is changed after light-induced 
retinal degeneration (Lin et al. 2002). 
Besides the identification of the exact target cell type, also the molecular target of DAD still 
remains unclear. HCN-channels, the target receptor of the second generation blockers 
DENAQ and PhENAQ, have shown to be up-regulated in degenerating retina (Tochitsky et 
al. 2014). However, application of ivabradine and cilobradine excluded HCN-channels as 
the molecular target of DAD. 
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Taken together, DAD has been shown to be a promising next -generation photochromic 
blocker for potassium channels in the retina. DAD targets cell types upstream from RGCs 
and in contrast to previous blocker generations (e.g. AAQ and DENAQ) is highly soluble in 
water and physiological buffer.  
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3.2 ATA: a selective photochromic AMPA receptor agonist for 
vision restoration 
In the previous section DAD has been shown to be a promising candidate for vision 
restoration. In this section I want to demonstrate that not only photochromic channel 
blockers, but also photochromic receptor ligands are powerful molecules for restoring li ght-
sensitivity to blind retinae. ATA is a selective photochromic AMPA receptor agonist in the 
dark and can be inactivated using blue light (440 nm480 nm) (Figure 4.1 A). Its specificity 
and photopharmacological properties have been investigated in detail  in cell culture and 
cortical neurons (Stawski et al. 2012).  
Because photochromic receptor ligands are very different from channel blockers they might 
be a good complementary approach for vision restoration. Until today, no freely diffusible 
photochromic receptor ligand has been tested in blind retinae.  
3.2.1 ATA conveys light-sensitivity to blind retinae 
The functional properties of ATA were characterized in blind TKO retina using MEA 
recordings to monitor the spiking behavior of RGCs. Prior to the experiments retinae were 
incubated for a three minute period with 25 µM ATA. When switching between blue light 
(460 nm) and darkness robust light responses were detected (Figure 4.1 B) for hours 
without a significant rundown (data not shown). As in studies by Stawski et al. (2012) ATA 
was also active in the thermodynamically more stable trans-configuration in the retina and 
therefore induced significantly increased spiking rates in RGCs in the dark (dark: 22.9±6.36 
spikes/s and 460 nm: 7.01±2.49 spikes/s, Figure 4.1 D). This spiking activity resulted in an 
overall negative PI of 0.50±0.05 (n = 10 retinae, Figure 4.1 C, red arrow).  
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Figure 4.1 - ATA induces robust light-responses in genetically blind TKO retinae. (A) Molecular 
structure of ATA. Highlighted in red is the molecular structure of AMPA. Switching from trans- to cis-
configuration is achieved using 460 nm light (Stawski et al. 2012). (B) Raster plot and histogram of 
MEA recording of ATA-treated TKO retina. The bar underneath the raster plot indicate the light 
stimulation protocol. (C) Statistics of light responses in ATA-treated TKO retinae. Distribution of PI for 
RGC populations (n = 962 cells). The red arrow indicates the mean PI for all recorded cells (PI = 
0.50±0.05). (D) Average spiking rate in darkness and with 460 nm light; mean indicated in red 
(n = 10 retinae). Significance level p < 0.01 calculated using the Wilcoxon rank sum test.  Figure 
adapted from (Laprell et al. 2015a). 
 
Although the overall response was dark active, on single cell level the light -dependent 
responses showed a strong diversity, indicating an upstream effect of ATA in the retina. 
This hypothesis is further supported by the different ATA-induced light responses in the 
RGC layer (Figure 4.1 C and 4.2). 
 
 
Figure 4.2 - ATA induces different light responses on single cell level. Raster plot of example RGCs 
showing slow on-light responses, sustained and transient off-light responses. The bar underneath the 
raster plot indicate the light stimulation protocol. Figure adapted from (Laprell et al. 2015a). 
 
 
The pharmacological profile of ATA was the same in the retina as in previous studies in 
cortical neurons (Stawski et al. 2012). Application of the AMPA receptor antagonist NBQX 
(25 µM) completely blocked light-dependent firing in RGCs confirming that ATA is also a 
selective agonist for AMPA receptors in the retina. Background spiking during light and 
dark cycles was unchanged and the overall PI was 0.06±0.004 with 2.74±0.44 spikes/s 
and 3.56±0.41 spikes/s in light and dark, respectively (n = 8 retinae) (Figure 4.3).  
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Figure 4.3 - ATA exclusively light-sensitizes AMPA receptors in the degenerating retina. (A) Raster plot 
and histogram of MEA recording of ATA-treated TKO retina in presence of 25 µM NBQX. (B) 
Statistics of light responses in ATA-treated TKO retinae. Distribution of photoswitch index for RGC 
populations (n = 286 cells). The red arrow indicates the mean photoswitch index for all recorded 
cells (Photoswitch Index = 0.06±0.004). (C) Average spiking rate in darkness and with 460 nm light 
(n = 8 retinae). Average is presented as MEAN±SEM. Figure adapted from (Laprell et al. 2015a). 
 
3.2.2 Various cell types shape the ATA-induced light response 
AMPA receptors are expressed in a wide variety of retinal cell types (Gilbertson et al. 1991, 
Zhou et al. 1993, Boos et al. 1993, Cohen and Miller 1994, Yu and Miller 1995) . To 
intentify the main target cell types of ATA pharmacological experiments were undertaken. In 
the first set of experiments CdCl2 was applied to isololate RGC light responses. The light 
response in presence of CdCl2 was significantly altered. Instead of a sustained light-off 
response (Figure 4.4 A), a strong transient light-off response with a following slower 
sustained response was observed in all experiments (Figure 4.4 B). The background 
spiking activity, however, was unchanged, resulting in a lower PI compared to retinae 
without blockers (PI (w/CdCl2) = 0.60±0.09, n = 6 retinae). Interestingly, in a few 
experiments the application of CdCl2 resulted in a brief transient light-on response in 
addition to the transient and sustained off-light responses (Figure 4.5). This effect is 
possibly induced by gap junctions generating homologous RGC-RGC as well as 
heterologous RGC-amacrine cell interactions (Bloomfield and Volgyi 2009). The slower 
onset of the sustained off-response is most likely due to the desensitization of AMPA 
receptors. 
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Figure 4.4 - Pharmacological approaches reveal that ATA mediates its light -responses primarily 
through RGCs and amacrine cells.  
(A-C) Top:: Schematic drawing of retinal cell types. Cells depicted in green may contribute to the 
light-dependent effect of ATA on RGC-output . Bottom: Histogram of ATA3-induced light-response.  
(A) No blockers are applied, therefore all retinal cell types may contribute to RGC output. (B) 
Synaptic inputs from amacrine and bipolar cells are blocked using CdCl2. Therefore, RGCs are 
synaptically isolated from the remaining retina. (C) Inhibitory input on RGCs are specifically blocked 
by strychnine, picrotoxine and TPMPA. RGC signal output consists of bipolar cell- and RGC-mediated 
components. (D) Statistical analysis of light responses in ATA-treated TKO retinae in presence of 
500 µM CdCl2. (Left) Distribution of PI for RGC populations (n = 797 cells). The red arrow indicates 
the mean PI for all recorded cells (PI = 0.6±0.09). (Right) Average spiking rate in darkness and with 
460 nm light (n = 6 retinae). Average is presented as mean±sem. (E) Statistical analysis of light 
responses in ATA-treated TKO retinae in presence of strychnine, picrotoxine and TPMPA. (Left) 
Distribution of photoswitch index for RGC populations (n = 418 cells). The red arrow indicates the 
mean PI for all recorded cells (PI = 0.36±0.03). (Right) Average spiking rate in darkness and with 
460 nm light (n=10 retinae). Average is presented as mean±sem. Significance level p < 0.01 
calculated using the Wilcoxon rank sum test. Figure adapted from (Laprell et al. 2015a). 
 
 
Together, the strong transient off-response and the slower sustained response in presence 
of CdCl2 demonstrate that ATA has its primary effects on RGCs. However, the different 
shape of light response further indicates a more complex mode of action. To determine, 
which other cell types shape the overall response, the inhbititory input from amacrine cells 
to RGCs was blocked using a combination of strychnine (1 µM), picrotoxin (5 µM) and 
TPMPA (10 µM). Thereby, only bipolar cell to RGC signal transmission was recorded. 
Interestingly, the light response was inverted when inhibitory inputs were blocked 
(PI = 0.36±0.03, n = 10 retinae) (Figure 4.4 C). This cannot be explained by a simple 
computational model of the retina, since ATA should have the same effect on all retinal cell 
types, i.e. it activates AMPA receptors in the dark. In this scenario, however, ATA would 
activate bipolar cells in light to a stronger extend than RGCs in darkness. In addition to the 
inversion the light-on response was slightly delayed compared to the light response in 
buffer (Figure 4.4 A). 
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Figure 4.5 - ATA induces small light-on responses in some TKO retinae after application of CdCl2.  
In rare cases CdCl2 did not only induce transient light-off responses, but also transient light on-
responses in comparable RGC spiking frequencies. Figure adapted from (Laprell et al. 2015a) 
 
Summarized, these results indicate that inputs from all three major cell types shape the 
overall output of ATA-mediated light response. The most prominent effects, however, result 
from a combination of amacrine cells and especially RGCs light activation.  
3.2.3 Intravitreal injections of ATA 
MEA recordings after intravitreally administered ATA were performed to demonstrate that 
the molecule is able to penetrate the retina and to induce light-responses after injection in-
vivo.  
Together with Arshan Perrera (LMU Munich, AK Prof. Biel), 1 µL of 1 mM ATA (Na
+
) in PBS 
was injected into the vitreal cavity in anaesthetized TKO mice. After 6 hours the animals 
were sacrificed and the retinae dissected. All injected animals did show ATA-mediated light 
responses on MEA (n = 5 retinae). Surprisingly, the spiking frequency was increased when 
light was switched on in contrast to the ex-vivo experiments (Figure 4.6) (section 3.2.1). 
Furthermore, in a few retinae the overall shape of the light response was altered to a more 
transient peak-response compared to the slow sustained light responses after short 
incubation times ex-vivo. The inversion of the light response may be due to desensitization 
of neurons, which are activated in the dark. However, it remains to be elucidated, which cell 
types are responsible for the light-on responses in RGCs (see also section 3.2.2). 
 
 
Figure 4.6 - ATA-mediated light responses show a transient light-on response  after intravitreal 
injections. Raster plot and histogram of a MEA recording 6 hours post injection.     
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3.2.4 Discussion ATA 
Although ATA has a broader action on different retinal cells and a less pronounced light-
response compared to DAD, it is yet a promising PCL for vision restoration. This molecule 
is the first diffusible photochromic receptor agonist, which has been tested in blind retinae. 
Therefore, ATA expands the range of molecule classes for the photopharmacological 
approach of vision restoration. 
ATA bears important new features compared to previous generation blockers, such as AAQ 
and DENAQ. First, ATA is highly solubility in water (200 mM when formulated as the Na
+
-
salt) and second, it activates cells from the extracellular site. Therefore, ATA does not need 
to be taken up by the cell and the ATA-induced stimulation resembles a more natural 
stimulus by mimicking excitatory synaptic transmission rather than blocking and unblocking 
potassium channels. 
ATA has been shown to be actively switched off using visible light in the blue range (440-
480 nm), but white light has been demonstrated to be as efficient as blue light  
(PI = 0.38±0.03, n  = 11 retinae) (Figure 4.7). In addition, working concentrations of ATA 
are very low (25 µM), only require short incubation times (3-5 minutes) and the light 
responses remain over several hours without significant rundown. This effect can likely be 
attributed to the hydrophobicity of the azobenzene photoswitch, serving as a reservoir in 
the membrane. This hypotheses is further supported by the yellow coloring of the retina 
after incubation, which last throughout the experiment.  
In pharmacological experiments it was demonstrated that primarily amacrine cells and 
RGCs shape the overall ATA-induced light response. However, the experiments with CdCl2 
revealed that ATA can act on RGCs alone. This might be beneficial for patients with 
advanced retinal degeneration, in which PCLs for upstream cell targets might not work.  
 
 
Figure 4.7 - ATA-induced light responses with Xenon light source. (A) Raster plot and histogram of 
MEA recording of ATA-treated TKO retina with white light application. Bar underneath the histogram 
represents dark and Xenon illumination. (B) Average spiking rate in darkness and with 460 nm light 
for individual experiments (n = 11 retinae, p < 0.01). The overall average is presented as mean±sem 
(red). (C) Statistics of light responses in ATA-treated TKO retinae. Distribution of PI for RGC 
populations (n = 577 cells). The red arrow indicates the mean PI for all recorded cells 
(PI = 0.38±0.04). Figure adapted from (Laprell et al. 2015a). 
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Taken together the pharmacological experiments revealed the molecular and the cellular 
targets of ATA. However, the effect of ATA in the absence of inhibitory input cannot be 
easily explained. It is clear that amacrine cell input inhibits signal transmission from bipolar 
to RGCs, by which the ATA response of RGCs prevails. Yet, the exact mechanism of bipolar 
cell light-activation cannot be clarified with this experiment. A simple explanation of the 
inversion in bipolar cells would have been the activation of metabotropic glutamate 
receptors in on-bipolar cells (such as mGluR6), which was ruled out by the NBQX 
experiments. Recent studies, however, demonstrated dramatic changes of iGluR expression 
levels in degenerating retinae. Studies of ret inal remodeling in rd1/rd1 mice showed that at 
postnatal day 15 on-bipolar cells exhibit poor activation of mGluR6 and show an increased 
expression level of iGluRs, thereby shifting its functionality from on- to off-bipolar cells 
(Chua et al. 2009). A different study revealed that as long as remaining cones are present, 
although non-functional, the distribution of off- to on-cone bipolar cells and rod-bipolar cells 
is shifted from 40:30:30 to nearly 80:15:05 (Marc et al. 2007, Jones et al. 2011). Loss of 
mGluR6 after photoreceptor ablation further substantiate this finding of change in cell f ate 
(Dunn 2015). Further complicating matters, Lin et al. could demonstrate that AMPA 
receptor composition is dramatically changed in retina after light -induced retinal 
degeneration (Lin et al. 2002). These physiological effects are only a few examples of the 
severe alterations happening through retinal degeneration. Remodeling not only affects 
expression levels of specific receptors, but lead to dramatic changes in the overall synaptic 
transmission, which further revises the fundamental topology of the retina (Jones et al. 
2012). These substantial changes in retinal architecture make it hard to predict and 
evaluate specific activation patters for ATA. However, retinal remodeling may not only 
influence PCL approaches, but also strongly impact genetic approaches using ChR2 or 
LiGluR. 
 
Taken together, ATA is the first freely diffusible photochromic receptor ligand used for 
restoration of light perception in blind retinae. It can be inactivated using blue or white light 
and most importantly, it was demonstrated that ATA is able to directly photosensitize RGCs, 
regardless of the effects on bipolar, amacrine cells and effects of retinal remodeling. 
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3.3 Restoration of transient light-on and light-off responses using 
a combination therapy approach 
DAD and ATA have been shown to exhibit very different properties. In the retina, DAD 
strongly increases spiking frequency in RGCs upon illumination with blue light, whereas 
ATA is active in the dark-adapted trans-state and needs to be actively switched off with 
light. Furthermore, DAD primarily targets bipolar cells, while RGCs and amacrine cells are 
the major target cell types of ATA.  
These different features made the molecules good candidates for a combinatorial approach 
to see whether strong on- and off-light responses can be restored using different PCLs. 
After a short 3-minute incubation with both compounds (100 µM DAD and 25 µM ATA), the 
same light stimulation protocol was applied to the retinae as in previous experiments with 
only one compound. Alternating blue light and dark stimulation was able to induce both 
light-on and -off responses (Figure 5.1). Interestingly, light-off responses, which can be 
attributed to ATA-activation, were transient rather than sustained. ATA application alone did 
only result in slow sustained light-off responses (see section 3.2.1). However, these 
transient light-off responses cannot be attributed to DAD, since it is much more pronounced 
compared to the light-off responses in retinae treated with DAD only (PIon = 0.52±0.06 and 
PIoff  = 0.26±0.06, n = 6 retinae) (Figure 5.1 A-D and 2.3 B, respectively). Furthermore, a 
complex signal output can be observed on single RGC level. In 42 % of all RGCs both, 
transient light-on and transient light-off responses, were detected. From the remaining cells 
37 % of RGCs exhibited transient light-on responses and only 21 % of RGCs showed 
transient light-off responses (n = 412 RGCs) (Figure 5.1 E). For comparison, in retinae 
treated with DAD only, the distribution was 22 % on-off, 66 % only on- and 12 % only light-
off responses (see section 3.1.3). The combination of DAD with ATA showed similar 
distributions of RGCs to wild type at postnatal day 13 (ON-RGC: 35.0 %, OFF-RGC: 10.8 % 
and ON-OFF-RGC: 54.1 %, (Liu et al. 2009). The shift in light-responses compared to DAD- 
or ATA-treatment alone is further supported by the PI distribution of TKO retinae treated 
with both, which spanned a range similar to the PI distribution of wt retinae (Figure 5.1 F).  
 
The shift from on-light responses to on-off light responses was further investigated by 
analysis of RGC spike correlation (Figure 5.2). Prior illumination RGC spiking activity was 
not correlated (Figure 5.2 A; blue-green), while activation of DAD and inactivation of ATA 
with blue light induced a strong positive correlation within the RGC layer (Figure 5.2 B). 
After switching light off many RGCs exhibit a transient increase in spiking frequency again, 
which led to a positive correlation within the first second in the dark (Figure 5.2 C). 
Importantly, this light-off correlation is much more pronounced when compared to 
correlation experiments with DAD alone (Figure 3.5 see section 3.1.2).  
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Figure 5.1 - Combination therapy induce transient light-on and light-off responses in blind retinae. (A) 
Raster plot and histogram of a MEA recording in a TKO retina after treatment with 200 µM DAD and 
25 µM ATA. The bar underneath the raster plot indicates light/dark stimulation (blue: 460 nm, black: 
dark). (B) Average spiking rates upon onset of 460 nm light (n = 6 retinae). Average is presented as 
mean±sem. (C) Average spiking rates upon offset of 460 nm light (n = 6 retinae). Average is 
presented as mean±sem. (D) Example histograms for DAD and ATA treated TKO RGC light 
responses. The bars underneath the histograms indicate the light stimulation protocol. (E) 
Percentage distribution of DAD and ATA mediated light responses. 42 % of all recorded RGCs in 
TKO mice show both, on- and off-light responses. 37 % only show only on- and 21 % solely off-
responses (n = 412 cells in 6 retinae). (F) Distribution of photoswitch index for RGC populations with 
combination therapy in TKO retinae (red) compared to wild type retinae (black) (n = 11 TKO retinae 
and n = 7 wt retinae). Figure adapted from (Laprell et al. 2015c). 
 
 
Taken together, the combination experiments demonstrated that PCLs are able to induce 
light responses similar to those in wt retinae. Although DAD, like ChR2 or LiGluR, is in 
principle able to restore both light-on and -off responses, the additional application of ATA 
revealed an even more pronounced effect. The exact working mode of the combinatorial 
approach needs to be further investigated, especially in respect to the shift from sustained 
to transient light-off responses. However, ATA has been the first photochromic receptor 
ligand applied to blind retinae and with novel next-generation molecules developed an even 
higher specificity may be achieved. To date, the only optochemical approaches able to 
restore both, light-on and -off responses, were to either targeting ChR2 or NpHR to 
remaining cones or on-bipolar cells (Busskamp et al. 2010, Werblin 2011, Mace et al. 
2015). Here, a novel photopharmacological approach for restoration of transient on- and 
off-responses is presented, which does not require any genetic manipulation.  
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Figure 5.2 - Example of correlation of light responses in DAD/ATA-treated retina. (A) Correlation of 
RGC responses 1 s before light stimulation. (B) Correlation during the first second of light 
stimulation. (C) Correlation within the first second after switching off light. One second binning was 
applied. Red indicates high correlation while green indicates no correlation (Scale bar at the right). 
During light stimulation most cells and after switching off light a fraction of cells show a positive 
correlation in RGC firing. Figure adapted from (Laprell et al. 2015c). 
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3.4 Conclusion: Vision restoration 
Degenerative diseases of the outer retina, such as RP and AMD, lead to visual impairment 
and eventually to complete blindness with no cure currently available.  In the past decade 
several approaches towards restoration of vision have been investigated (see section 1.2). 
Opto-electronic devices, such as Argus II and alpha-IMS, as well as the still more 
experimental optogenetic approaches are promising strategies for the restoration of vision 
(see section 1.4). However, both exhibit specific limitations. Introduction of retinal implants 
is highly invasive and may lead to severe scarring of ocular tissue. Furthermore, the 
durability of the devices is limited due to corrosion of material and the density of 
stimulation electrodes is not only restricted by the size, but also by safe levels of 
extracellular current. In principle, this approach is reversible and would allow exchange for 
novel devices, but scarring of tissue and high costs may limit the realization.  
Optogenetic approaches are invasive on a different level than opto -electronic devices. The 
introduction of the genes may have no effect on ocular tissue in respect to scarring. 
However, it remains to be seen, whether adding new genes (especially non-human genes) 
may induce undesirable side effects. Furthermore, optogenetic approaches are irreversible 
and cannot be readily terminated or exchanged for next-generation approaches. The 
introduction of modified channels, such as LiGluR, may circumvent some of  these 
limitations as it is not 'xenogenetic' and the ligand would be interchangeable, nevertheless 
the target protein would remain the same (Gaub et al. 2014, Caporale et al. 2011).  
In this chapter three different photopharmacological approaches towards restoration of 
vision were presented. The first approach is based on the photochromic potassium channel 
blocker DAD, which selectively targets bipolar cells in the degenerating retina ( see section 
3.1). In the second approach the photochromic excitatory amino acid, ATA, was applied to 
blind retinae. This is the very first example of a freely diffusible PCL based on a receptor 
ligand applied for vision restoration (see section 3.2). As such, it complements previous 
pharmacological approaches based on photochromic channel blockers . The potential of 
photopharmacology in vision restoration is further increased by the possibility to combine 
PCLs with different properties. Using this strategy robust light-on as well as light-off 
responses can be induced similar to those in wt retinae (see section 3.3). These 
photopharmacological approaches circumvent almost all drawback mentioned for the 
implantation or optogenetic approaches by being a mere pharmacological strategy. PCLs 
can be added or removed from the system as required without the need of genetic 
modification. This not only allows to stop treatment in case of side effects, but its 
reversibility also rises the opportunity to develop better molecules and to adjust the 
treatment to the needs of the patient. Furthermore, the photopharmacological approach is 
not limited to a specific stage of disease onset. DAD has been shown to effect only 
degenerating retinae, however, it already induces light sensitivity in young mice in which 
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only parts of the retinae were degenerated (see section 3.1.6). Opto-electronic devices and 
optogenetics would always target both, healthy and degenerated tissue, thereby interfering 
with the remaining vision during early onset of disease. Additionally, the 
photopharmacological approach is adaptable to the progress of the disease by targeting 
different cell types. During early onset photochromic ligands for the activation of bipolar 
cells could be applied, while late stage patients would receive ligands that primarily target 
the remaining RGCs.  
Taken together, the photopharmacological approach using freely diffusible photochromic 
ligands is not only minimally invasive and cheaper, but it is also flexible in its application.  
In respect to previous photopharmacological approaches, DAD and ATA have been shown 
to be advantageous in terms of application. Both molecules, when formulated as salts, are 
highly soluble in physiological buffers giving the opportunity for sustained drug release 
using nano-/microparticle approaches (Rowe-Rendleman et al. 2014, London et al. 2011). 
Furthermore, DAD and ATA both need substantially shorter incubation times. This may be 
likely attributed to the molecular structures, i.e. both compounds are non-permanently 
charged. Another advantage of DAD and ATA over previous generation photochromic 
ligands is the activation of upstream cell targets. Thereby, the remaining retinal circuitry is 
utilized, which will most likely lead to higher image resolution and increased information 
transferred to higher brain regions. 
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4 PCL characterization 
4.1 ATG 
4.1.1 Introduction ATG 
Ionotropic glutamate receptors (iGluR) form non-selective cation channels that mediate fast 
excitatory synaptic transmission. The group of iGluRs can be subdivided according to their 
specific agonist, i.e. AMPA, kainate and NMDARs. They are ubiquitously expressed 
throughout the nervous system where they are responsible for the excitatory synaptic 
transmission between neurons. In this chapter I will focus on NMDARs, which are 
associated with synaptic plasticity, i.e. long-term depression and potentiation (Paoletti et al. 
2013). In addition, many diseases have been linked to NMDARs dysfunction, such as 
Alzheimer's and Huntington's diseases.  
NMDARs are composed of four subunits as hetero-oligomeric membrane proteins. GluN1 
subunits are obligatory for receptor formation and the binding of the co -agonist, i.e. glycine 
or D-serine, whereas glutamate binds to the GluN2 subunits.  
Recently, a functional tetrameric receptor structure has been described, which will provide 
deep insights into specific receptor function and disease mechanisms (Karakas and 
Furukawa 2014, Lee et al. 2014). However, most NMDAR properties were obtained through 
electrophysiological recordings, demonstrating the relevance of these experiments.  To 
probe the function of iGluRs in the brain several variants of caged agonists and antagonists 
have been developed, which take advantage of the spatio-temporal precision of light. 
Compounds like caged glutamate, caged NMDA or caged MK-801 have been proven to be 
useful elucidate the function of glutamate receptors in synaptic transmission (Gee et al. 
1999, Maier et al. 2005, Rodriguez-Moreno et al. 2011, Kramer et al. 2009, Thompson 
2005). Caged compounds, however, entail one major drawback: Although receptor 
activation can be precisely timed, they cannot actively be switched off and therefore the 
deactivation remains diffusion limited (DiGregorio et al. 2007).  
PCLs circumvent this limitation and can be called 'reversibly caged' ligands. They can 
repeatedly be switched between their active and inactive state. Furthermore, PCLs do not 
generate photochemical byproducts, which may have toxic side effects when accumulated. 
In this section azobenzene-triazole-glutamate (ATG), a novel photoswitchable glutamate 
derivate will be described (Figure 6.1 A).  
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Figure 6.1 - Action spectrum, kinetics and dose-response curve. (A) Molecular structure of ATG. Trans- 
to cis- and cis- to trans-conversion can be achieved using near UV and blue light, respectively. (B) 
Wavelength screening for activation of ATG-mediated currents. Current amplitude was measured after 
5 s light stimulation with the respective wavelength and normalized to the maximal current amplitude 
at 360 nm. Inset: Raw data traces for 5 s light stimulation from 360 nm to 410 nm light (dark to light 
violet. (C) Wavelength screening for τoff  kinetics of ATG-mediated currents. Measurement of τoff 
kinetics for wavelengths between 400 nm and 540 nm light. Inset: Raw data traces showing the off-
kinetics after a 5 s light-stimulation with 370 nm. Best τoff kinetics were achieved at 425-450 nm light 
(red trace: exponential fit). (D) Dose-response relationship of ATG-mediated currents in cortical slice 
preparations. Concentrations from 1 to 500 µM were tested. The EC50 is 185 µM and was calculated 
using the Hill-equation. (E) UV/vis spectra of ATG in the dark-adapted state and during illumination 
with 370, 405 and 420 nm light. Figure modified from (Laprell et al. 2015b). 
 
4.1.2 ATG: a selective PCLs for NMDA receptors 
Characterization of ATG was performed in mouse layer 2/3 cortical neurons. Perfusion with 
200 µM ATG allowed photo-control of neural activity by toggling between 360-370 nm and 
420 nm light (Figure 6.1). ATG is inactive in its thermodynamically stable trans-
configuration and induces large currents after switching to cis-configuration with near UV-
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light, in contrast to previously published glutamate receptor agonists, e.g. GluAzo and ATA 
(Volgraf et al. 2007, Stawski et al. 2012). Lambda screen experiments revealed that 
wavelengths between 350 nm and 370 nm were best for receptor activation (Figure 6.1 B) 
and that τoff was fastest using 420 nm light (τoff = 0.17 s ± 0.03; n = 16, Figure 6.1 C). 
These findings are in accordance with measured UV/vis spectra , in which 365 nm was best 
for trans- to cis-isomerization and 405 nm420 nm wavelengths were best for switching 
back (Figure 6.1 E). If no light is applied after trans- to cis-isomerization, thermal relaxation 
into the trans-isoform was very slow in physiological buffer solution (Figure 6.2).  
Together with the lab of Prof. DiGregorio (Institute Pasteur, Paris) we could further show 
that ATG can also be two-photon activated (720 nm), which allows high spatio-temporal 
precision, such as single spine activation (Laprell et al. 2015b). 
 
Figure 6.2 - Thermal stability of ATG. Kinetics of the conversion of trans- to cis-ATG during 
illumination with 460 nm and 365 nm light (high power LEDs) measured at the maximal absorption 
wavelength of trans-ATG (330 nm). Figure adapted from (Laprell et al. 2015b). 
 
In current-clamp mode switching to cis-configuration using 370 nm light induced strong 
action potential firing (Figure 6.3 A), which was readily terminated after switching back to 
420 nm light. Furthermore, using dose-response experiments an EC50-value of 185 µM for 
cis-ATG was determined (Figure 6.1 D). 
The molecular target receptors of ATG were identified in various pharmacological 
experiments. Photosensitization of cortical neurons was completely abolished in presence 
of D-AP5, a competitive NMDAR antagonist (Figure 6.2 B). Current-voltage relationships 
further substantiated the finding that ATG selectively activates NMDARs. The ATG-induced 
IV-relationship was directly compared to an NMDA puff induced IV-relationship. In presence 
of ATG alone, currents had the characteristic J-shaped relationship attributable to the 
magnesium (Mg
2+
) block of the NMDAR pore at membrane resting potential (Dingledine et 
al. 1999) (Figure 6.3 C). In absence of Mg
2+
 the IV-relationship was found to be linear and 
the reversal potential was close to 0 mV, as it is expected for a non-selective cation 
channel. IV-relationships showed no current in presence of the NMDAR antagonist D-AP5 or 
MK-801, a pore blocker of NMDARs (Figure 6.4, green and blue traces, respectively). 
NBQX on the other hand, had no significant effect on the IV-relationship (Figure 6.4, red 
trace). Taken together, the pharmacological experiments and the IV-relationships 
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demonstrate that ATG selectively activates NMDARs and has no effect on AMPA or kainate 
receptors in mouse cortical neurons. 
 
Figure 6.3 - Photopharmacology of ATG. (A) Current-clamp recording of a cortical neuron in an acute 
slice preparation. Irradiation with 370 nm light (violet) induces robust action potential firing that is 
terminated by irradiation with 420 nm light (blue). (B) Washing in AP-5 (50 µM), an NMDA-specific 
antagonist, blocks the ATG-mediated light-dependent action potential firing. (C) Current-voltage 
relationships indicative of NMDARs as targets for ATG. Black: Current-voltage relationship of puff-
applied NMDA currents (n = 12 cells). Red: Current-voltage relationship of ATG-mediated currents 
under 370 nm light (n = 10 cells). Blue: Current-voltage relationship of ATG-mediated currents in the 
absence of Mg
2+
 ions (n = 10 cells). Error bars indicate SEM. Figure adapted from (Laprell et al. 
2015b). 
 
In collaboration with Jan Terhag (Prof. Michael Hollmann, Ruhr-University Bochum, 
Germany) we investigated, whether ATG is NMDAR-subtype selective. We therefore 
heterologously expressed different heterotetramers of GluN1 with GluN2A-D in Xenopus 
oocytes. Here, ATG was able to light-activate NMDARs equally for all subtype compositions, 
however, to a much smaller extent than glutamate (max. 9 % of glutamate-evoked currents 
(Laprell et al. 2015b). This finding demonstrates that ATG-activation is less efficient when 
receptors are heterologously expressed.  
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Figure 6.4 - Current-voltage relationship of ATG-mediated currents (370 nm) in the presence of 
NMDAR and AMPAR antagonists in cortical neurons. 200 µM ATG was used for all experiments. 
Black: control Red: 25 µM NBQX (n=8 cells), a selective AMPAR antagonist. Green: 40 µM AP-5, a 
selective NMDAR antagonist (n = 3 cells). Blue: 50 µM MK-801, a selective NMDAR blocker (n = 5 
cells). Single data points represent mean±SEM. Modified from (Laprell et al. 2015b). 
4.1.3 Calcium imaging 
In contrast to AMPA and kainate receptors, NMDARs are highly permeable to Ca
2+
 and are 
therefore important mediators for intracellular calcium signaling. Ca
2+
 influx through 
NMDARs is in particular associated with postsynaptic alterations, such as glutamate 
receptor expression, thereby influencing synaptic plasticity (Dingledine et al. 1999). To 
investigate whether ATG-mediated currents are large enough to increase intracellular Ca
2+
 
levels, imaging experiments were performed using the fluorescent Ca
2+
-indicator Quest-
Fluo-8-AM. Acute brain slices were incubated with the membrane-permeable indicator and 
TTX was added to the perfusion to prevent calcium entry through spontaneous network 
activity (Figure 6.5). After light activation of ATG large calcium-transients were detected 
(ΔF/F = 20±3 %, n = 18 cells) (Figure 6.5 B left). Since the activation of NMDARs 
depolarizes the membrane, a fraction of the calcium signal can be attributed to calcium 
entry through voltage-gated calcium channels. Therefore, felodipine a VGCC-blocker was 
applied which significantly reduced the calcium signal (ΔF/F = 13±3 %, n = 10 cells, 
p < 0.05, Wilcoxon rank sum test, Figure 6.5 B right), leaving the remaining Ca
2+
 transients 
exclusively evoked by ATG-mediated NMDAR activation (Figure 6.5 B inset). 
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Figure 6.5 - Calcium imaging using ATG in hippocampal neurons. (A) ATG-mediated electrical signals 
elicited with 370 nm light and terminated with 420 nm (250 ms light pulse). right – in the presence 
of 40 µM Felodipine (Fel) and 1 µM TTX. (B) Corresponding calcium transients to (a). Bar graph: 
Quantification of calcium transients (ATG+TTX: n = 18 and ATG+TTX+Felodipine: n=10). *p < 0.05, 
Wilcoxon rank-sum test. Error bars indicate SEM. (C) Changes in fluorescence (ΔF/F) at different 
time points of the calcium transient; prior to light stimulation, immediately after illumination and after 
returning to basal calcium levels. Figure adapted from (Laprell et al. 2015b). 
 
4.1.4 Mimicking synaptic coincidence detection with ATG 
NMDARs are coincidence detectors of post- and presynaptic activity due to their 
physiological properties. Activation of NMDARs not only require binding of two agonists, 
glutamate and an allosteric modulator (i.e. glycine or D-serine), but also the Mg
2+
 block 
needs to be removed from the pore by an initial depolarization through AMPARs (Nevian 
and Sakmann 2004). This Mg
2+
 block endows NMDARs with a voltage-dependent gating 
mechanism. Therefore, NMDARs can act as 'coincidence detector', as they require both 
glutamate release from the presynaptic terminal and simultaneous postsynaptic 
depolarization to fully activate. To test whether ATG-activated NMDARs are also able to act 
as coincidence detectors a combined light-electrical stimulus protocol was applied. Here, 
an antidromic stimulation of the axon hillock, i.e. depolarization of the postsynaptic cell, 
was paired with 370 nm light activation (black and violet lines, respectively) (Figure 6.6 A-
C). The electric stimulation was set sub-threshold and only in the case of coincidence with 
light stimulation, action potential firing was induced (Figure 6.6 A-C center). When light 
stimulation was applied before electrical stimulation, the threshold was not exceeded 
(Figure 6.6 A-C right). The spiking rate was also significantly reduced when the interval 
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between electrical and light stimulation was too long (Figure 6.6 B, C left). The statistical 
analysis of the experiments summarized in figure 6.6 D clearly show that ATG-activated 
NMDARs can operate as coincidence detectors. 
 
 
 
Figure 6.6 - Coincidence detection using ATG. Coincidence detection of light-induced ATG current 
paired with antidromic stimulation. (A) Antidromic stimulation (black bars) of the postsynaptic cell 
10 ms prior to, simultaneous and 10 ms after the light stimulation (violet trace). (B) Same experiment 
as in (A) with 50 ms interval between pre and post stimulus. (C) Same experiment as in (A) and (B) 
with 100 ms interval between pre and post stimulus. (D) Quantification of coincidence detection. 
Relative number of spikes compared to condition ZERO, when both stimuli were applied together 
(n = 11 cells). Statistics calculated using Wilcoxon rank sum test. (*p < 0.05, **p < 0.01, 
***p < 0.001). Figure adapted from (Laprell et al. 2015b). 
 
4.1.5 cis-STG: a selective NMDAR agonist 
Stilbenes are thermally stable molecules of an ethene double bond substituted with a 
phenyl ring on both ends of the double bond. The molecular structure resembles that of an 
azobenzene and the stilbene can also exist in either trans- or cis-configuration. However, 
stilbenes are not photoswitchable. The cis-stable stilbene version of ATG, cis-STG, can be 
used as a model for and exhibits a similar pharmacological profile as cis-ATG. Patch clamp 
experiments in cortical neurons could show that puff application of cis-STG (200 µM) was 
able to induce action potential firing. In addition, the J-shaped IV relationship and the 
sensitivity towards a block by D-AP5 (cis-STG current in presence of D-AP5 and TTX 
1.45±0.09 pA; <15 % of cis-STG-currents in absence D-AP5) indicate the same selectivity 
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of cis-STG for NMDARs (Figure 6.7 A and B, respectively). Taken together, cis-STG 
represents a novel class of selective, synthetic NMDAR agonists.  
 
Figure 6.7 - Characterization of cis-STG. (A) Current-clamp recording in cortical neuron with cis-STG. 
Puff-application of 200 µM cis-STG for 500 ms result in robust action potential firing.  (B) Current-
voltage relationship of cis-STG in cortical neurons. Ramps were performed between –70 mV and 
50 mV. Single cell recordings are depicted in grey (n = 5), average trace of all experiments is shown 
in red. Figure adapted from (Laprell et al. 2015b) 
4.1.6 ATG-mediated currents in murine Purkinje cells 
It was thought for a long time that cerebellar Purkinje cells do not express functional 
NMDARs (Perkel et al. 1990, Llano et al. 1991). In the past decade, however, significant 
evidence was found that NMDARs are postsynaptically expressed at the climbing fiber to 
Purkinje cell synapse. The expression of NMDARs in Purkinje cells show a late 
developmental onset and are barely detectable until postnatal week four (Piochon et al. 
2007). Therefore, Purkinje cells from mice postnatal day 15 to 17 would provide a good 
negative control for ATG specificity, because no NMDAR currents should be detectable. 
Application of 200 µM ATG (in presence of 1 µM TTX) to mouse cerebellar slices, however, 
induced large light-dependent currents (Figure 6.8 A, B) (283.4±10.5 pA), as did puff 
application of NMDA (Figure 6.8 A, B, 440±183.4 pA). To elucidate the molecular target of 
these currents pharmacological experiments were performed. NMDA puff induced currents 
were completely blocked using D-AP5, which indicates that mice older than two weeks 
already express substantial levels of NMDARs (Figure 6.8 C, 8.33±0.33 pA). However, 
currents induced by ATG were insensitive to the NMDAR antagonist D-AP5 (50 µM) and to 
the NMDAR pore blocker MK-801 (1 mM) (Figure 6.8 C) (273.6±18.6 pA and 
343.5±15.5 pA, respectively). Blockers for AMPARs (NBQX), mGluRI (YM298198, 50 µM) 
and mGluRII/III (CPPG, 300 µM) were also not able to block ATG-mediated currents. NBQX 
application, however, reduced leak currents, which led to a relative increase in ATG-
mediated currents (Figure 6.8, 624.00±26.66 pA). The reduction of leak currents by NBQX 
might be due to residual activation of AMPARs by trans-ATG in cerebellar Purkinje cells. 
Furthermore, blocking synaptic transmission using CdCl2 had only a minor effect on ATG-
mediated currents, excluding the possibility of primarily activating cells presynaptic to 
Purkinje cells (498.55±13.42 pA in presence of ATG, NBQX and CdCl2) (Figure 6.8). 
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Two more experiments were performed to confirm that cis-ATG induced currents are not 
mediated through NMDARs in cerebellar Purkinje cells. First, the concentration of the 
allosteric modulator D-serine (10 µM) was increased and second, extracellular Ca
2+
 was 
depleted. Application of D-serine led to slightly increased ATG-mediated currents, whereas 
depletion of Ca
2+
 had no effect (Figure 6.8, 370.63±21.27 pA and 267.00±5.85 pA, 
respectively).  
 
Figure 6.8 - Characterization of ATG-mediated currents in Purkinje cells. (A) Raw data trace for ATG-
light activated current at 60 mV holding potential. Blue bar represents 420 nm illumination and 
violet 370 nm. (B) Current-voltage (IV) relationship of ATG-induced currents in Purkinje cells. Black: 
IV-relationship in ACSF . Red: IV-relationship without Mg
2+
. Holding potentials larger than 20 mV 
may not be exact due to the size of Purkinje cells ('space clamp'). (C) Pharmacology of ATG- and 
NMDA-induced currents. Currents were normalized to ATG-currents and statistical analysis was 
performed using Student's t-test. *p < 0.05, **p < 0.01, ***p < 0.001. Error bars represent SEM. 
 
In conclusion, these results indicate that ATG does not activate common NMDARs, but an 
unknown receptor in cerebellar Purkinje cells and has only little effect on AMPARs in trans-
configuration. These findings were unexpected, since ATG has been shown to be a 
selective NMDAR agonist and induced no significant leak currents in mouse cortical 
neurons (see section 4.1.2). 
Interestingly, receptors composed of GluN1 and GluN3 subunits have been shown to be 
unaffected by glutamate or NMDA, resistant to the intrinsic Mg
2+
 block and to specific 
NMDAR blockers, such as MK-801, or competitive antagonists. These receptor 
combinations only respond to glycine and are inhibited by D-serine (Chatterton et al. 2002). 
Whether it is this receptor combination that ATG is able to activate remains to be 
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investigated. However, as expression levels in the cerebellum are low and as they do not 
respond to glutamate it seems unlikely that ATG could activate these NMDARs.  
The only receptor that is highly expressed in Purkinje cells and exhibits a similar structure 
to glutamate receptors is the orphan receptor GluRδ2. This receptor has been shown to be 
almost exclusively expressed in Purkinje cells of the cerebellum and plays a crucial role in 
synaptic plasticity and motor coordination (Zuo et al. 1997, Kakegawa et al. 2007a, 
Kakegawa et al. 2007b, Lomeli et al. 1993). Due to structural similarities to other glutamate 
receptors, such as NMDARs and AMPARs, several studies have been undertaken to identify 
agonists or antagonists of the receptor. Zuo et al. (1997) reported that addition of 100 µM 
AP5, 100 µM CNQX or 100 µM 7-chlorokynurenic acid, a blocker of the glycine binding site 
of NMDARs, did not alter holding current or membrane conductance. Furthermore, 
application of 1 mM glutamate, 1 mM aspartate or 0.1 mM kainate in presence of 10 µM 
glycine failed to open the GluRδ2 pore. However, evidence exists that the channel pore of 
Gluδ2 is functional (Kohda et al. 2000, Schmid and Hollmann 2008, Schmid et al. 2009) . A 
recent study also demonstrated that Gluδ2 is activated by mGluRI activation (Ady et al. 
2014). To date, most information about GluRδ2 function has been obtained from a gain of 
function mutation in lurcher (Lc) mice, in which a highly conserved alanine is replaced by a 
threonine residue in the third hydrophobic protein segment (Vogel et al. 2007). This point 
mutation renders the receptor constitutively open and leads to ataxia in heterozygous and 
early death in homozygous lurcher mice. As for the wt receptor also the lurcher mutant 
receptor does not respond to any NMDAR- or AMPAR-blockers. GluR2
Lc
-mediated currents 
were only considerably reduced by the application of pentamidine (10 µM), an NMDAR 
blocker (Williams et al. 2003), or 1-naphthyl acetyl spermine (NASP; 10 µM), a polyamine 
analog of Joro spider toxin, an open-channel blocker of AMPA and kainate receptors 
(Kohda et al. 2000). Furthermore, D-serine and glycine had reducing effects on membrane 
currents similar to NASP, when applied at high concentrations (Naur et al. 2007). 
To investigate whether ATG may activate GluRδ2 receptors in Purkinje cells, pentamidine 
(50 µM) was applied to cerebellar slices in presence of ATG. The application of 
pentamidine significantly reduced light-induced currents by ATG (Figure 6.8), but also leak 
currents were substantially reduced (ATG-mediated currents in presence of pentamidine 
127.41±11.24 pA, p < 0.001 and leak currents before and after application of 
pentamidine, respectively 878.8.41±68.1 pA and 426.5±49.8 pA, p < 0.001). The 
reduction of ATG-mediated currents by 50 % is similar to the results in lurcher mice and 
indicates that ATG might activate GluRδ2 receptors in mouse Purkinje cells (Williams et al. 
2003). To further substantiate this finding, light -induced IV-relationships with ATG were 
performed. The ATG-mediated IV-relationship resembles the IV recorded in Purkinje cells of 
lurcher mice (Figure 6.8 B, black trace) (Naur et al. 2007). Furthermore, the absence of 
Mg
2+
 had no effect on the shape of the IV (Figure 6.8 B, red trace). Thus, ATG-mediated 
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activation of NMDARs in Purkinje cells of the cerebellum plays a minor role and an 
activation of GluRδ2 seems to be more likely. 
To further investigate ATG's activity on GluRδ2 receptors, both, GluRδ2 and NMDARs were 
heterologously expressed in HEK cells. Surprisingly, neither GluRδ2 nor NMDARs could be 
activated by ATG after heterologous expression (data not shown), which might be due to 
low channel number (see section 4.1.2). Therefore, investigation of ATG-mediated activation 
of GluRδ2 will concentrate on the GluRδ2 knockout animal, Hotfoot-Nancy, in which a lack 
of ATG-mediated currents would ultimately proof GluRδ2 specificity in Purkinje cells 
(Lalouette et al. 2001). 
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4.1.7 Red-shifted ATG  
Application of UV light to neural tissue may have undesirable side effects. Therefore, many 
PCLs have been red-shifted by attaching an additional dimethylamine group in para-position 
to the azo-group (N=N), e.g. ATA. This red-shifting effect is induced by the electron-donating 
group and can be further enhanced by an electron-withdrawing group on the other end of 
the molecule ('push-pull' azobenzenes) (Mourot et al. 2011) (Sadovski et al. 2009). Besides 
red-shifting the absorption spectrum these modifications have the additional effect of an 
increased rate of thermal relaxation from cis to trans, which are further influenced by polar 
protic solvents (Whitten et al. 1971). However, depending on the photoswitch and its target 
receptor modifications can have dramatic effects on its functionality, positively and 
negatively. In case of ATG, this small modification led to the complete loss of ATG's activity 
in cortical neurons (Figure 6.9). Patch-clamp experiments in layer 2/3 cortical neurons 
revealed that red shifted-ATG (rs-ATG) had neither influence on leak currents, nor did it 
elicit light-induced currents (data not shown). This result indicates that ATG is completely 
enclosed by the clamshell domain of NMDARs, which may be the reason for its high 
selectivity for NMDARs in cortical neurons. In Purkinje cells , however, rs-ATG was able to 
induce light-dependent currents. Here, the molecule was trans-active, therefore induced 
currents in the dark, and could effectively be switched of f using light between 480 nm and 
500 nm (Figure 6.9 B, C). Not only was the polarity of activation inverted, but also the 
currents induced by rs-ATG were much smaller compared to ATG (92.24±7.17 pA and 
283.4±10.5 pA, respectively). Although no pharmacological experiments have been 
performed in the cerebellum yet, these results indicate a completely different functionality of 
rs-ATG compared to ATG.  
 
 
Figure 6.9 - Characterization of red-shifted ATG (rs-ATG) in cerebellar Purkinje cells. (A) Structure of 
trans-rs-ATG. (B) Raw data trace of lambda screen for best inactivation wavelengths. (C) Data 
analysis of lambda screens. Maximal switching current in % for cis- to trans-isomerization. Best 
inactivation is achieved using wavelengths between 480 nm and 500 nm. Data points represent 
mean±SEM (n = 5 experiments). 
4.1.8 Discussion ATG 
ATG is a freely diffusible photochromic ligand that selectively activates NMDARs in mouse  
cortical neurons. It has the unique features of being inactive in its thermodynamically stable 
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trans-configuration and can be quickly switched to its active state using near UV light (360 -
370 nm). As such, it is not excitotoxic when applied to neural networks in the dark. 
Furthermore, it is the first diffusible photoswitch that can be activated using two -photon (2-
P) activation (720-740 nm). Until today only photochromic tethered ligands (PTLs) have 
been shown to be excitable by two-photon activation (Carroll et al. 2015). In contrast to 
caged-NMDAR agonists ATG has the advantage that it can be switched back to its inactive 
state using blue light (405-420 nm). Rapid laser experiments furthermore demonstrated 
that photoswitching occurs in the timescale of intrinsic receptor deactivation (Laprell et al. 
2015b).  
Calcium-imaging and coincidence detection experiments revealed that ATG selectively 
activates NMDARs in the mouse cortical neurons and two-photon excitation of ATG result in 
high spatio-temporal precision of NMDAR activation (Laprell et al. 2015b). These results 
demonstrate that ATG is a useful tool for the study of NMDARs in cortical neurons. In 
addition, cis-STG has been shown to represent a new class of selective synthetic NMDAR 
agonists. Only red-shifting the PCL did not lead to NMDAR currents; most likely, because 
ATG may be completely enclosed in the clamshell leaving no room for modifications.  
In cerebellar Purkinje cells ATG seems to elicit its action through a different type of 
receptor. Here, in contrast to NMDA application, ATG activation could not be eliminated by 
D-AP5 application. Furthermore, antagonists for AMPA, mGluR I and mGluR II/III did not 
prevent light-induced currents. On the other hand the open channel blocker pentamidine 
has shown to reduce ATG-mediated currents significantly. Similar results have been 
obtained for the orphan receptor GluR2
Lc
. Also the IV-relationship of ATG-mediated 
currents in Purkinje cells were comparable to those in lurcher mice.  Only the relative 
increase in ATG-mediated currents by application of 10 µM D-serine does not fit into the 
overall picture. Naur et al. (2007) demonstrated that D-serine reduce the GluRδ2
Lc
 currents 
with an EC50 of 182±11 µM. However, these results may be different in native GluRδ2, 
which share strong structural similarities with NMDARs, who's currents are also potentiated 
by D-serine application. 
Taken together, pharmacological experiments as well as the comparison of IV-relationships 
indicate that ATG activates the orphan receptor GluRδ2 in cerebellar Purkinje cells. On the 
other hand, GluRδ2 heterologously expressed in HEK cells as well as in Xenopus oocytes 
did not show ATG-mediated currents. This, however, seems to be a general problem for 
ATG-mediated currents. ATG-activation on heterologously expressed NMDAR compositions 
was not able to provoke membrane currents in HEK cells and only significantly smaller 
currents compared to glutamate- or NMDA-induced currents were observed after expression 
of NMDARs in Xenopus oocytes (Laprell et al. 2015b).  
The only way to ultimately prove an ATG specificity towards GluRD2 in Purkinje cells is to 
do the same experiments in a GluRD2 knockout animal, e.g. Hotfoot -Nancy. We are 
currently waiting for them to breed in the lab of our collaborator . These mice bear deletions 
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in the GluRδ2 encoding gene, lacking the channel pore and the ligand binding domain 
(Mendoza et al. 2010, Lalouette et al. 2001, Ady et al. 2014) . Lack of ATG-mediated 
currents in these mice would ultimately proof a GluRD2 specificity and would lead to the 
first ever published agonist of these receptors. 
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4.2 GluAzo and red-shifted GluAzo 
In 2007 Volgraf et al. published a reversible caged glutamate (GluAzo) for activation of 
ionotropic glutamate receptors (Volgraf et al. 2007). Studies in HEK cells expressing 
iGluR5 and iGluR6 showed that GluAzo is able to activate non-NMDA receptors with an 
EC50 of 9 µM under 500 nm and an approximately 10-fold reduced EC50 under 380 nm 
illumination. Furthermore, experiments with 25 µM GluAzo in dissociated rat hippocampal 
neurons revealed that GluAzo induces action potential firing in its dark adapted trans-
isoform and can be actively switched off using green light. Application of 10 µM DNQX, a 
selective non-NMDAR antagonist, was able to prevent light-induced action potential firing 
(Volgraf 2008).  
Further evaluation of GluAzo selectivity has not been undertaken. Therefore, experiments in 
acute murine coronal brain slice were performed using 25 µM GluAzo (Figure 7.1). 
Surprisingly, GluAzo induced action potential firing in its cis-isoform in contrast to previous 
results from dissociated rat hippocampal cells (Figure 7.1 B). Further experiments in whole-
cell voltage clamp mode showed that cis-GluAzo induced currents were significantly 
reduced by 50 µM D-AP5 (67.77±10.13 pA and 18.31±8.15 pA, respectively) (Figure 7.1 
C and D). These results indicate that GluAzo is more selective for NMDA receptors in acute 
brain slices as opposed to non-NMDA receptors in cultured neurons or HEK cells. This 
finding is further supported by the typical J-shaped IV-relationship induced by the Mg
2+
 
block in acute brain slices (Figure 7.1 E). As ATG was able to elicit light-dependent 
currents in cerebellar Purkinje cells, the same experiment was performed using GluAzo. In 
presence of 25 µM GluAzo inward-currents could be detected under 380 nm light 
(96.05±13.77 pA, n = 3 cells), however, considerable smaller than ATG-induced currents 
(see section 4.1.6). Similarly to ATG, these currents could not be blocked by application of 
1 mM MK-801 in the intracellular solution (75.89±10.18 pA, n = 3 cells). 
Since GluAzo showed similar functionalities to ATG, we tried to 'red -shift' this molecule in 
order to prevent UV-irradiation of the tissue. The same approach as for ATG was 
undertaken, i.e. attaching an additional dimethylamine group in para-position to the azo-
group (N=N) yielding rs-GluAzo (Figure 7.1 F). As previously for ATG, GluAzo-mediated 
activity was prevented by this modification (Figure 7.1 G).  
Taken together, these data demonstrate that in acute coronal brain slices GluAzo is a cis-
active NMDAR selective agonist and that it can activate cerebellar Purkinje neurons in a 
similar fashion as ATG. 
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Figure 7.1 - GluAzo is a selective cis-active NMDAR agonist in acute coronal brain slices. (A) 
Molecular structure of GluAzo in trans- and cis-configuration. Switching between the two states is 
achieved using 380 nm and 500 nm, respectively. (B) Current-clamp recording in a layer 2/3 cortical 
neuron. Light-dependent action potential firing occurs at 380 nm. (C) Whole cell voltage-clamp 
recording of a layer 2/3 cortical neuron displaying large inward currents at 380 nm, which can 
significantly reduced by application of the selective NMDAR antagonist, D -AP5. (D) Quantification of 
GluAzo experiments in absence and presence of D-AP5. (E) Current-voltage relationship of GluAzo 
under 380 nm light shows the typical J-shaped form due to Mg
2+
 block of NMDA receptors. (F) 
Molecular structure of rs-GluAzo in trans-configuration. (G) Lambda screen between 430 nm and 
510 nm in voltage-clamp mode showed no light-induced currents in layer 2/3 cortical neurons. 
Overlay of all 10 traces. 
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4.3  AzoChol ine 
Acetylcholine is an important neurotransmitter involved in a variety of neural functions such 
as movement and cognition (Kalamida et al. 2007, Lemoine et al. 2012). Acetylcholine 
receptors (AChRs) can be divided into two main classes, muscarinic and nicotinic AChRs 
(see section 1.1.4). Due to the large distribution and combinatorial diversity optical control 
of AChRs would be favorable. Therefore, acetylcholine was modified in such a way that it 
contains a light-switchable azobenzene moiety yielding AzoCholine (Damijonaitis et al. 
2015). AzoCholine is a freely diffusible PCL bearing not only resemblance to acetylcholine, 
but also to the α7 specific antagonist MG624 (Figure 8.1 A). Experiments in HEK cells 
revealed that AzoCholine specifically activates α7 nicotinic AChRs in its dark-adapted trans-
configuration and can be actively switched off using UV-light (Damijonaitis et al. 2015).  
More detailed information about the working mode of AzoCholine in neural networks was 
obtained in multielectrode recordings from acute hippocampal brain slice preparations 
(Figure 8.1 B). After mounting the brain slice, recordings were performed in presence and 
absence of 50 µM AzoCholine (Figure 8.1 C and D, respectively). To increase the baseline 
spiking activity the potassium concentration was increased to 7.5 mM. Before AzoCholine 
application no light-dependent spiking pattern was observed by switching between 370 nm 
and 440 nm light (Figure 8.1 G). After wash-in of AzoCholine the bursting pattern in 
hippocampal neurons followed the light stimulation protocol , i.e. an increase in spiking rate 
upon illumination with 440 nm light (Figure 8.1 C and E). As in the HEK cells experiments 
bursting was induced in trans-configuration and was suppressed by 370 nm illumination 
(n = 6 experiments, 173 with bursting cells) (Figure 8.1 E). Application of MG624 further 
revealed that AzoCholine is specifically activating α7 nicotinic AChRs in acute brain slice, 
as light-dependent bursting activity was prevented (Figure 8.1 D and F). Control 
experiments were done using brain slices not treated with AzoCholine and slices in the 
presence of AzoCholine, but without light stimulation. These experiments demonstrated that 
the observed effects were all due to light activation of α7 nicotinic AChRs (Figure 8.1 G 
and H).  
Taken together, these results demonstrate that AzoCholine is a promising tool for the light 
activation of α7 nicotinic AChRs. Besides the described experiments, Damijonaitis et al. 
(2015) further showed that AzoCholine is not only functional in brain slices ex-vivo, but that 
it also functions on rat primary afferent DRG neurons and effects thrashing behavior in 
C. elegans in-vivo (Damijonaitis et al. 2015). 
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Figure 8.1 - AzoCholine activates α7 nicotinic AChRs in acute hippocampal brain slices. (A) Molecular 
structures of Acetylcholine (1), AzoCholine (2) and MG624 (3). (B) Image of an acute hippocampal 
brain slice mounted on the 8x8 MEA. (C) MEA recording of an acute hippocampal brain slice. Top: 
Raster plot. Bottom: Histogram and light stimulation protocol. Switching between 370 nm and 
440 nm modulates bursting activity. (D) Same brain slice as in (C) in presence of 5 µM MG624. (E)-
(H) Analysis of MEA experiments. (E) in presence of 50 µM AzoCholine (n = 6 experiments, 173 
cells, p < 0.001, Student's t-test). (F) in presence of 50 µM AzoCholine and 5 µM MG624 (n = 6 
experiments, 121 cells, p > 0.05, Student's t-test). (G) in absence of AzoCholine (n = 6 experiments, 
103 cells, p > 0.05, Student's t-test) and (H) in presence of 50 µM AzoCholine without light 
stimulation (n = 4 experiments, 98 cells, p > 0.05 Student's t-test). The bursting activity was analyzed 
in Matlab for the whole light stimulation of 15 s for each wavelength. The circle size is related to the 
number of cells responding, i.e. a larger circle indicates a higher number of cells responding with the 
same bursting activities at 370 nm and 440 nm, and vice versa. Figure modified from (Damijonaitis 
et al. 2015). 
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*  Experiments performed by Dr. Ivan Tochitsky (Prof. Richard Kramer, University of California, Berkeley, USA) 
** Experiments performed with Dr. Kuldeep Kaur (Prof. Russell Van Gelder, University of Washington, Seattle, USA)  
5  Summary 
The experiments performed and the outcomes of this dissertation are summarized in the 
following four tables.  
 
Table 8 - Part 1: DAD, a photochromic potassium channel blocker for vision restoration 
 
 
 
First tests in acute 
coronal brain slices 
Patch-clamp in layer 2/3 cortical 
neurons 
DAD can be switched using blue 
light and blocks in the dark 
Pharmacology in acute 
coronal brain slices 
Patch-clamp in layer 2/3 cortical 
neurons 
DAD is a potassium channel blocker 
First tests in blind 
retinae (TKO) 
Multielectrode-array (MEA) 
recordings in blind retinae 
DAD activates the retina during light 
and is inactive in the dark 
Identification of target 
cell type (general) 
Pharmacology in blind retinae on 
MEA 
DAD specifically targets bipolar 
cells 
Identification of synaptic 
transmission pathways 
Patch-clamp experiments in whole 
mount preparations from blind 
retinae 
DAD utilizes the remaining retinal 
circuitry: Excitation via BC-RGC and 
inhibitory inputs via BC-amacrine 
cell-RGC signal transmission 
Experiments in different 
mouse models 
MEA recordings in five different 
mouse lines:  
1. TKO 
2. rd1/rd1, opn4
-/-
 
3. gnat1
-/-
,gnat2
-/-
, opn4
-/-
 
4. cnga3
-/-
, gnat1
-/-
, opn4
-/-
  
5. wt w/ and w/o L-AP4 and NBQX 
DAD only targets cell types in blind 
and degenerating retinae, healthy 
tissue is not affected. 
Light sensitivity* 
MEA recordings with light-intensities 
between 10
12
 and 10
16
 photons cm
-
2
 s
-1
 
DAD can be activated under bright 
daylight conditions, with blue and 
white light (10
14
 photons cm
-2
 s
-1
) 
Spatial precision* 
MEA recordings with increasing 
light spot size 
DAD can activate RGCs with small 
spot stimulation (30 µm)  
Temporal precision 
MEA recordings with increasing 
frequency of light stimulation 
DAD can follow 1 Hz light 
stimulation with a mismatch of only 
12 % 
Intravitreal injections 
MEA recordings after intravitreal 
injections in anaesthetized mice 
using different concentrations and 
different time points 
5-10 mM DAD activates blind retina 
2-8 hours post injection  
In-vivo behavioral 
experiments ** 
Intravitreal injection of 5 mM DAD 
and light-dark shuttle box test after 
2-6 hours 
DAD is capable of restoring light-
dependent visual responses to blind 
mice 
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Table 9 - Part 2: ATA, a photochromic AMPA receptor agonist for vision restoration 
 
 
 
Table 10 - Part 3: Combination therapy restores on- and off-light responses similar to wildtype 
Test of photoswitch 
combination in blind 
retinae 
Multielectrode-array (MEA) 
recordings in blind retinae
ATA and DAD restore transient light-
on and light-off responses in blind 
retinae similar to wildtype  
 
 
 
Table 11 - Part 4: Characterization of the NMDA receptor specific PLC, ATG, in acute murine brain 
slices 
Basic characterizations 
and  
wavelengths-screenings 
Patch-clamp in layer 2/3 cortical 
neurons 
ATG is a cis-active iGluR agonist 
that can be switched from trans- to 
cis- with 360 nm and with 420 nm 
from cis- to trans-configuration 
Pharmacology in brain 
slices 
Patch-clamp in layer 2/3 cortical 
neurons 
ATG is NMDA receptor specific 
Calcium imaging 
Patch-clamp and imaging in 
hippocampal neurons 
ATG can be combined with 
calcium imaging experiments 
Coincidence detection 
Patch-clamp in layer 2/3 cortical 
neurons 
ATG-activated NMDA receptors 
function as coincidence detectors 
2-P activation
†
 
Patch-clamp in hippocampal 
neurons 
ATG can be 2-P activated 
Single spine
†
 
Patch-clamp in hippocampal 
neurons 
ATG can be activated in a local 
precise manner  
First tests in 
dissociated neurons 
and acute hippocampal 
brain slices
#
 
Patch-clamp in hippocampal 
neurons 
ATA can be switched using blue light 
and is active in the dark 
Pharmacology in brain 
slices
#
 
Patch-clamp in hippocampal 
neurons 
ATA is an AMPA receptor specific 
agonist 
First tests in blind 
retinae (TKO) 
Multielectrode-array (MEA) 
recordings in blind retinae 
ATA activates the retina in the dark 
and is inactive during light 
application 
Identification of target 
cell type (general) 
Pharmacology in blind retinae on 
MEA 
ATA targets primarily amacrine cells 
and retinal ganglion cells 
Light sensitivity 
MEA recordings with different 
light-intensities 
ATA can be inactivated under bright 
daylight conditions, with blue and 
white light (10
14
 photons cm
-2
 s
-1
) 
Intravitreal injections
##
 
MEA recordings after intravitreal 
injections in anaesthetized mice 
using different concentrations and 
different time points 
1 mM ATA activates blind retina 2-8 
hrs post injection 
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7  Appendix 
7.1 Matlab scripts 
7.1.1 Raster plot and photoswitch index 
source_directory = uigetdir('C:\ '); 
%source_directory='WTF2'; 
  
%get the filenames of all files in the directory 
d=dir(source_directory); 
  
  
names=strvcat(d.name); 
%strvcat=string vertical catination 
%the first two filenames are not informative (Matlab stuff) 
num_files=size(names,1)-2; %how many files do I have 
  
file_counter=1:num_files; 
  
for file_counter=1; 
    %substract 2 to get rid of Matlab/Windows-based two first file names; 
    %names,1 takes only the first dimension of the names (get nur, wenn alle 
filenames wirklich exakt gleich lang sind!) 
     
    %build the filename including path as a sting 
    filename=[source_directory '\' deblank(names(file_counter+2,:))]; 
    %try to open the file 
    %file identifier (fid) 
    fid=fopen(filename); %looks, if file exists; positive/negative file identifier 
    %read the first line 
    header=fgetl(fid); 
    %read in the spike times 
    [spt, count]=fscanf(fid,'%f'); 
    fclose(fid); 
    %plot the spike times as rasterplot using spt as x-values and always the 
    %same y-value depending on the counter 
    max_data=spt; 
    [maxdur, ind] = max(max_data); 
     
end 
  
%maxdur=input('for how many seconds did you record? '); 
%define matrix for photoswitch values calculated in each loop 
PI=[]; 
  
%define start and end point for PI calculation here 
  
PI1_100ms = input ('Start calculation before light at [sec] '); 
PI2_100ms = input ('End calculation before light at [sec] '); 
%PI3=PI2 = input ('Start calculation with light at '); 
%PI3_100ms=PI2_100ms; 
PI3_100ms = input ('Start calculation with light at [sec] '); 
PI4_100ms = input ('End calculation with light at [sec] '); 
  
%we have 10 zeros before the histogram starts to make it fit better to the 
%graph. we therefore need to add 10 for the calculation of the PI. 
  
PI1=PI1_100ms*10+10; 
PI2=PI2_100ms*10+10; 
PI3=PI2; 
PI4=PI4_100ms*10+10; 
  
%how do I tell my computer that I mean the time axis? 
  
%predefine a figure for the rasterplot 
fh=figure; 
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%define the axis 
ah=axes; 
axis ij; 
set(ah,'fontsize', 14,'xlim',[-1 maxdur+1],'ylim' ,[0 num_files+1]) 
xlabel ('Time [sec]'); 
ylabel ('cell #'); 
  
hold on 
  
%define empty matrix for the summary spike times 
sum_spt=[]; 
mean_dark_end=[]; 
mean_light_end=[]; 
  
% in this cell array all spt are saved as indivudial rows, not concatenated 
spikes=cell(file_counter,1); 
  
%make edges for histogramm (100ms steps) 
hist_edges=-1:0.1:maxdur+1; 
  
  
for file_counter=1:num_files; 
    %substract 2 to get rid of Matlab/Windows-based two first file names; 
    %names,1 takes only the first dimension of the names (get nur, wenn alle 
filenames wirklich exakt gleich lang sind!) 
     
    %build the filename including path as a sting 
    filename=[source_directory '\' deblank(names(file_counter+2,:))]; 
    %try to open the file 
    %file identifier (fid) 
    fid=fopen(filename); %looks, if file exists; positive/negative file identifier 
    %read the first line 
    header=fgetl(fid); 
    %read in the spike times 
    [spt, count]=fscanf(fid,'%f'); 
    fclose(fid); 
    %plot the spike times as rasterplot using spt as x-values and always the 
    %same y-value depending on the counter 
     
    xdata=spt; 
     
    %put all spike times (spt) in one matrix; concatenate matrix next to each other; 
    % this does not work because of different number of spike times... 
    % sum_spt=[sum_spt spt]; 
     
    %make histogram for calcuation of PI 
    hist=histc(spt, hist_edges); 
    %calculate PI from hist 
    Mean_Dark=mean(hist(PI1:PI2)); 
    Mean_Light=mean(hist(PI3:PI4)); 
    PI_value=((Mean_Light)-(Mean_Dark))/((Mean_Light)+(Mean_Dark)); 
    PI=[PI;PI_value]; 
     
    sum_spt=[sum_spt;spt]; 
     
    mean_dark_end=[mean_dark_end;Mean_Dark]; 
    mean_light_end=[mean_light_end;Mean_Light]; 
     
    %add all spt to individual row in cell array. 
    spikes{file_counter}=spt; 
     
    %create a vector with 1 with exactly the same size as spt 
   %{ 
    ydata=file_counter*ones(size(spt)); 
    ph=plot(xdata,ydata,'k.'); 
    set (ph, 'markersize', 4); 
    %} 
      ydata=file_counter*ones(size(spt)); 
    ph=plot(xdata,ydata,'ko'); 
    set (ph, 'markersize', 1.5,'linewidth',1.2); 
     
end 
  
%calculate the PI by averaging the PI values the individual cells. 
PI=PI(~any(isnan(PI),2),:); 
PI_mean=mean(PI) 
  
%calculate the PI by taking the average spiking rates of all cells (should 
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%be similar.) The difference results from the deletion of single NaN in the 
%PI determination using (PI=PI(~any(isnan(PI), 2), :)). This does not 
%happen for mean_values! 
mean_spikes_light=mean(mean_light_end); 
mean_spikes_dark=mean(mean_dark_end); 
PI_spikes=((mean_spikes_light)-
(mean_spikes_dark))/((mean_spikes_light)+(mean_spikes_dark)) 
  
  
%figure 
%bar(hist_edges,spt_hist); 
%bar(hist_edges,hist); 
%set (gca, 'fontsize' ,14,'xlim', [-1 maxdur+1]); 
  
%now calculate the histogram 
% be careful, this is the event number over all channels. more channels 
% means more events. this is not the frequency!!! frequency will be: 
% #events/#cells --> therefore I introduce 'freq', which divides the 
% #events/#cells. 
spt_hist=histc(sum_spt,hist_edges); 
%spt_hist=histc(b,hist_edges); 
freq=spt_hist./num_files; 
[freq_max,ind] = max(freq); 
  
  
figure 
%bar(hist_edges,spt_hist); 
bar(hist_edges,freq, 'k'); 
set (gca, 'fontsize' ,14,'xlim', [-1 maxdur+1], 'ylim', [0 10]); 
ax2 = gca; 
  
%the next section is needed, if the light stimulus protocol was added to the 
%workspace before. In that case, the light stimulus protocol will be 
%applied to the graph 
  
hold on; 
plot (Ts, Bit0); 
hold off; 
 
%create a new figure for subplots --> this will be the final figure 
h3 = figure;  
s1=subplot ('position', [0.15 0.4 0.8 0.55]); 
set(gca,'fontsize', 14,'xlim',[-1 maxdur+1],'ylim' ,[0 num_files+1], 'XTickLabel', 
[]); 
%set(gca,'fontsize', 14,'xlim',[60 80],'ylim' ,[0 num_files+1], 'XTickLabel', []); 
grid on; 
%ax = copyobj(gca, gcf); 
%set(ax,'color','none','xgrid','off', 'xcolor','k', 'ygrid','off', 'ycolor','k'); 
%set(gca,'Xcolor','r'); 
%set(gca,'Ycolor','r'); 
ylabel ('cell #') 
s2=subplot ('position', [0.15 0.1 0.8 0.25]); 
set (gca, 'fontsize' ,14,'xlim', [-1 maxdur+1], 'ylim', [0 freq_max+1]); 
%set (gca, 'fontsize' ,14,'xlim', [60 80]); 
xlabel ('Time [sec]');  
fig1 = get (ah, 'children'); 
fig2 = get (ax2, 'children'); 
ylabel ('#spikes/100ms'); 
grid on; 
%set(gca,'Xcolor','r'); 
%set(gca,'Ycolor','r'); 
  
%Caxes = copyobj(gca, gcf); 
%set(Caxes, 'color', 'none', 'xcolor', 'k', 'xgrid', 'off', 'ycolor','k', 
'ygrid','off'); 
copyobj (fig1, s1); 
copyobj (fig2, s2); 
  
close Figure 1; 
close Figure 2; 
 
%Make population plot for PI values; 
  
op10=PI(PI>0.8 & PI<1); 
num10=numel(op10); 
op9=PI(PI>0.6 & PI<0.8); 
num9=numel(op9); 
op8=PI(PI>0.4 & PI<0.6); 
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num8=numel(op8); 
op7=PI(PI>0.2 & PI<0.4); 
num7=numel(op7); 
op6=PI(PI>0.0 & PI<0.2); 
num6=numel(op6); 
op5=PI(PI>-0.2 & PI<0); 
num5=numel(op5); 
op4=PI(PI>-0.4 & PI<-0.2); 
num4=numel(op4); 
op3=PI(PI>-0.6 & PI<-0.4); 
num3=numel(op3); 
op2=PI(PI>-0.8 & PI<-0.6); 
num2=numel(op2); 
op1=PI(PI>-1 & PI<-0.8); 
num1=numel(op1); 
  
%define maximum in cell distribution to use it for plotting 
num_arr = [num1, num2, num3, num4, num5, num6, num7, num8, num9, num10]; 
[maximum,ind] = max(num_arr); 
num_dist=[num1;num2;num3;num4;num5;num6;num7;num8;num8;num9;num10]; 
  
figure 
  
bar(num_dist, 0.6, 'k', 'EdgeColor',[1,0.5,0.5], 'LineWidth', 2); 
set(gca,'XTickLabel',{'-1','-0.8','-0.6','-0.4','-
0.2','0','0.2','0.4','0.6','0.8','1'}); 
grid on; 
  
%use maximum here to plot cell distribution +5 
ylim ([0 (maximum+5)]); 
  
display (PI_mean); 
 
7.1.2 Find peaks 
%first determine the 4xSD and set this as 'minpeakheight', in case of unstable 
baseline use larger SD. Depending on the light stimulation protocol, i.e. the 
frequency define the 'minpeakdistance'. For 0.2 Hz > 4500 ms, for 0.5 Hz > 1500, for 
1 Hz > 750 ms and for 2 Hz > 450 ms. 
  
[pks,locs]=findpeaks(freq,'minpeakheight',1.3,'MinPeakDistance', 50); 
 
plot (freq)  % freq needs to be calculated before using the raster plot script 
hold on 
plot(locs,pks,'ro'); 
 
 
% the peaks found need then to be compared to the light stimulation protocol. A time 
delay between the light stimulation can be determined, depending on the light 
stimulation frequency. Further analysis of peaks found and the stimulation protocol 
was performed in Microsoft excel. An automatic script still need to be written. 
 
7.1.3 On- versus Off-activity distribution 
%first the PI-values need to be determined for the light-on time frame and for the 
light-off time frame using the raster plot script. These need to be saved separately 
named PI_on and PI_off, respectively. 
 
index_on = find(PI_on >0.1 & PI_on <=0.99); 
index_off = find(PI_off>0.1 & PI_off <=0.99); 
  
%index_on = find(PI_on <-0.1 & PI_on >=-0.99); 
%index_off = find(PI_off <-0.1 & PI_off >=-0.99); 
  
X_on=ismember (index_on, index_off); 
X_off=ismember (index_off, index_on); 
  
X_on_sum=sum(X_on); 
X_off_sum=sum(X_off); 
  
only_on=size (index_on,1) - X_on_sum 
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only_off=size (index_off,1) - X_off_sum 
both=X_on_sum 
  
PI_mean_on=mean(PI_on); 
PI_mean_off=mean(PI_off); 
PI_compare=PI_mean_on/PI_mean_off 
  
%vertically concatenate index_on and off  
    X=vertcat(index_on, index_off); 
 %find all unique values and keep the duplicates in X. 
 uniqueX = unique(X); 
 countOfX = hist(X,uniqueX); 
 indexToRepeatedValue = (countOfX~=1); 
 repeatedValues = uniqueX(indexToRepeatedValue) 
  
%Quotient der PI/Werte von allen Zellen, die eine on und off response haben 
Quotient = (PI_on(:,1)./PI_off(:,1)); 
extract_quotient=Quotient((repeatedValues),:) 
  
figure 
  
bar(extract_quotient, 0.6, 'k', 'EdgeColor',[1,0.5,0.5], 'LineWidth', 2); 
ylim ([0 (5)]); 
 
7.1.4 Correlation plots 
% For the correlation plots the histograms of each channel need to be transferred to 
IGOR Pro; the time frame for the correlation analysis need to be copied into Matlab 
and named 'set_of_histograms' 
  
set_of_histograms( :, all( ~any( set_of_histograms ), 1 ) ) = []; % delete all 
histograms that cotain only zeros 
  
[rho, p] = corrcoef( set_of_histograms); 
%significant p-values [R,P]=corrcoef(...) also returns P, a matrix of 
%p-values for testing the hypothesis of no correlation. Each p-value is the 
%probability of getting a correlation as large as the observed value by 
%random chance, when the true correlation is zero. If P(i,j) is small, say 
%less than 0.05, then the correlation R(i,j) is significant. 
  
  
%Visulisation 
  
imagesc(rho); 
colormap('jet);colorbar; 
image(rho); 
colormap('gray');colorbar; 
  
imshow(rho); 
colormenu;colorbar %a colormap menu is added to your figure 
  
spy(rho) 
  
  
[i,j] = find(p<0.05);  % Find significant correlations. 
  
  
%calculatate percentage of statistically significant correlations 
  
A=size(set_of_histograms,2); 
  
max=A*A; %maximale Anzahl aller Korrelationen 
  
xpercent=(100/max)*size(i,1) 
  
  
imagesc(p); 
colormap('jet);colorbar; 
  
image(p); 
colormap('gray');colorbar; 
  
imshow(p); 
colormenu;colorbar %a colormap menu is added to your figure 
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